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Abstract 
  
In Saccharomyces cerevisiae, Gpx3 is a H2O2 sensor that resides in the cytosol, the 
mitochondrial intermembrane space (IMS) and the peroxisomal matrix. Upstream 
translation from a non-AUG codon after exposure to H2O2 results in production of an N-
terminally extended form, N18Gpx3, that targets the protein to mitochondria in a more 
efficient manner. Whilst the major role of Gpx3 in the cytosol is known, notably its 
interaction with (and activation of) the transcription factor Yap1, the role/s of Gpx3 and 
N18Gpx3 in the mitochondrial IMS and peroxisomal matrix are yet to be fully determined. 
Previous work published by our lab and collaborators identified the oxidoreductase 
Mia40 as an interactor of Gpx3; however, others were anticipated. Here, we identified 
two new putative IMS interactors of Gpx3: Cytochrome c (Cytc) and Cytochrome b2 
(Cytb2). Cytc is an abundant electron carrier in the IMS that plays a role in both 
respiration and the mitochondrial IMS assembly (MIA) oxidative folding pathway, and in 
mammals Cytc is also involved in triggering apoptosis. In contrast, little is known about 
Cytb2. We focused our attention on the potential Gpx3-Cytc interaction and found that by 
mutating Cys64 of Gpx3, a highly conserved cysteine residue with no known function, its 
interaction with Cytc was affected. As both Mia40 and Cytc are components of the MIA 
pathway, we hypothesise that Gpx3 plays a role in oxidative folding and may be a 
regulator of this pathway under oxidative stress. Next, we uncovered six small proteins 
with no previous mitochondrial associations and went on to investigate one in particular, 
Ypl107w, an uncharacterised protein containing a highly conserved oxidoreductase-like 
domain (OXLD) that, despite being present in thousands of proteins across hundreds of 
species, has an unknown function. We confirmed its targeting and localisation to the 
mitochondrial matrix and hypothesise, based on bioinformatics and BN-PAGE data, that 
Ypl107w has many interactors and may be involved in mitochondrial assembly. There may 
also be a link between Ypl107w, Gpx3 and Cytc as ypl107wD mitochondria have lower 
amounts of both Gpx3 and Cytc. Finally, we confirmed the presence of Gpx3 in 
peroxisomes and discovered a shorter version of Mia40 along with Trx1 and Trx2 also 
residing in peroxisomes. We hypothesise that the targeting of these proteins occurs by 
previously unrecognised peroxisomal targeting signals, and that the MIA pathway may 
operate in both mitochondria and peroxisomes. Altogether, the work presented in this 
thesis adds to our knowledge of yeast Gpx3 in regards to its compartment-specific roles. 
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1. Introduction 
  
1.1. Mitochondria 
  
In the final decade of the nineteenth century, the first account of mitochondria was 
documented by a German pathologist, Richard Altmann, who originally referred to them 
as “bioblasts” (Altmann, 1890). Altmann believed that these organelles were self-
governing living organisms present within cells which were capable of performing cellular 
functions. Eight years later they were renamed mitochondria (Benda, 1898). After more 
than a century’s research, mitochondria are now widely accepted to have arisen as a 
result of an endosymbiotic event whereby a proteobacterium entered a eukaryotic cell 
sparking a series of evolutionary steps which led to their progressive integration (Roger et 
al., 2017). They are also now known to be involved in a multitude of intra- and extra-
cellular functions (Spinelli and Haigis, 2018). One very well-known and important function 
is mitochondrial respiration, a series of metabolic reactions which generates adenosine 
triphosphate (ATP) at the final step of oxidative phosphorylation (OXPHOS); this ATP is 
then used to drive many diverse cellular processes (Smeitink et al., 2001). Other functions 
include calcium homeostasis, synaptic homeostasis, apoptosis, production of reactive 
oxygen species (ROS), cell signalling, and iron-sulphur (Fe/S) cluster biogenesis, but this is 
by no means an exhaustive list (Joza et al., 2001; Finkel, 2012; Kallergi et al., 2014; Lill et 
al., 2014; Picard et al., 2015; Pathak and Trebak, 2018).  
 
The most fundamental milestones in mitochondrial research underpinning what we know 
today were made in the mid 20th century. In 1937, Krebs and Johnson discovered the 
tricarboxylic acid (TCA) cycle (also known as the Kreb’s or citric acid cycle) that was later 
found to occur within mitochondrial isolates (Kennedy and Lehninger, 1947; Schneider, 
1948). Then in 1953, the first electron microscope images of mitochondria revealed their 
classic rod-like structure comprising two lipid bilayers: a smooth outer membrane and a 
transverse, irregular inner membrane (Sjöstrand, 1953; Palay and Palade, 1955). Ten 
years on, mitochondria were found to contain their own circular DNA (mtDNA) which was 
entirely separate from the cells nuclear genome; however, the mtDNA itself only encodes 
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~15% of all mitochondrial respiratory complex subunits – 13 in humans and 8 in yeast 
(Nass and Nass, 1963; Clayton and Vinograd, 1967; Chacinska et al., 2009). Furthermore, 
to carry out their extensive range of functions mitochondria require approximately 1000-
1500 proteins depending on the organism, of which 99% are encoded by the nuclear 
genome and are synthesised on cytosolic ribosomes (Chacinska et al., 2009). Of course, 
this then raised many important questions regarding the targeting and import of these 
proteins into mitochondria.  
  
1.2. Mitochondrial biogenesis 
  
As the majority of mitochondrial proteins are translated in the cytosol, they must be 
correctly targeted, imported, sorted and folded into their specific mitochondrial 
subcompartment. The next sections describe the structure of mitochondria and discuss 
the many sophisticated protein import pathways that govern these crucial events. As S. 
cerevisiae has been the most commonly used model organism to identify mitochondrial 
protein import pathways, the following sections refer to S. cerevisiae unless otherwise 
stated. Although, the pathways are generally well conserved from yeast to mammals. 
  
1.2.1. Mitochondrial structure 
  
Four mitochondrial subcompartments exist: the outer membrane (OM), the inner 
membrane (IM) which form folds known as cristae, and two enclosed aqueous 
subcompartments, one entirely sealed by the IM, known as the matrix, and the other 
sealed by both the OM and the IM, known as the intermembrane space (IMS) (Figure 1.1). 
Although the OM and IM are both phospholipid bilayers, they differ from each other in 
terms of both phospholipid and protein content which reflect their distinct functions. The 
OM contains small channels, including the major voltage-anion dependent channel (VDAC, 
also known as porin), that permit the diffusion of small molecules up to 5000 Da in size 
(Becker and Wagner, 2018). Whereas the IM has a much tighter structure that consists of 
three times more cardiolipin (CL) than the OM and is impermeable to small molecules 
(Houtkooper and Vaz, 2008). Proteins of the OM are largely involved in the entry of all 
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mitochondrial proteins from the cytosol as well as fusion/fission events. Whereas the IM 
plays a major role in respiration as it harbours all of the respiratory chain complexes 
whilst also containing some protein import machineries - the final entry gates to the 
matrix (Wiedemen and Pfanner, 2017). Matrix proteins are largely involved in Fe/S cluster 
biogenesis and cellular respiration (Lill, 2009; Lill et al., 2014). Finally, IMS proteins play 
important roles in redox regulation, oxidative folding and apoptosis (Joza et al., 2001; 
Vögtle et al., 2012; Kritsiligkou et al., 2017). The ratio of mitochondrial proteins across the 
OM, IMS, IM and matrix is roughly 1:4:1:4, with fourfold more proteins present in the IMS 
and the matrix in comparison to the OM and IM (Calvo et al., 2017; Morgenstern et al., 
2017). 
 
 
 
 
 
 
  
Figure 1.1. Structure of a mitochondrion. OM – outer membrane; IM – inner membrane; 
IMS – intermembrane space. The matrix is enclosed by the IM; the IMS by the OM and IM. The 
panel on the right is a cryo-electron tomography image of a mouse heart mitochondrion taken 
from Brandt et al. (2017).  
 
1.2.2. Outer membrane protein translocation 
  
All precursors arrive at the OM and must translocate through in order to reach any one of 
the mitochondrial subcompartments. Up until recently, only one OM protein import 
channel had been characterised – the translocase of the outer membrane (TOM) – which 
is thought to act as the main entry gate (Neupert and Herrmann, 2007; Dudek et al., 
2013). However, new OM channels are being discovered; one of which has already been 
shown to be capable of importing proteins - the MIM channel (Krüger et al., 2017; 
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Checchetto and Szabo 2018). Regardless of which channel precursors enter, specific 
chaperones are first required to keep precursors in an import-competent state, i.e. by 
preventing misfolding and aggregation, and to carry them to the OM where they will be in 
close proximity to OM receptors (Komiya et al. 1997, Chacinska and Rehling, 2004). At this 
stage, the OM receptors recognise some of the mitochondrial targeting signals (MTSs) 
present within precursor proteins that begin to dictate which pathways they will use in 
order to reach their final destination (Mossmann et al., 2012; Melin et al., 2014). Two 
thirds of mitochondrial proteins contain classical N-terminal α-helical signals that are 
usually cleaved upon import (Vögtle et al., 2009), but there are many others, including 
internal signals, that will be discussed throughout Section 1.2.  
  
The TOM complex 
Seven subunits make up the TOM complex: three receptors – Tom20, Tom22 and Tom70 
that interact with incoming precursors on the cytosolic side; the main pore forming 
subunit Tom40; and three non-essential smaller subunits (Tom5, Tom6 and Tom7) that 
also make up the main pore-forming core (Dietmeier et al., 1997; Dekker et al., 1998; Hill 
et al., 1998; Sherman et al., 2005; Neupert and Herrmann 2007; Shiota et al., 2015). 
Although Tom20 and Tom70 exhibit their own preference for substrates, they are both 
anchored to the OM via their N-terminal regions, with hydrophilic domains exposed to 
the cytosol that are responsible for recognising precursors. Their main difference lies in 
how they recognise their precursors as the cytosol-exposed domain of Tom20 contains a 
groove that binds hydrophobic residues within MTSs, whereas Tom70 recognises internal 
targeting signals (Abe et al., 2000; Chan et al., 2006). Tom22 is entirely different in the 
sense that it has two domains exposed either side of the OM – a cytosol-exposed, 
negatively charged N-terminal domain, and an IMS-exposed, negatively charged C-
terminal domain (van Wilpe et al., 1999). Upon entering the TOM complex, proteins are 
then sorted based on their final destination.  
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The SAM complex 
For β-barrel proteins that are for insertion into the OM, the SAM complex (the Sorting 
and Assembly Machinery) is required (Neupert and Herrmann, 2007). Precursors move 
from TOM to SAM via the Tim9/Tim10 chaperone complex (Höhr et al., 2015). Three 
subunits make up the SAM complex: the essential main subunit Sam50 with its C-terminal 
β-barrel domain embedded in the OM and an IMS-exposed N-terminal hydrophilic 
domain; and two entirely cytosol-exposed hydrophilic subunits, Sam35 and Sam37, of 
which only Sam35 is essential (Wiedemann et al., 2003; Chan and Lithgow, 2008). Unlike 
the majority of precursors, OM proteins that follow the SAM pathway do not contain N-
terminal presequences. Instead, they harbour internal hydrophobic β-hairpin motifs that 
are recognised by Tom20 upon entry to mitochondria (Jores et al., 2016). 
  
The MIM complex 
For α-helical proteins that are to be inserted into the OM, the newly discovered 
mitochondrial import (MIM) complex is required (Checchetto and Szabo, 2018). Two 
subunits make up the MIM complex: Mim1 and Mim2. Mim1, a small 13 kDa OM protein, 
was found to promote the import of these proteins (Becker et al., 2008; Becker et al., 
2011; Papic et al., 2011), and was later shown to form a channel with a predicted α-helical 
structure (Krüger et al., 2017). Mim1 also has a cytosol-exposed N-terminal domain and 
an IMS-exposed C-terminal domain (Popov-Celeketić et al., 2008). This is in contrast to 
the TOM and SAM complexes which both have β-barrel structures (Hill et al., 1998; 
Neupert and Herrmann, 2007). Mim2 has been shown to physically interact with Mim1, 
and its absence causes defects in the TOM complex, import of OM proteins, and 
mitochondrial morphology (Dimmer et al., 2012), but the actual mechanism of the MIM 
pathway is still unknown. Furthermore, it is unlikely that all of the OM pathways have yet 
been discovered as there are more recently identified channels that have yet to be 
characterised, such as Ayr1 (Krüger et al., 2017). A summary of all the known OM import 
channels is shown in Figure 1.2. 
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Figure 1.2. Mitochondrial outer membrane import pathways. β-barrel OM precursors 
enter the TOM complex via Hsp chaperones then travel to the SAM complex via the chaperone 
complex Tim9/Tim10 (the β-barrel pathway). Arrows with question marks are present next to the 
MIM pathway that inserts α-helical proteins as the exact mechanism has yet to be elucidated. OM 
– outer membrane; IMS – intermembrane space; Hsp – Heat-shock proteins 70 or 90. See Section 
1.2.2 for detailed descriptions. 
  
1.2.3. Matrix and inner membrane protein import 
  
Upon entry into the IMS, proteins that are destined to the matrix follow the matrix 
pathway that takes precursors through the TIM23 complex assisted by PAM, the 
presequence translocase-associated motor. Those that are destined to the IM follow one 
of two pathways: the stop-transfer pathway or the carrier pathway that utilise the two 
translocases of the inner membrane, TIM22 and TIM23, respectively (Neupert and 
Herrmann, 2007). Another IM complex exists, OXA, the oxidase assembly translocase, 
which is involved in exporting mitochondrial encoded proteins from the matrix to the IM 
(Wiedemen and Pfanner, 2017). OXA has also been implicated in the import of nuclear 
encoded IM proteins (Stiller et al., 2014), but this is still debated and will not be discussed 
here. This section discusses the roles of the TIM23, TIM22, and PAM complexes in the 
import of matrix and/or IM proteins. 
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The TIM23 complex 
The TIM23 complex comprises its main pore-forming channel, TIM23 that comprises two 
subunits, Tim23 and Tim17; Tim50; Tim21; and its motor, the presequence-associated 
motor (PAM) which comprises three subunits – Tim44, Tim14 and Tim16 (Backes and 
Herrmann, 2017). Both Tim23 and Tim17 have IMS-exposed N-terminal domains but with 
slight differences; Tim23’s has a coiled-coil domain that is involved in substrate binding 
and dimerisation and can stretch across to the OM (Bauer et al., 1996; Donzeau et al., 
2000), whereas Tim17’s is shorter and contains conserved negatively charged residues 
and is involved in gating of the channel (Meier et al., 2005; Martinez-Caballero et al., 
2007). Tim50 exposes a large domain to the IMS where it interacts with precursors in the 
IMS bringing them closer to the main pore of the channel (Geissler et al., 2002; 
Yamamoto et al., 2002), and is involved in controlling the gating of the channel 
(Mokranjac et al., 2009; Schulz et al., 2011; Bajaj et al., 2014). Lastly, Tim21 has been 
shown to interact with the IMS-exposed domain of Tom22, one of the TOM channel 
receptors, and is only required for the import of IM embedded proteins (Chacinska et al., 
2005; Mokranjac et al., 2005). To drive proteins into the IM through the TIM23 complex, 
membrane potential ∆Ψ is required; but for the complete import of precursors through to 
the matrix, the ATP-powered PAM motor is additionally required. The Tim17 subunit of 
TIM23 is involved in switching between TIM23 and TIM23-PAM, and has regions that 
directly bind to PAM (Chacinska et al., 2005; Demishtein- Zohary et al., 2017). 
  
The PAM motor 
PAM comprises five subunits: the main component Tim44 that harbours a binding site for 
the matrix localised mitochondrial Hsp70 chaperone, mtHsp70 (also known as Ssc1); two 
DnaJ-like proteins – Tim14 and Tim16 – that regulate mtHsp70 binding to precursors; and 
two mtHsp70 co-chaperones - Mge1 and Mdj1 (Backes and Herrmann, 2017). Tim44 also 
has a hydrophobic binding site that binds precursors upon their entry to the matrix 
(Josyula et al., 2006). Precursors are then pulled through via the mtHsp70 chaperone, 
Ssc1, upon hydrolysis of Ssc1’s N-terminal ATPase domain (Kang et al., 1990; Voos et al., 
1993; Liu et al., 2001). Mge1, a nucleotide release factor, facilitates ADP release from Ssc1 
after substrates enter the matrix which are then correctly folded by a complex consisting 
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of Ssc1/Mdj1/Mge1 (Horst et al., 1997). However, despite this knowledge the full 
mechanistic details of how PAM functions is still to be fully uncovered, and many models 
exist for how mtHsp70 pulls precursors through (Backes and Herrmann, 2017; Craig, 
2018). Once precursors enter the matrix, their mitochondrial presequences are usually, 
but not always, cleaved by MPP (the matrix processing peptidase) (Braun and Schmitz, 
1997). Precursors that laterally enter the IM after entering the TIM23 complex are also 
cleaved by MPP if their N-terminal presequences are exposed. The matrix import pathway 
is depicted in Figure 1.3. 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1.3. Mitochondrial matrix protein import pathway. Matrix precursors follow the 
matrix pathway whereby precursors cross the OM and are pulled through the TIM23-PAM 
complex. Ssc1 represents the major mitochondrial Hsp70 which, along with its co-chaperones 
(Mdj1 and Mge1), helps to refold proteins as they enter the matrix. Some N-terminal 
mitochondrial targeting presequences are cleaved by MPP upon entry/exposure to the matrix. 
OM – outer membrane; IMS – intermembrane space; IM – inner membrane; Hsp – heat-shock 
proteins 70 or 90. See Section 1.2.3 for detailed descriptions. 
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The TIM22 complex 
Three subunits make up the TIM22 complex: Tim22, which forms the main core; and two 
accessory subunits - one essential, Tim18, and the other non-essential, Tim54 (Sirrenberg 
et al., 1996; Kerscher et al., 1997; Kovermann et al., 2002). An additional subunit, Tim29, 
exists but is specific to metazoan TIM22 complexes (Callegari et al., 2016; Kang et al., 
2016). Akin to the TOM and SAM complexes, chaperone proteins are also required to 
bring precursors to the TIM22 complex whilst preventing them from aggregation – these 
are the small TIMs of the IMS, including Tim8, Tim9, Tim10, Tim12 and Tim13 (Kovermann 
et al., 2002; Truscott et al., 2002; Koehler, 2004; Vergnolle et al., 2005; Webb et al., 2016). 
The small TIMs contain CX3C motifs that form hetero-oligomeric protein complexes that 
recognise and bind to hydrophobic regions on precursors. After precursors are ‘carried’ to 
the TIM22 complex, they are inserted into the IM, thus this pathway is known as the 
carrier pathway. IM insertion via the TIM22 complex requires the mitochondrial inner 
membrane potential (denoted ∆Ψ) (Dyall et al., 2003). Figure 1.4 summarises the import 
pathways for IM targeted proteins. 
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Figure 1.4. Mitochondrial inner membrane protein import pathways. IM precursors can 
follow one of two pathways: the carrier pathway whereby precursors cross the OM and are 
carried to the TIM22 complex via hetero-oligomeric small Tim complexes, and then laterally 
inserted into the IM; or by the stop transfer pathway whereby precursors cross the OM and are 
pulled through the TIM23 complex followed by lateral insertion in the IM. OM – outer membrane; 
IMS – intermembrane space; IM – inner membrane; Hsp – heat-shock proteins 70 or 90. See 
Section 1.2.3 for detailed descriptions. 
  
1.2.4. Intermembrane space protein import 
  
IMS proteins can follow one of four known import pathways: (i) a variation of the TIM23 
stop-transfer pathway whereby precursors are released into the IMS from the IM; (ii) a 
direct ‘non-conservative’ import pathway into the IMS after entry via the TOM channel; 
(iii) a co-factor driven import pathway into the IMS by co-factor binding after entry via 
TOM; and (iv), an oxidative folding import pathway mediated by Mia40 in the IMS (Glick 
et al., 1992; Steiner et al., 1995; Mordas and Tokatlidis, 2015; Manganas et al., 2017). 
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The IMS stop-transfer pathway 
IMS precursors containing bipartite presequences (N-terminal MTSs followed by a 
hydrophobic region), such as Cytochrome c (Cyt c, isoform 1) and Cytochrome b2 (Cyb2), 
are imported via the stop-transfer pathway (Glick et al., 1992), similar to the one 
described in Section 1.2.3. The difference being that after entering the TIM23 channel 
their hydrophobic sequences cause an arrest that then allows an IMS protease (IMP or 
Pcp1), to cleave off their presequences, releasing precursors into the IMS (Nunnari et al., 
1993; Esser et al., 2002; McQuibban et al., 2003). 
  
The direct import pathway 
Unlike the IMS stop-transfer pathway, the direct import pathway is a one-step route that 
does not require the IM; example proteins include the two Cytc heme lyases, CCHL and 
CC1HL (Steiner et al., 1995). Precursors are recognised by two TOM receptors – Tom20 
and Tom22 – and enter the IMS through the TOM channel (Mayer et al., 1995; Künkele et 
al., 1998; Kiekert et al., 1999). As the IM is not needed in this pathway, neither ∆Ψ nor 
ATP is required; nor are any Hsp chaperones (Steiner et al., 1995). A conserved internal 
targeting signal within CC1HL was found to be necessary for its targeting and import 
(Diekert et al., 1999).  
  
The co-factor import pathway 
The co-factor import pathway was uncovered when determining the import of an 
apoprotein, apocytochrome c, which like the direct import pathway, does not involve the 
IM (Diekert et al., 2001). However, instead of precursor recognition by the TOM receptors, 
Tom40 itself was required for substrate interaction, followed by an interaction with the 
IMS heme lyase CCHL that then covalently attaches its heme group creating a fully folded 
Cytc. No targeting signals have been found within apocytochrome c.  
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The MIA pathway 
The MIA oxidative folding pathway differs from all other import pathways as it is the only 
one that results in the covalent modification of precursors; this being the introduction of 
disulphide bonds (Mordas and Tokatlidis, 2015). IMS precursors following this pathway 
contain internal, non-cleavable targeting signals, known as either ITS or MISS, that are 
usually nine amino acids in length which are recognised by the redox-regulated IMS 
receptor Mia40 (Milenkovic et al., 2009; Sideris et al., 2009). Cysteine motifs are also 
present, either upstream or downstream of the ITS/MISS. Typically, these are twin 
cysteine motifs of either CX3C or CX9C, such as those found in the small TIMs and 
members of the cytochrome c oxidase (COX) family that all share a coiled coil-helix1-
coiled coil-helix2 (CHCH) fold (Chacinska et al., 2004; Allen et al., 2005; Mesecke et al., 
2005; Rissler et al., 2005). However, the repertoire of cysteine motifs has expanded in 
recent years as new precursors following this pathway are uncovered, such as Atp23 and 
Ccs1 (Reddehase et al., 2009; Weckbecker et al., 2012).  
  
Precursors enter the IMS using the TOM channel in a reduced and unfolded state where 
Mia40 then recognises them (Lu et al., 2004; Chacinska et al., 2004). In yeast, Mia40 is 
anchored to the IM after its import through TIM23, and has a large IMS-exposed C-
terminal region (Chatzi et al., 2013). Upon substrate binding, Mia40 introduces disulphide 
bonds within precursors via a series of electron transfer reactions upon their entry into 
the IMS (Figure 1.5). The IMS sulfhydryl oxidase Erv1 functions as a recycler of Mia40 as it 
binds to and accepts electrons from Mia40 in its reduced state, i.e. after Mia40 has 
accepted electrons from incoming precursors as a result of disulphide bond formation 
(Allen et al., 2005; Mesecke et al., 2005; Rissler et al., 2005). Erv1 then passes electrons to 
Cytc, and Cytc then shuttles electrons to COX/Complex IV of the respiratory chain (Ang 
and Lu, 2009), and molecular oxygen becomes the final electron acceptor (Bihlmaier et al., 
2007; Dabir et al., 2007). Alternatively, Erv1 can pass electrons directly to molecular 
oxygen, or Cytochrome c peroxidase (Ccp) in yeast. Hydrogen peroxide, H2O2, is produced 
as a by-product of electron transfer to molecular oxygen; whereas H2O is the final by-
product of electron transfer after Cytc has transferred electrons to the respiratory chain 
(Farrell and Thorpe, 2005). In humans, MIA40/CHCHD4 is a 16 kDa soluble protein 
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1 
(Hofmann et al., 2005) that has been shown to interact with apoptosis-inducing factor, 
AIF, a protein also involved in respiratory chain complex biogenesis (Hangen et al., 2015). 
 
   
  
Figure 1.5. The MIA oxidative folding pathway. Electron transfer across the MIA pathway 
in yeast vs mammalian cells. IMS precursors cross the OM via the TOM channel in a reduced and 
unfolded state, and are recognised by Mia40. Electron flow begins from the reduced precursor to 
the redox active CPC of Mia40/MIA40, on to the N-terminal domain of one Erv1/ALR subunit, then 
to the C-terminal FAD core domain of the second Erv1/ALR subunit, then to Cytc, and finally to 
either COX which then donates electrons to O2, or Ccp1 (in yeast). Figure adapted from Mordas 
and Tokatlidis (2015). 
  
Site-specific hydrophobic interactions, occurring within milliseconds upon precursor entry 
to the IMS, are involved in substrate recognition of precursors by Mia40 between 
precursor ITS/MISSs and the CPC site of Mia40 (Milenkovic et al., 2009; Sideris et al., 2009; 
Banci et al., 2010;). These interactions facilitate a two-step event resulting in initial 
precursor disulphide bond formation, and typically occurs at the first “docking” cysteine 
within the N-terminal CXnC motif following a nucleophilic attack from the second cysteine 
of Mia40’s CPC motif (Figure 1.6A); a process which is coupled to Mia40-induced folding 
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of the first coiled-helix (CH). A second nucleophilic attack then occurs at the second 
“resolving” cysteine within the CXnC motif from the first “docking” cysteine, followed by 
substrate release leaving Mia40’s CPC motif in a reduced state. At this stage substrates 
containing twin CXnC motifs still require a second S-S but the mechanism is unknown. 
 
Three hypothesis currently exist for the formation of the second disulphide bond. The 
first hypothesis, Figure 1.6B(i), proposes that an oxidant such as molecular oxygen, 
glutathione or another unknown oxidant, catalyses oxidation of the second disulphide 
bond, whilst the first folded CH induces folding of the second CH – both without the need 
for Mia40 (Sideris et al., 2007; Banci et al., 2010; Bien et al., 2010; Fraga et al., 2014). The 
second possibility, Figure 1.6B(ii), suggests that another oxidised Mia40 in close proximity 
to the partially oxidised precursor allows for a second round of oxidation. However, an 
experiment whereby Cox19 was presented to an excess of oxidised Mia40, long-lived 
mixed disulphide intermediates were present alongside completely oxidised Cox19, which 
suggests that this is not an efficient mechanism (Bien et al., 2010). The third hypothesis, 
Figure 1.6B(iii), proposes that Mia40, Erv1 and the substrate form a ternary complex 
which allows Mia40 to introduce more than one disulphide bond before the substrate is 
released; evidence for this complex has been observed in vivo and in organello but how 
exactly electrons are shuttled through is yet to be explained (Stojanovski et al., 2008; 
Bottinger et al., 2012). More recent evidence suggests a fourth possibility, not shown in 
Figure 1.6B, that implies Mia40 can catalyse up to three disulphide bonds by utilising all 
three of its cysteine pairs as they can all become completely reduced, a scenario which 
has been seen both in vivo and in vitro (Neal et al., 2015). 
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Figure 1.6. Mia40 recognition and oxidation of substrates. (A) Molecular recognition of 
substrates containing classical ITS/MISS and twin CX3C or CX9C motifs. Hydrophobic interactions 
allow precursors with ITS/MISS to “slide” onto Mia40’s hydrophobic binding cleft. Once in place, 
the redox active CPC motif of Mia40 then forms an intermolecular interaction with the first 
substrate cysteine motif via its docking cysteine. Substrates are released when the resolving 
cysteine forms an S-S with the docking cysteine. (B) Three possible mechanisms for completion of 
substrate oxidation: (i) an unknown oxidant induces formation of the second disulphide bond, 
coupled to substrate release; (ii) substrates “slide” onto a nearby oxidised Mia40 which triggers 
the same reaction; or (iii) sequential reactions take place at the same site as part of a ternary 
complex involving Mia40, Erv1 and substrate, whereby Erv1 cyclically reoxidises Mia40. Figure 
adapted from Mordas and Tokatlidis (2015). 
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Whilst these hypotheses may explain how two disulphide bonds can be introduced into 
substrates with classical twin CXnC motifs, it has yet to be uncovered how Mia40 catalyses 
the folding and oxidation of substrates with more complex cysteine motifs, such as the 
copper chaperone Ccs1 with a CX2CX6CX36CXnC motif (Reddehase et al., 2009) amongst 
others (see Mordas and Tokatlidis 2015). Furthermore, the import of proteins by Mia40 
can also occur as an oxidation-independent event, implying that Mia40 is not just a 
foldase but a holdase as well, as substrates could still be imported when the CPC of Mia40 
was mutated (Baker et al., 2012; Weckbecker et al., 2012; Wrobel et al., 2013; Peleh et al., 
2016; Ramesh et al., 2016). In addition, some Mia40 substrates can still be imported 
when their cysteine residues are mutated, for example: Atp23 – an IM-associated IMS 
protease with five cysteine pairs. An Atp23 mutant with all 10 of its cysteines abolished 
can still be imported in a process dependent on Mia40; the critical feature being the 
hydrophobic binding cleft of Mia40 (Weckbecker et al., 2012). Other proteins that rely on 
the holdase function of Mia40 are Tim22, Mrp10, and hCHCHD3; notably none of which 
are IMS resident proteins (Darshi et al., 2012; Wrobel et al., 2013; Longen et al., 2014). 
Thus, it is now accepted that Mia40 has a distinct chaperone-like role for both IMS and 
non-IMS proteins.  
  
Looking at the recycler of Mia40 in more detail, Erv1 is a soluble sulfhydryl oxidase that 
binds to its redox-cofactor flavin adenine dinucleotide (FAD) and, like Mia40, contains 
three conserved cysteine pairs (Ang and Lu, 2009). Its C-terminal cysteine pair (C159/C176) 
acts as a structural disulphide when oxidised, but upon Erv1 import to the IMS it is 
recognised by Mia40 which introduces this disulphide bond (Terziyska et al., 2007; 
Kallergi et al., 2012). Once folded in the IMS, its N-terminal cysteine pair (C30/C33), 
known as its shuttle disulphide, is directly responsible for interacting with and accepting 
electrons from Mia40’s CPC motif, thus reoxidising Mia40 (Bien et al., 2010; Lionaki et al., 
2010; Banci et al., 2011). These electrons are then shuttled to Erv1’s middle cysteine pair 
(C130/133), before being transferred to bound FAD which then passes electrons to either 
Cytc or molecular oxygen - as shown in Figure 1.5. 
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Similar to the prokaryotic oxidative folding of periplasmic proteins, the eukaryotic MIA 
pathway can also function under both aerobic and anaerobic conditions. Whilst all of the 
Erv1 electron acceptors described above function aerobically, until very recently no 
electron acceptors had been identified that could function anaerobically. In 2017, the 
IMS-localised fumarate reductase Osm1 was found to complete the oxidation of 
substrates in reconstitution assays with reduced Tim13, Mia40 and Erv1, and with an 
efficiency comparable to Cytc (Neal et al., 2017). In addition, yeast mutants lacking Osm1 
exhibit decreased import of Mia40 substrates and an upregulation of Cytc expression. As 
Osm1 has the ability to transfer electrons from fumarate to succinate without the need 
for molecular oxygen (Muratsubaki and Enomoto, 1998), Osm1 is both an aerobic and 
anaerobic electron acceptor of Erv1. However, the exact physiological conditions needed 
to specify electron flow to a particular electron acceptor are not known, but it is plausible 
that oxygen levels and respiratory chain activity might dictate the decision. 
  
To conclude Section 1.2, although the separate mitochondrial import pathways have 
been discussed, it is becoming more apparent that these pathways do not always act as 
independent units. New evidence is emerging regarding the role of mitochondrial 
membrane contact sites (Horvath et al., 2014), and the import of proteins, such as the 
OM protein Om45, that require both the TOM channel and TIM23 thus combining the use 
of two import pathways (Song et al., 2014; Wenz et al. 2014). 
  
1.3. Conservation and evolution of protein import pathways 
  
Eukaryotes can be split into numerous major groups: Opisthokonts, including metazoa 
and fungi; Archaeplastida, including plants and green/red algae; Excavata, including 
kinetoplastid parasites and trichomonads and Giardia; Chromalveolata, including 
apicomplexan parasites and dinoflagellates; and two others – Rhizaria and Amoebozoa 
(Figure 1.7) (Adl et al., 2005). The majority of studies on mitochondrial protein import 
have been carried out in two Opisthokonts, yeast and humans, which share many of the 
same characteristics due to their close evolutionary lineage. However, as mitochondrial 
endosymbiosis is thought to have occurred as a one-time only event at the very beginning 
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of eukaryotic life (Lang et al., 1999), it is therefore not surprising that many features of 
mitochondrial protein import have been conserved across these groups (Lister et al., 2005; 
Kutik et al., 2009). 
  
  
 
 
 
 
 
 
 
 
Figure 1.7. The six major eukaryotic groups. Eukaryotes are currently split into six major 
groups that all diverged from a common eukaryotic ancestor. These include: Opisthokonts, 
Archaeplastida, Excavata, Chromalveolata, Rhizaria and Amoebozoa (Adl et al., 2005).  
  
A combination of in silico analyses and functional complementation assays indicates that 
three classes of mitochondrial protein import components exist: (i) those derived from 
the original proteobacterium, (ii) ‘de novo’ components that arose during the early days 
of the eukaryotic endosymbiont, and (iii) those that arose after eukaryotes diverged and 
are thus specific to lineages. For example, whilst the pore-forming subunits of protein 
import translocases remain well conserved, some additional smaller subunits such as the 
receptors are not. Despite this, the majority of the known mitochondrial protein import 
pathways and precursor targeting signals are largely functionally conserved, and thus are 
a great example of convergent evolution (Murcha et al., 2007; Eckers et al., 2012; Mani et 
al., 2015; Backes and Herrmann, 2017). However, the story is somewhat different for the 
MIA oxidative folding pathway. 
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1.3.1. The MIA pathway across eukaryotes 
  
The small TIMs of the IMS, which are all substrates of the MIA pathway, are found across 
all eukaryotic lineages as they share conserved sequence motifs with distinct features 
(Gentle et al., 2007). This suggests they were present in at least the last common ancestor 
before the eukaryotic divide. However, the number of small TIMs present within and 
across different eukaryotic lineages does differ, ranging from 1-5. For example, the 
apicomplexan Plasmodium has four distinct TIMs (Tim8, Tim9, Tim10 and Tim13), 
whereas the closely related apicomplexans Theileria and Cryptosporidium have either 
Tim9, Tim10 and a Tim8-Tim13 hybrid, or a Tim8-Tim13 hybrid only. Thus, the small TIMs 
have evolved differently even within individual eukaryotic groups. Despite this, because 
all eukaryotes have at least some of the small TIMs present in Opisthokonts, it can be 
inferred that they must all have an oxidative protein import pathway capable of bringing 
these proteins into the IMS that was present at the beginning of the eukaryotic divide. In 
addition, a systematic analysis of proteins containing a twin CX9C motif, identified 
proteins that are conserved across animals, fungi and plants. 
  
Both Mia40 and Erv1 are present in plants such as Arabidopsis from the Archaeplastida 
group, along with classical IMS substrate proteins. Whereas although Mia40 substrates 
have been identified during in silico analyses across all groups, intriguingly it appears that 
kinetoplastid and apicomplexan parasites from both the Excavata and Chromalveolata 
groups respectively, do not have a Mia40 homolog (Allen et al., 2008). However, Erv1 
homologs are present as they are universally found in all eukaryotes, but their domain 
organisations do vary widely (Eckers et al., 2013). The next three sections discuss what is 
currently known about Archaeplastida, Excavata, and Chromalveolata IMS oxidative 
protein folding in relation to the well-studied yeast and human pathways.   
  
1.3.1.1. The Arabidopsis MIA pathway 
  
Research on the model organism Arabidopsis thaliana has revealed differences in the way 
that the two core components of the MIA pathway function in plants. Unlike Mia40 and 
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Erv1 in yeast which are both essential, only AtErv1 is essential in A. thaliana (Carrie et al., 
2010). Data gathered using A. thaliana lacking Mia40 (Δmia40) implies that Mia40 does 
not play an essential role in the import of the small TIMs as no defects were found in the 
carrier pathway. Instead, Erv1 was upregulated in this mutant, which suggests that Erv1 
might function alone in the import of IMS proteins. Interestingly, AtMia40 localises to 
both mitochondria and peroxisomes - a cellular compartment that typically does not 
harbour any mitochondrial protein import components. Furthermore, these organelles 
exhibited a reduction in protein abundance when isolated from Δmia40 plants, as well as 
a decreased ability to import both mitochondrial and peroxisomal proteins. Finally, AtErv1 
could not complement a yeast Erv1 mutant thus suggesting that both AtErv1 and AtMia40 
have novel functions in plants.  
  
A recent study by Peleh et al. (2017) focused on characterising AtErv1 and confirmed the 
previous finding that AtErv1 could not complement yeast Erv1, as it was unable to 
reoxidise yeast Mia40 and actually resulted in a dominant-negative effect on Mia40. 
However, it could directly interact with IMS precursors and facilitate their import and 
oxidative folding, thus confirming the likelihood that Erv1 can act alone when importing 
IMS proteins in plants. The authors therefore suggest that the evolution of the MIA 
pathway began from a system that contained Erv1 without Mia40, as had previously been 
hypothesised by Allen et al. (2008), and that Mia40 evolved to add substrate specificity. 
Although it is still possible that Mia40 once existed but became lost during the evolution 
of certain eukaryotic lineages as its function was obsolete. 
  
1.3.1.2. Parasitic MIA pathways 
  
Parasitic protists are believed to be more representative of ‘primitive’ eukaryotes and fall 
under two classification groups: Excavata and Chromalveolata, including the non-related 
kinetoplastid and apicomplexan parasites, respectively. A comparison of Erv homologs 
across both kinetoplastid and apicomplexan parasites revealed that, although they all 
share the conserved FAD-binding domain, there are some potentially significant 
differences (Eckers et al., 2013). Firstly, they lack the N-terminal cysteine-containing 
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domain of yErv1 responsible for its import in yeast, as well as lacking the final alpha-
helical structure (α5), and harbour a variety of cysteine motifs. Despite this, structural 
predictions suggest they more than likely adopt the same Erv1/ALR fold seen in yeast and 
humans (Eckers et al., 2013). This fold is crucial for FAD-binding and homo-dimerisation of 
Erv. The bioinformatics analysis also revealed an additional C-terminal domain that is 
specific only to kinetoplastids; this domain has been coined ‘KISS’ for kinetoplastid-
specific second domain. Akin to AtErv1, a representative Erv homolog from each group 
(LtErv from the kinetoplastid Leishmania tarentolae, and PfErv from the apicomplexan 
Plasmodium falciparum) could not functionally replace yeast Erv1. Schematic 
representations of parasitic Erv homologs that have been identified in organisms from 
both the kinetoplastid and apicomplexan groups, along with yErv1 and AtErv1, is shown in 
Figure 1.8. From now on, studies that have explored kinetoplastid and apicomplexan 
mitochondrial protein import will be discussed separately.  
 
 
Figure 1.8. Schematic representation of Erv homologs. S. cerevisiae Erv1, A. thaliana 
Erv1, T. brucei Erv1, L. tarentolae Erv, P.  falciparum Erv, and T. gondii Erv1, Erv2 and Erv3 (Eckers 
et al., 2013). 
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Kinetoplastid parasites 
Two model organisms for kinetoplastid parasites are currently used for mitochondrial 
protein import studies: Leishmania tarentolae, a parasite that can cause Leishmaniasis; 
and Trypanosoma brucei, the parasite responsible for causing African trypanosomiasis. 
LtErv, TbErv1 and another Erv homolog from another Leishmania parasite, L. infantum, 
LiErv can all be successfully imported into yeast mitochondria (Basu et al., 2013; Eckers et 
al., 2013; Specht et al., 2018). TbErv1 has also been implicated in the import of IMS 
proteins based on its TbErv1 RNAi knockdown in T. brucei that causes both mitochondrial 
morphology defects (Haindrich et al., 2017), and the downregulation of candidate IMS 
substrates with twin CXnC motifs (Peikert et al., 2017). However, no TbErv1 IMS 
interactors have been identified despite mass spectrometry efforts, suggesting that it acts 
alone in the IMS and may only be involved in transiently interacting with precursors.  
  
From a biochemical perspective, kinetic analyses using recombinant proteins indicate that 
LtErv has the ability to reduce Cytc (Eckers et al., 2013), and TbErv1 can reduce Cytc and 
molecular oxygen simultaneously (Eckers et al., 2013; Basu et al., 2013). As mentioned 
previously, LtErv cannot complement yeast cells lacking Erv1; however, a recent study has 
shown that a single cysteine mutant, LtErvC17S, can (Specht et al., 2018). Furthermore, 
chimeras between the N-terminal arm of yeast Erv1 and various truncated LtErvs could 
also functionally rescue Erv1 mutant yeast. Although it is not yet known why these 
versions of LtErv can compensate for yErv1, it does suggest there is some degree of 
flexibility between the kinetoplastid and yeast systems, but they definitely both have 
their stark differences. The evidence gathered so far is certainly suggestive of 
kinetoplastid parasites employing an Erv-only oxidative folding pathway. However, a very 
recent paper by Kaurov et al. (2018) has suggested that one essential component of the 
MICOS complex (mitochondrial contact site and cristae organising system) in T. brucei, 
TbMic20, has thioredoxin-like activities and is involved in the import of IMS proteins. 
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Apicomplexan parasites 
Two model organisms are commonly used to study apicomplexan parasites: Plasmodium 
falciparum, responsible for transmitting malaria; and Toxoplasma gondii, responsible for 
causing toxoplasmosis. In comparison to kinetoplastid parasites, no published literature 
exists on their Erv homologs other than in silico analysis of their mitochondrial protein 
import systems (Eckers et al., 2013).  A side project to this PhD was to investigate the 
three T. gondii Erv homologs: TgErv1, TgErv2 and TgErv3. Some of these data are shown 
in Appendix 5, Figures 7.6-7.13. 
 
1.4. Intermembrane space proteins 
  
The importance of oxidative protein folding in the IMS is apparent across eukaryotic 
groups when considering that most IMS proteins contain disulphide bonds that are critical 
for their function (Haque et al., 2012; Backes and Herrmann, 2017; Habich et al., 2018). 
Most of these proteins harbour conserved cysteine residues (around 82%, at least in 
mammalian mitochondria) that are involved in a variety of functions within the IMS, such 
as: substrate binding, oxidative folding itself, protein homo- and hetero-dimerisation, 
detoxification of H2O2, and the transfer of metal ions (Habich et al., 2018). Aside from 
cysteine residue function, IMS proteins can be categorised into four groups depending on 
their broader role (metabolism, morphology, signalling, and logistics). Around 50-150 
proteins are currently known; ~50 in yeast and ~150 in humans. Although it should be 
noted that for roughly 20% of IMS proteins, their functions have yet to be determined, 
and new proteins are continuously being added to the mitochondrial IMS proteome 
(Vögtle et al., 2012; Morgenstern et al., 2017). For example, the addition of Gpx3, Trx1 
and Trr1 to the yeast IMS proteome in 2012 raised questions regarding the significance of 
these redox proteins within such a highly redox-active subcompartment. 
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1.5. Redox regulation of protein disulphide bond formation 
  
The oxidative folding of proteins is compartmentalised in cells due to the reducing nature 
of the cytosol, and occurs within the endoplasmic reticulum (ER), the mitochondrial IMS, 
and the bacterial periplasm (Kojer and Riemer, 2014). All three compartments utilise 
similar oxidative folding pathways whereby electrons flow from substrates to thiol 
oxidoreductases, to thiol oxidases and then finally to electron acceptors. In mitochondria, 
protein oxidation occurs specifically in the IMS, as like the cytosol, the mitochondrial 
matrix must maintain a reducing environment in order to carry out protein translation. 
The importance of disulphide bonds in the correct folding, stability and function of many 
proteins means it is no surprise that cells must tightly regulate this process, especially 
within environments where both oxidising and reducing pathways exist. It is also critical 
for cells to prevent irreversible protein oxidation, such as the hyperoxidation of cysteine 
residues, under conditions whereby the levels of reactive oxygen species (ROS) exceeds 
the antioxidant capacity of cells; a situation known as either oxidative stress or oxidative 
distress (Sies et al., 2017). Therefore, cells have evolved a wide range of strategies, both 
non-enzymatic and enzymatic, to protect themselves against the damaging effects of 
excessive oxidation and to reverse the formation of non-native disulphide bonds. Non-
enzymatic defences include small molecules such as Glutathione (GSH) and ascorbic acid; 
whereas enzymatic defences which are believed to be responsible for the majority of 
antioxidant activity include catalases, peroxiredoxins and the two disulphide reductive 
systems - the Glutaredoxin and Thioredoxin systems (Morano et al., 2012).  
  
In the bacterial periplasm, oxidative protein folding is achieved by the oxidoreductase 
DsbA that, upon substrate oxidation, becomes re-oxidised by the thiol oxidase DsbB that 
then passes electrons on to the respiratory chain (Kojer and Riemer, 2014). To remove 
non-native disulphides, the oxidoreductase DsbC is required in its reduced state 
(Missiakas et al., 1995; Rietsch et al., 1996). DsbC is kept reduced by the plasma 
membrane protein DsbD that receives electrons from the cytosolic Thioredoxin A (TrxA) 
and shuttles them across the membrane via three redox-active domains (Stewart et al., 
1999; Collet et al., 2002; Rozhkova et al., 2004). The NADPH-dependent cytosolic 
Thioredoxin reductase (TrxB) then reduces TrxA. Thus, oxidative protein folding in the 
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bacterial periplasm is linked to the reducing Thioredoxin pathway. The oligomeric states 
of the oxidoreductases that participate in these pathways ensure that they are kinetically 
separated; DsbD cannot reduce DsbA in its monomeric state, and DsbB cannot oxidise 
DsbC in its dimeric state (Goldstone et al., 2001; Rozhkova and Glockshuber, 2008). 
  
The situation in the ER is similar with respect to the use of reduced oxidoreductases in 
isomerising non-native disulphide bonds, but more complex as both the oxidising and 
isomerising/reducing pathways use the same oxidoreductases (Oka and Bulleid, 2013; 
Bulleid and van Lith, 2014). In the ER, protein disulphide isomerases (PDIs) are responsible 
for introducing disulphide bonds into substrates and removing non-native disulphides. 
Separate domains within PDIs are responsible for either the oxidation or reduction of 
disulphide bonds (Appenzeller-Herzog and Ellgaard, 2008; Oka and Bulleid, 2013). Like 
DsbA and Mia40, oxidised PDIs introduce disulphide bonds to substrates and electrons 
are then passed on to a thiol oxidase, in this case Ero1, which then transfers electrons to 
molecular oxygen, with H2O2 produced as a by-product (Gross et al., 2006; Baker et al., 
2008). In addition, a complex feedback mechanism exists to regulate the activity of Ero1 
when the pool of oxidised Ero1 becomes too high (Appenzeller-Herzog et al., 2008; Baker 
et al., 2008). This mechanism involves the introduction of ‘regulatory’ disulphide bonds in 
Ero1 that block its activity; this process is reversible upon changing redox conditions. In 
order to reduce non-native disulphides in substrates, PDI must first be reduced by 
reduced Glutathione (GSH); reduced PDI can then accept electrons from non-native 
disulphides. As a result, oxidised Glutathione (GSSG) accumulates in the ER (Chakravarthi 
et al., 2006). However, little is currently understood about how the ER balances 
GSH/GSSG levels and its transport across the ER.  
  
In the IMS, the oxidoreductase Mia40 introduces disulphide bonds into substrates (as 
described in detail in Section 1.2.4), but the mechanism for removal of non-native 
disulphide bonds has not yet been characterised, and Mia40 has not been shown to 
exhibit in vivo isomerase activity. In 2010, GSH was proposed to play a proofreading role 
based on the finding that its addition to an in vitro reconstitution system alongside 
oxidised Mia40 and reduced Cox19 resulted in accelerated Cox19 oxidation with fewer 
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long-lived intermediates (Bien et al., 2010). Though a direct role of GSH could not be 
established in this particular setup as the intermediates that were present could not be 
characterised. However, since then evidence has shown that the redox state of Mia40 is 
affected by GSH levels in vivo as GSH was shown to partially reduce Mia40 (Kojer et al., 
2012). The potential role of semi-reduced Mia40 in regulating disulphide bond formation 
in the IMS has yet to be determined. On the other hand, an in vitro study has suggested 
that Mia40 itself can act directly and concurrently as both an oxidase and an isomerase as 
Mia40 was shown to reduce Cox17 in a reconstituted system (Koch and Schmid, 2014a, b), 
although its efficiency in doing so was relatively poor in comparison to both DsbA and PDI. 
Despite all this, the role of Mia40 and/or GSH in the removal of non-native disulphide 
bonds remains unclear; perhaps a separate reductive pathway exists. 
  
Interestingly, the components from two cytosolic reductive systems (the Thioredoxin and 
Glutaredoxin systems) have also been found in the IMS (Vögtle et al., 2012; Kojer et al., 
2015; Manganas, 2017, PhD thesis, University of Glasgow), and a study has shown that 
Glutaredoxin 2 (Grx2) levels in the IMS can influence the redox state of Mia40, shifting 
Mia40 to its reduced state which then indirectly affects IMS protein import. Furthermore, 
the presence of Thioredoxin in the IMS has also been shown to affect Mia40 oxidation 
levels (Mauricio Cárdenas-Rodriquez, 2019, PhD Thesis, University of Glasgow). In 
addition to the likelihood that two reductive systems operate within the IMS that may 
both play roles in fine-tuning oxidative protein folding, the well-characterised cytosolic 
H2O2 transducer, Glutathione peroxidase 3 (Gpx3), was also found in the IMS (Vögtle et al., 
2012) and has been shown to interact with Mia40 (Kritsiligkou et al., 2017). Until Gpx3, no 
H2O2 sensor had been discovered in the IMS. Therefore, determining how the MIA import 
pathway is regulated under different redox conditions, i.e. oxidative vs reductive stress, is 
an important topic to address. As this PhD continued to investigate the role of Gpx3 in the 
yeast IMS, the following section will discuss Gpx3 in detail, including its well-characterised 
role in cytosolic H2O2 signalling.    
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1.6. Glutathione peroxidases in yeast 
  
Gpx3 is one of three Glutathione peroxidases (Gpx1, Gpx2 and Gpx3/Hyr1/Orp1) in S. 
cerevisiae that play multiple roles in defending cells against oxidative stress, such as by 
reducing phospholipid hydroperoxides and quenching reactive oxygen species (Inoue et 
al., 1999; Avery and Avery, 2001). All three are classified as atypical 2-Cys peroxiredoxins 
(Ohdate et al., 2010) and are all present within the cytosol of the cell; however, they each 
have their individual associations with various mitochondrial subcompartments and with 
peroxisomes. Gpx1 is associated with the cytosolic-side of the outer membrane (OM) and 
the peroxisomal matrix (Ukai et al., 2011; Ohdate and Inoue, 2012). Gpx2 is also 
associated with the cytosolic-side of the OM, and the matrix-side of the inner 
mitochondrial membrane (IM) (Ukai et al., 2011). Gpx3 is found within the mitochondrial 
intermembrane space (IMS) and the peroxisomal matrix (Ohdate and Inoue, 2012; Vögtle 
et al., 2012; Kritsiligkou et al., 2017).  Although all three Gpxs exhibit peroxidase activity, 
their differing localisations within yeast cells suggest that each have their own niche roles 
in redox regulation.  
  
The peroxidase activity of yeast Gpx3 is considered to be the most important of the three, 
based on evidence that a yeast strain harbouring a single deletion of GPX3 (gpx3Δ) is 
hypersensitive to peroxides, and is more detrimental to yeast cells than gpx1Δ or gpx2Δ 
single mutants under oxidative stress (Inoue et al., 1999). In contrast to Gpx1 and Gpx2, 
and despite its name, Gpx3 utilises Thioredoxin as its reducing substrate (Delaunay et al., 
2002; Maiorino et al., 2007). The reaction that Gpx3 catalyses is: Gpx3(-SH) + H2O2 → 
Gpx3(-SOH) + 2H2O; the sulphenylated form of Gpx3 can then form transient conjugates 
with other proteins via intermolecular disulphides, or, form an intramolecular disulphide 
bond Gpx3 (S-S). The oxidised form of Gpx3(S-S) is then reduced by Thioredoxin. Thus, 
Gpx3 can already be distinguished from the other Glutathione peroxidases. Gpx3 may 
therefore utilise the IMS pool of Trx1 as its reducing substrate. A similar mechanism to 
reduce Gpx2 on the OM might be employed by the cytosolic pool of Trx1, as the active 
domain of Gpx2 is exposed to the cytosol. Gpx3 further differentiates itself from the 
others as it acts as a transducer of H2O2 signals in the cytosol (Delaunay et al., 2002). 
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1.6.1. Cytosolic Gpx3 
  
In the cytosol, Gpx3 transduces H2O2 signals via the activation of the yeast AP-1-like 
transcription activator 1, Yap1, by multi-step disulphide bond formation – see Figure 1.9 
(Delaunay et al., 2002; Ma et al., 2007; Okazaki et al., 2007). Under H2O2 exposure, the 
Cys36 residue of Gpx3 becomes sulphenylated and forms either an intermolecular 
disulphide bond with the Cys598 residue of Yap1, or, an intramolecular disulphide bond 
with another of its cysteine residues, Cys82 (Delaunay et al., 2002). The former scenario 
causes a Yap1 conformational change whereby the nuclear export signal (NES) of Yap1 
becomes blocked due to the formation of an intramolecular disulphide bond within Yap1 
between Cys303 and Cys598 thus allowing the nuclear accumulation of Yap1 and 
subsequent activation of its target genes (Wood et al., 2004). Under reducing conditions, 
the intramolecular disulphide bond in Yap1 is reversed, the NES unblocked, and Yap1 
exported back to the cytosol (Wood et al., 2004). Another protein, Yap1-binding protein 1 
(Ybp1), is also required for inducing the nuclear accumulation of Yap1 under H2O2 stress 
by forming a noncovalent ternary complex with Yap1 and Gpx3, that brings these proteins 
into close proximity and inhibits Gpx3 from forming an intramolecular disulphide bond 
(Veal et al., 2003; Gulshan et al., 2011; Patterson et al., 2013; Bersweiler et al., 2017). 
Thus, Ybp1 promotes Yap1 activation via Gpx3 and is consequently a rate-limiting factor.  
 
 
 
 
 
 
 
 
Figure 1.9. H2O2-induced activation of Yap1 by Gpx3 and Ybp1. Upon exposure to H2O2, 
Cys36 of Gpx3 becomes sulphenylated (-SOH) which can then form either a mixed disulphide 
bond with Yap1 via C598 of Yap1, or an intramolecular disulphide bond with C82 of Gpx3. The 
mixed disulphide formed between Gpx3 and Yap1 induces a further disulphide bond between 
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C303 and C598 of Yap1 which causes a protein conformational change in Yap1, blocking its 
nuclear export signal (NES). This leads to the nuclear accumulation of Yap1 and activation of >70 
stress response genes. Ybp1 acts as a scaffold protein and forms a ternary complex between Gpx3, 
Yap1 and Ybp1 which promotes the formation of an intermolecular disulphide bond between 
Gpx3 and Yap1. NOTE: This diagram represents a wild-type BY4741 S. cerevisiae strain; wild-type 
W303 S. cerevisiae possess a ybp1 mutation therefore the peroxiredoxin Tsa1 replaces Gpx3 
(Okazaki  et al., 2005). See Section 1.6.1 for a detailed description. 
   
Around 70 genes are known to be activated by Yap1 as a result of H2O2 exposure, many of 
which are involved in mounting a response to oxidative stress, such as TRX2 (Ouyang et 
al., 2011; Veal et al., 2003; Kho et al., 2008). A study by Kho and colleagues in 2008 
identified around 30 Gpx3-dependent proteins in response to H2O2 using a combination 
of proteomic and bioinformatics analyses (Kho et al., 2008). As expected, these included 
proteins involved in cell defence and survival. Interestingly, they also identified 17 
proteins that respond to Gpx3 that are indifferent to H2O2 conditions which suggests a 
functional role of Gpx3 in scenarios other than just Yap1 activation as the 17 proteins 
include those involved in metabolism and protein fate (Kho et al., 2008). In another study, 
Lee et al. (2008) investigated the yeast Gpx3 interactome by immunoprecipitation using 
Myc-tagged Gpx3 proteins and crude yeast proteins extracted after the addition of H2O2, 
followed by mass spectrometry. Their analysis highlighted 11 interactors, including some 
already known to interact with Gpx3 (Yap1, Peptide methionine sulfoxide reductase and 
Glutamine synthetase) and others that were newly identified (Glutaredoxin 2, Protein 
disulphide isomerase 1, and SSY protein 3 among others) (Lee et al., 2008). Some of these 
proteins, like the genes identified by Kho et al. (2008), are involved in metabolism, 
transcription, and protein folding. 
   
In 2012, Gerashchenko and colleagues carried out yeast mRNA ribosomal profiling along 
with deep sequencing to identify differentially translated proteins (from non-AUG codons) 
during H2O2 stress; one of these proteins was Gpx3 with a predicted N-terminal extension 
(Gerashchenko et al., 2012). The role of this extension is not yet fully understood; 
however, evidence suggests that it facilitates the import of Gpx3 into the mitochondrial 
IMS and allows it to associate more tightly with the IM (Kritsiligkou et al., 2017).  
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1.6.2. Mitochondrial Gpx3 
  
Mitochondria are a major source of cellular ROS, particularly H2O2, as H2O2 is produced 
from the dismutation of superoxide anion radicals by superoxide dismutases, and as a by-
product of NADPH oxidases, the respiratory chain and the MIA pathway (see Section 1.2.4) 
(Allen et al., 2005; Murphy, 2009; Sies et al., 2017). Although H2O2 can cause oxidative 
damage, it is also an important signalling molecule (Veal and Day, 2011). Therefore, H2O2 
levels must be under tight control, particularly in the mitochondrial IMS and the ER. In the 
ER, H2O2 that is produced by Ero1 is quenched by peroxiredoxin IV (PrxIV) along with 
GPX7 and GPX8 (Tavender et al., 2010; Zito et al., 2010). As Gpx3 is the only known Gpx in 
the yeast IMS, it is likely that Gpx3 plays a role in H2O2 detoxification and signalling, akin 
to its role in the cytosol (Delaunay et al., 2002). 
  
The presence of Gpx3 and its N-terminal extended version of around 18 amino acids 
(denoted N18Gpx3) have been confirmed within the IMS using a combination of import 
and localisation assays along with confocal microscopy (Kritsiligkou et al., 2017). 
Furthermore, experiments using gpx3D yeast have shown that these cells exhibit defects 
in mitochondrial morphology and inner membrane potential. Whilst Gpx3 does not rely 
on the MIA pathway for its import into the IMS, it has been shown to interact with and re-
oxidise Mia40, thus implicating Gpx3 in mitochondrial oxidative protein folding. 
  
Based on the previous evidence for multiple interactors and functional roles of Gpx3 in 
the cytosol, one aim of this PhD was to elucidate additional mitochondrial interactors of 
Gpx3 and N18Gpx3 in the IMS. It should be noted that the study by Lee et al. (2008) could 
not determine which cellular compartment the additional Gpx3 protein interactions 
occurred in as whole yeast cell extracts were used; only four of them were mitochondrial, 
none of which are solely localised within the IMS (see Chapter 3, Section 3.1). By 
identifying IMS-specific interactors of Gpx3, all of Gpx3s potential functional role/s in 
mitochondria can be uncovered.    
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1.6.3. Peroxisomal Gpx3 
  
As mentioned previously, Gpx3 was also found to localise within the peroxisomal matrix, 
another cellular organelle that plays a role in metabolism and redox regulation (Ohdate 
and Inoue, 2012). No literature exists regarding the potential role(s) of Gpx3 within 
peroxisomes; however, it is likely that Gpx3 plays a role in detoxifying and transducing 
H2O2 signals in yet another important organelle. To summarise this section, an illustration 
of where Gpx3 is known to reside within S. cerevisiae cells is shown in Figure 1.10.  
 
 
 
 
 
 
 
 
 
  
   
Figure 1.10. Localisation of Gpx3 in S. cerevisiae cells. Gpx3 resides in several cellular 
compartments including the cytosol, the mitochondrial IMS and the peroxisomal matrix. 
Upstream translation from a non-AUG codon in GPX3 results in the production of an N-terminally 
extended Gpx3 of around 18 amino acids, N18Gpx3. Both Gpx3 and N18Gpx3 are imported into 
the IMS, but the N18 provides a more efficient import and results in a stronger association with 
the IM. It is not known which version of Gpx3 is imported into the peroxisomal matrix. ER – 
endoplasmic reticulum; OM – outer membrane; IM – inner membrane; IMS – intermembrane 
space; Matrix – mitochondrial matrix; PM – perixosomal membrane.  
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1.7. Peroxisomes 
  
Peroxisomes are universal, essential organelles characterised by a single lipid-bilayer 
membrane that encapsulates a matrix full of proteins involved in oxidative metabolism. 
When peroxisomes were first isolated in the 1960s, their main functions were thought to 
be fatty acid b-oxidation and H2O2 degradation (De Duve and Baudhuin, 1966). However, 
recent research has uncovered their involvement in many metabolic pathways, and that 
their functions vary across eukaryotic groups and between different tissues, cell types 
and changing environmental conditions (Erdmann 2016; Reumann and Bartel, 2016; 
Waterham et al., 2016). It has also become apparent that they are both physically and 
metabolically linked with other cellular organelles, including the ER and mitochondria, 
and share some of the same proteins. Unlike mitochondria, they do not contain any of 
their own DNA and thus solely rely on nuclear-encoded proteins that are imported into 
peroxisomes in order to carry out their metabolic functions. Whilst mitochondria also 
import the vast majority of their proteins from the cytosol, the major protein targeting 
and import mechanisms exploited by peroxisomes are very different (Baker et al., 2016; 
Sibirny 2016; Schwerter et al., 2017). 
  
1.7.1. Peroxisome protein targeting and import 
  
Two types of targeting signals are so far known to exist: peroxisomal-targeting signal 1 
(PTS1), short peptide sequences located at the extreme C-terminus, and peroxisomal-
targeting signal 2 (PTS2), N-terminal sequences of which some share structural similarities, 
i.e. amphipathic alpha-helices, with mitochondrial presequences (Aitchison et al., 1991; 
Osumi et al., 1992; Brocard and Hartig, 2006; Kunze et al., 2011; Pan et al., 2013; Kunze 
and Berger, 2015). Whilst many variations of these targeting signals exist there are 
general consensuses for both PTS1 and PTS2 signals that can be used to identify potential 
peroxisomal proteins using various algorithms (refer to Chapter 5, Figure 5.3). Moving on 
from targeting signals, peroxisomal protein import machineries are comprised mainly of 
PEX (peroxin) proteins and are unusual for many reasons: (i) they can import folded 
proteins and oligomeric proteins (Glover et al., 1994; McNew et al., 1994), (ii) the same 
receptor can recognise a range of targeting signals with various affinities, (iii) the whole 
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process is cyclical and involves the docking of cargo proteins onto receptors, and (iv) 
protein import is coupled with protein export, the latter of which is ATP-dependent 
(Brown et al., 2014; Baker et al., 2016). As peroxisome protein import by peroxins is 
incredibly complex, a detailed description is unfortunately outside the scope of this 
introduction (refer to excellent reviews by Baker et al., 2016; Sibirny 2016; and Schwerter 
et al., 2017). Though what is interesting is that components of the MIA pathway exist in A. 
thaliana peroxisomes and are involved in the import of some plant peroxisomal matrix 
proteins (Carrie et al., 2010) - see previous Section 1.3.1.1. 
  
The identification of bona fide peroxisomal proteins is hindered for various reasons, such 
as: contamination of other organelles when isolating peroxisomes and carrying out 
proteomic analyses; low levels of some proteins; dually-localised proteins; changes in 
protein content depending on physiological conditions; and the inability to predict 
proteins that do not contain PTS1 or PTS2 canonical signals. While new technological 
methods are being developed to assist in establishing the true peroxisomal proteome, 
until then bottom-up approaches are useful in detecting previously unidentified proteins, 
many of which are dually-localised. As this PhD project uncovered a number of 
mitochondrial proteins co-localising with peroxisomes in yeast, such as Gpx3 and Mia40, 
the following section briefly lists some inter-organelle connections currently unravelling 
between mitochondria and peroxisomes. 
  
1.7.2. Mitochondria-peroxisome links 
  
Although it is well known that peroxisomes are non-autonomous organelles that rely on 
highly interconnected metabolic networks with other organelles such as mitochondria 
(see Wanders et al., 2016), many questions remain with regards to the targeting of dually-
localised proteins and their precise roles in other aspects of organelle interplay. Aside 
from their cooperation with mitochondria in metabolic pathways such as b-fatty acid 
oxidation, shared proteins are also known to be involved in eliciting responses including (i) 
organelle division, (ii) redox regulation, (iii) antiviral signalling, and (iv) vesicular trafficking. 
For a recent review of mitochondria-peroxisome connections, see Costello et al. (2018).  
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1.8. Protein targeting and import in disease 
  
Diseases associated with mitochondrial protein targeting and import 
Dysfunctional mitochondria are implicated in a number of human diseases, including two 
well-known neurodegenerative diseases - Alzheimer’s and Parkinson’s, but whether they 
play a direct or indirect role has yet to be established (Schapira, 2012; Mossman et al., 
2014).  However, there are a handful of rare diseases caused by known mutations within 
nuclear genes encoding mitochondrial proteins (Pfanner, Warscheid & Wiedemann, 2019). 
These mutations can affect mitochondrial targeting signals (MTSs) within precursors, the 
function of individual protein import components, and the processing and folding of 
mitochondrial proteins upon their import. On the other hand, there are mutations that 
can introduce MTSs in non-mitochondrial proteins (including peroxisomal proteins) which 
results in their mistargeting. Excellent examples of the above are highlighted in a recent 
review by Pfanner, Warscheid & Wiedemann (2019).  
  
Connections with peroxisomes 
Mutations within many of the PEX genes that play important roles in the biogenesis of 
peroxisomes are known to cause disorders such as Zellweger syndrome (Fujiki, Yagita & 
Matsuzaki, 2012). In addition to this, gene mutations can generate MTSs in peroxisomal 
proteins, for example, human EHHADH, which instead directs EHHADH to mitochondria 
causing renal Fanconi syndrome (Klootwijk et al., 2014). To conclude, thoroughly 
understanding organellar targeting signals and complex protein import machines across 
both mitochondria and peroxisomes will be of upmost importance in the development of 
novel therapeutic strategies to combat a multitude of human diseases.  
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1.8. Aims 
  
Chapter 3 – Investigating the role of Gpx3 in the mitochondrial IMS 
The initial aim of this PhD project was to identify Gpx3 and N18Gpx3 interactors in the 
yeast mitochondrial IMS, and determine whether they interact with different proteins. By 
determining mitochondrial-specific interactors, our aim was to elucidate the function/s of 
both Gpx3 and N18Gpx3 in the IMS. Our hypothesis was that Gpx3 is required in the 
defence against oxidative stress within the IMS, and that it also has additional roles akin 
to the multiple roles suggested for the cytosolic pool of Gpx3. Possible roles include 
general H2O2 detoxification to prevent oxidative damage to proteins, preventing lipid 
peroxidation at the IM, and transduction of H2O2 signals via various interaction partners.  
  
Chapter 4 – Investigating the role of Gpx3 in peroxisomes 
Based on the fact that Gpx3 was also found to localise within the peroxisomal matrix 
(Ohdate and Inoue, 2012), an additional aim was to investigate Gpx3 in peroxisomes. 
After confirming its dual-localisation to both organelles, we began to search for putative 
peroxisomal interaction partners. During this work, serendipitous findings led us to 
explore (i) the potential localisation of a shorter, soluble version of Mia40 in peroxisomes 
that may interact with Gpx3 and Trx1, and (ii) the potential localisation of an N-terminally 
extended version of Pex11 in mitochondria. 
  
Chapter 5 – Ypl107w: a putative oxidoreductase of unknown function 
The mass spectrometry data in Chapter 3 uncovered Ypl107w as a previously unidentified 
mitochondrial protein with no known functions despite having a highly conserved 
oxidoreductase-like domain (OXLD). This warranted further consideration which began 
with us performing a thorough bioinformatics analysis of Ypl107w and its homologs whilst 
confirming its mitochondrial localisation. Although Ypl107w was found to localise to the 
mitochondrial matrix, we continued to carry out proteomics and phenotypic analyses in 
order to help elucidate its potential function. 
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2. Materials and methods 
 
2.1. Materials 
  
2.1.1. Plasmids 
  
Table 2.1. List of plasmids. 
  
A list of all plasmids used in this study and where they were obtained from. Plasmids that were 
created for this study were made following the protocol described in Section 2.2.1.3. 
 
 
Plasmids 
Gene Plasmid Source Use 
GPX3 
pET-24/GPX3 (Kritsiligou et al., 2017) Protein purification 
pET-24/N18GPX3 This study Protein purification 
pET-24/N18M20LGPX3 This study Protein purification 
pET-24/GPX3C36S This study Protein purification 
pET-24/GPX3C64S This study Protein purification 
pET-24/GPX3C82A (Kritsiligou et al., 2017) Protein purification 
pSP64/GPX3 (Kritsiligou et al., 2017) Radiolabelled expression 
pSP64/N18GPX3 (Kritsiligou et al., 2017) Radiolabelled expression 
pSP64/N18M20LGPX3 (Kritsiligou et al., 2017) Radiolabelled expression 
CYC1 pET-24/CYC1 This study Protein purification pSP64/CYC1 This study Radiolabelled expression 
YBR124W pSP64/YBR124W This study Radiolabelled expression pSP64/YBR124W3Met This study Radiolabelled expression 
YPL107W 
pSP64/YPL107W This study Radiolabelled expression 
pSP64/N26∆YPL107W This study Radiolabelled expression 
pET-24/YPL107W This study Protein purification 
PEX11 pSP64/PEX11 This study Radiolabelled expression pSP64/N17PEX11 This study Radiolabelled expression 
SU9-DHFR pSP65/SU9-DHFR (Pfanner et al., 1987) Radiolabelled expression 
ERV1 pTUB8/MYC-ScERV1 Sheiner lab Parasite transfection 
TgERV1 pGEX-4T-1/TgERV1 Tokatlidis lab Protein purification pTUB8/MYC-TgERV1 Sheiner lab Parasite transfection 
TgERV2 pGEX-4T-1/TgERV2 Tokatlidis lab Protein purification pTUB8/MYC-TgERV2 Sheiner lab Parasite transfection 
TgERV3 pGEX-4T-1/TgERV3 Tokatlidis lab Protein purification pTUB8/MYC-TgERV3 Sheiner lab Parasite transfection 
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2.1.2. Primers 
  
All primers used in this thesis are listed in Appendices, Table 7.3. 
  
2.1.3. Antibodies 
  
All antibodies used in this thesis are listed in Appendices, Table 7.4. 
  
2.1.4. Bacterial strains and media for bacterial growth 
  
All Escherichia coli strains used in this study are listed in Table 2.2; DH5α cells were used 
to propagate plasmids ready for plasmid DNA extraction whereas DE3 cells with various 
genotypes were used to express plasmids by induction of T7 polymerase with Isopropyl β-
D-1-thiogalactopyranoside (IPTG) ready for protein purification. E. coli were grown in 
either liquid Luria-Bertani (LB) medium (1% (w/v) bacto-tryptone, 0.5% (w/v) yeast 
extract and 1% (w/v) NaCl) or on solid LB plates containing 2% (w/v) agar. All media 
preparations were autoclaved at 121°C for 15 minutes. Media for bacterial growth also 
contained antibiotics where required: 25 µg/ml chloramphenicol or 12.5 µg/ml 
tetracycline for selection of pLysS and ORI cells, 100 µg/ml ampicillin for transformation 
and propagation of pSP64 vectors, and 30 µg/ml kanamycin for pET-24 vectors. 
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Table 2.2. List of bacterial strains. 
 
A list of all bacterial strains used in this study, names used throughout this thesis, where they 
were obtained from and what they were used for. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bacterial strains 
Strain Name Genotype Source Use 
DH5α DH5α 
F– φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 
hsdR17(rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Life Tech Plasmid propagation 
BL21 
(DE3) DE3 
E. coli B F– dcm ompT hsdS(rB– mB–) gal λ(DE3)  Stratagene Plasmid expression 
BL21 
(DE3) 
PLysS 
PLysS 
E. coli B F– dcm ompT hsdS(rB– mB–) gal λ(DE3) BB 
[pLysS Camr] Stratagene 
Plasmid 
expression 
OrigamiTM 
2 (DE3) ORI 
Δ(ara-leu)7697 ΔlacX74 ΔphoA PvuII phoR araD139 
ahpC galE galK rpsL F’[lac+ lacIq pro] (DE3) 
gor522::Tn10 trxB pLysS [CamR, StrR,TetR]  
Novagen Plasmid expression 
BL21-
CodonPlu
sTM (DE3) 
C+ 
E. coli B F– ompT hsdS(rB– mB–) dcm+ Tetr gal λ(DE3) 
endA Hte [argU ileY leuW Camr] Stratagene 
Plasmid 
expression 
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2.1.5. Yeast strains and media for yeast growth 
  
All Saccharomyces cerevisiae strains used in this study are listed in Table 2.3. Yeast were 
grown at 30°C in rich media containing 1% (w/v) yeast extract, 2% (w/v) peptone, plus a 
carbon source: 2% (w/v) glucose (for YPD), 2% (w/v) galactose (for YPG), 2% (w/v) lactic 
acid (for YPL), 3% (w/v) glycerol (for YPGly) or 0.12% (w/v) oleic acid (for YPOle). Solid 
plates also contained 2% (w/v) agar. All media preparations were autoclaved at 121°C for 
15 minutes. Media for yeast growth also contained antibiotics where required, such as 
G418 at 200 µg/ml.  
  
Table 2.3. List of yeast strains.  
  
A list of all yeast strains used in this study, their genotypes, a brief description and either the 
company where they were obtained from or the first publication in which a strain was described. 
 
Yeast strains 
Name Genotype Description Source 
D273-10B MATα mal 
wild-type strain used for 
mitochondrial studies, 
constructed in the Sherman 
lab 
(Sherman, 1964) 
BY4741 MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 
wild-type strain derived 
from S288C 
(Brachmann et al., 
1998) 
gpx3∆ (BY4741) MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, gpx3Δ0 
strain deleted for the 
endogenous GPX3 gene 
Dharmacon – GE 
healthcare 
ypl107w∆ (BY4741) 
MATa, his3Δ1, leu2Δ0, 
met15Δ0, ura3Δ0, 
ypl107wΔ0 
strain deleted for the 
endogenous YPL107W gene 
Dharmacon – GE 
healthcare 
W303 
MATα ,ura3-52, leu2-3, 112, 
trp1-1, ade2-1, his3-11, 15, 
can1-100 
wild-type strain derived 
from S288C, constructed by 
R Rothstein 
Gifted by Prof. C. 
Grant 
trr1∆ (W303) 
MATa ura3–52 leu2–3, 112 
trp1–1 ade2–1 his3–11, 15, 
can1–100, trr1::HIS3 
strain deleted for the 
endogenous TRR1 gene 
Gifted by Prof. C. 
Grant 
trx1/2∆ (W303) 
MATa ura3–52 leu2–3, 112 
trp1–1 ade2–1 his3–11, 15, 
can1–10, trx1::TRP1, 
trx2::URA3 
strain deleted for the 
endogenous TRX1 and TRX2 
genes 
Gifted by Prof. C. 
Grant 
FT5 MATα, ura3-52, trp1-Δ63, his3-Δ200, leu2::PET56 wild-type strain 
(Tzamarias and 
Struhl, 1994) 
galMia40 (FT5) 
MATα, ura3-52, trp1-Δ63, 
his3-Δ200, leu2::PET56 
kanMX- GAL1-10-MIA40 
conditional knock-out strain 
in FT5 background, MIA40 
under the control of the 
GAL1-10 promoter 
(Banci et al., 2009) 
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2.1.6. Solutions and buffers 
  
ACA750: 750 mM aminocaproic acid, 50 mM Bis-Tris, 0.5 mM EDTA, adjusted to pH 7.0 
with HCl 
Binding buffer: 150 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM DTT 
Blocking buffer: 1 X PBS, 0.2% (v/v) Triton-X-100, 2% (w/v) BSA 
BN acrylamide solution: 48% acrylamide, 1.5% bisacrylamide 
BN gel buffer: 100 mM Bis-Tris-HCl pH 7.0, 1 M 6-aminocaproic acid 
Breaking buffer (isotonic buffer): 600 mM sorbitol, 20 mM HEPES-KOH pH 7.4  
Buffer A: 150 mM NaCl, 50 mM Tris-HCl pH 8.0, 10% (w/v) glycerol 
Buffer B: 8 M urea, 50 mM Tris-HCl pH 8.0, 50 mM NaCl 
Coomassie buffer (for Tricine gels): 30% (v/v) methanol, 10% (v/v) acetic acid, 0.2% (w/v) 
Coomassie Brilliant Blue R-250 
Coomassie buffer (for BN-PAGE gels): 50% (v/v) methanol, 7% (v/v) acetic acid, 0.05% 
(w/v) Coomassie Brilliant Blue R-250 
Denaturing/reducing buffer: 8 M urea, 20 mM DTT, 50 mM HEPES-KOH pH 7.4, (plus 5 
mM EDTA for Gpx3 proteins) 
Destaining buffer (for BN-PAGE gels): 50% (v/v) methanol, 7% (v/v) acetic acid 
Destaining buffer (for Tricine gels): 15% (v/v) methanol, 10% (v/v) acetic acid 
Elution buffer: 50 mM Tris-HCl pH 8.0, 10 mM reduced glutathione 
ETS buffer: 3 mM EDTA, 50 mM Tris-HCl pH 8.0, 3% (w/v) SDS 
Equilibration buffer (for Ni-NTA beads): 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 10 mM 
imidazole, 1 mM PMSF 
Import buffer: 600 mM sorbitol, 2 mM KH2PO4, 50 mM KCl, 50 mM HEPES-KOH pH 7.4, 10 
mM MgCl2, 2.5 mM Na2EDTA pH 7, 5 mM L-methionine, 1 mg/ml fatty acid free BSA 
IP buffer: 50 mM NaCl, 50 mM Tris-HCl pH 7.4, 5 mM EDTA, 2 mM PMSF 
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Lysis buffer (for in vitro binding assays): 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM 
PMSF and either 1% (w/v) DDM or 0.1% (v/v) Trixton-X-100 
Lysis buffer (for yeast genomic DNA extraction): 2% (v/v) Triton-X-100, 1% (w/v) SDS, 100 
mM NaCl, 10mM Tris-HCl pH 8.0, 1 mM EDTA 
Mitoplasting buffer: 20 mM HEPES-KOH pH 7.4, 1 mM DTT 
Native buffer: 50 mM HEPES-KOH pH 7.4 
PBS: 10 mM PO43−, 137 mM NaCl, and 2.7 mM KCl 
Reducing buffer: 20 mM DTT, 50 mM HEPES-KOH pH 7.4 
Renaturing buffer: 150 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM DTT, 10 µM FAD 
Solubilisation buffer (for creating IMS fractions): 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 
10% (w/v) glycerol, 2 mM PMSF  
Solubilisation buffer (for in vitro binding assays): 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 
mM PMSF 
Solubilisation buffer (for pulldown assays): 10 mM Tris-HCl pH 7.4, 50 mM NaCl, 2 mM 
PMSF 
TAE: 40 mM Tris-HCl pH 8.0, 20 mM acetic acid, 1 mM EDTA 
TBST: 150 mM NaCl, 100 mM Tris-HCl pH 7.4, 0.01% (v/v) Tween 20 
Tricine gel buffer: 3 M Tris, 0.3% (w/v) SDS, adjusted to pH to 8.45 with HCl 
Ponceau buffer: 10% (v/v) acetic acid, 0.1% (w/v) Ponceau S 
1-5% milk: 1-5% (w/v) skimmed milk powder, TBST 
5x cathode buffer: 250 mM Tricine, 75 mM Bis-Tris, adjusted to pH 7.0 with HCl 
5% serva blue solution: ACA750, 5% (w/v) Coomassie G250 
6x anode buffer: 300 mM Bis-Tris, adjusted to pH 7.0 with HCl 
6x Laemmli sample buffer (SB): 375 mM Tris-HCl pH 6.8, 40% (w/v) glycerol, 9% (w/v) SDS, 
0.03% (w/v) bromophenol blue, -/+ 600 mM β-mercaptoethanol 
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2.2. Methods 
  
2.2.1. Molecular biology assays 
  
2.2.1.1. Yeast genomic DNA extraction 
  
Yeast cells were pelleted from 15 ml of overnight culture by centrifugation at 3500g for 5 
minutes at room temperature (RT) and the cell pellet washed in dH2O and resuspended in 
lysis buffer. An equal volume of glass beads and phenol:chloroform:isoamyl alcohol 
(50%:49%:1%) was added and then vortexed for 4 minutes. dH2O was added and pelleted 
by centrifugation at 15000g for 5 minutes, RT. The supernatant was then washed twice 
with 100% ethanol and pelleted by centrifugation at 15000g for 5 minutes, RT and 
resuspended in dH2O and RNAase A (75 ng/µl) followed by incubation at 37°C. After 10 
minutes, 150 mM ammonium acetate and 2x volume of 100% ethanol were added 
followed by centrifugation at 15000g for 5 minutes, RT for 2 minutes to pellet the DNA 
before a final resuspension in 50 µl dH2O. 
  
2.2.1.2. PCR 
The primers listed in Table 7.3 were used to amplify S. cerevisiae genes from either yeast 
genomic DNA or plasmid DNA using polymerase chain reaction (PCR). PCR amplifications 
were carried out using a Biometra® T3 Thermocycler. In general, the final concentrations 
of PCR reagents were: 1 X PCR buffer, 1 mM dNTPs (Invitrogen), 0.4 mM of each primer 
(Sigma), 1 ng/µl DNA, and 0.1 u/µl polymerase. For difficult to amplify regions or 
reactions with non-specific products, 1% (v/v) dimethyl sulfoxide (DMSO) and/or 2-5 mM 
MgCl2 were added and the concentration of each primer altered to 0.2-0.8 mM. Different 
polymerases were used depending on whether the PCR amplicon was for use in 
subsequent clonings (Pfu polymerase – high fidelity) or whether it was for gene detection 
only (Taq polymerase – low fidelity). Thermocycling conditions used were: 95°C for 5 
minutes; 35 cycles of 95°C for 2 minutes, 50-60°C for 2 minutes, 72°C for 2-8 minutes; and 
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a final extension at 72°C for 10 minutes. Annealing temperatures and extension times 
varied depending on primer melting points and size of amplicons. 
  
PCR products were visualised by gel electrophoresis on 1% (w/v) agarose gels containing 1 
X TAE buffer and 0.5 X SYBR®Safe DNA gel stain (Invitrogen), and run at 60 V in 1 X TAE 
buffer for 45-60 minutes. Fragment sizes were determined by comparison with a 1 kb 
DNA ladder (Promega). PCR products were cleaned up using either NucleoSpin® Gel and 
PCR Clean-Up (Macherey-Nagel) or QIAEX II beads (QIAGEN) following the manufacturer’s 
protocols. DNA concentrations were measured using a NanoDrop Spectrophotomer ND-
1000 (Thermo). 
  
2.2.1.3. Cloning 
  
For clonings, primers were designed with both 5’ and 3’ restriction enzyme sites (refer to 
Table 7.3) which were then digested alongside the vector of choice. Digestion reaction 
mixes for both inserts (PCR products) and vectors contained 1 X CutSmartTM buffer, 0.4 
u/µl Restriction enzyme I, 0.4 u/µl Restriction enzyme II, and 10 ng/µl DNA in a total 
reaction volume of 50 µl and were incubated at 37°C for 3 hours. Ligations of digested 
vectors with genes of interest were carried out using 1 X Buffer for T4 DNA ligase with 1 
mM ATP, 40 u/µl T4 DNA ligase, plus a ratio of either 1:1, 1:3, 1:5, 1:7, or 1:9 of 
vector:insert in a total reaction volume of 15 µl. Ligation reactions were incubated at 25°C 
for 1-3 hours. All restriction enzymes and ligase reagents were obtained from New 
England BioLabs®. Half of the ligated DNA reaction mix (7.5 µl) was added to 100 µl DH5α 
competent cells and kept on ice for 30 minutes followed by a heat shock at 42°C for 45 
seconds, then 2 minutes on ice. 900 µl LB were added and incubated at 37°C for 1 hour 
and the cells were pelleted by centrifugation at 4000g for 5 minutes. The pellet was 
resuspended in 200 µl LB before plating on LB + 30 µg/ml kanamycin or LB + 100 µg/ml 
ampicillin depending on vector resistance, and plates were left to grow at 37°C overnight. 
Positive colonies were then selected by checking for the presence of the gene of interest 
by using both colony PCR and digestion tests.  
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Colony PCRs were carried out using E. coli DNA (obtained by suspending individual 
colonies in 50 µl dH2O) as a template. The conditions were otherwise as described in 
Section 2.2.1.2. Digestion tests were carried out after plasmid DNA purification (see 
Section 2.2.1.4) in digestion reaction mixes as described in this section. 
  
2.2.1.4. Plasmid DNA purification and sequencing 
  
Plasmid DNA was isolated using a QIAprep® Spin Miniprep Kit (QIAGEN) as per the 
manufacturer’s protocol. Samples were sent to GATC Biotech for Sanger sequencing on 
ABI 3730xl platforms, and sequences were checked and aligned using CLC Genomics 
Workbench 7.  
  
2.2.1.5. Mutagenesis 
  
Primers were designed specifically for mutagenesis PCR (see Table 7.3) to introduce point 
mutations in the DNA sequences of our genes of interest which would result in amino 
acid residue changes. Plasmids containing the genes we wished to mutate were used as 
template DNA, and the high fidelity Accuzyme DNA polymerase (Bioline) was used to limit 
the likelihood of other mutations arising. Reaction conditions were as described in 
Section 2.2.1.2. with the following exceptions: 0.5 µM each primer and a minimum 
extension time of 8 minutes at 72°C. PCR products were then treated with 1 µl DpnI (10 
u/µl) per 50 µl reaction volume and incubated at 37°C for 1 hour to digest all non-
mutated parental plasmid DNA. After DpnI digestion, PCR products were transformed into 
DH5α E. coli as described in Section 2.2.1.3. Positive colonies were confirmed by colony 
PCR and digestion tests also as described in Section 2.2.1.3 followed by plasmid DNA 
purification and sequencing as described in Section 2.2.1.4.  
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2.2.1.6. Protein expression and purification 
  
The expression of proteins from pET-24 and pGEX plasmids were tested in various E. coli 
cells (see Table 2.4) to first determine which cell type and individual colony produced the 
largest quantity of recombinant protein. The pET-24 plasmid introduces a C-terminal 
6xHistidine (His) tag to proteins, whereas pGEX produces glutathione S-transferase (GST) 
fusion proteins. Plasmids were transformed into E. coli as described in Section 2.2.1.3, 
and then induced using IPTG -/+ FAD depending on the protein. Table 2.4 lists all of the 
proteins expressed in this study and their final expression conditions. Individual colonies 
were grown overnight at 37°C in LB plus either 30 µg/ml kanamycin for pET-24 plasmids 
or 100 µg/ml ampicillin for pGEX plasmids. In the morning, a 1:50 dilution of each colony 
was made into fresh LB plus the required antibiotic and incubated at 37°C for 2-3 hours 
until their OD600nm reached 0.4-0.8 (logarithmic growth phase). IPTG was then added, 
along with FAD for proteins requiring FAD as a redox co-factor, for 4-16 hours at 18-30°C. 
  
Table 2.4. List of individual protein expression conditions 
 
A list of all proteins, the plasmids they were expressed from, the cell type they were transformed 
into and the final expression conditions used after small-scale expression and solubility tests. h - 
hours 
 
 
Protein expression conditions 
Protein Plasmid E. coli IPTG/FAD Temp Time 
Gpx3His pET-24/GPX3 DE3 0.4 mM IPTG 37°C 4 h 
Gpx3C36SHis pET-24/GPX3C36S DE3 0.4 mM IPTG 37°C 4 h 
Gpx3C64SHis pET-24/GPX3C64S DE3 0.4 mM IPTG 37°C 4 h 
Gpx3C82AHis pET-24/GPX3C82A DE3 0.4 mM IPTG 37°C 4 h 
N18Gpx3His pET-24/N18GPX3 DE3 0.4 mM IPTG 18°C 16 h 
N18M20LGpx3His pET-24/N18M20LGPX3 DE3 0.4 mM IPTG 18°C 16 h 
N18M20LGpx3C82AHis pET-24/N18M20LGPX3C82A DE3 0.4 mM IPTG 18°C 16 h 
CytcHis pET-24/CYC1 DE3 0.4 mM IPTG 37°C 4 h 
Ypl107wHis pET-24/YPL107W DE3 0.4 mM IPTG 18°C 16 h 
GST pGEX-4T-1 (empty) pLysS 0.4 mM IPTG 37°C 4 h 
GST-TgErv3 pGEX-4T-1/TgERV3 pLysS or C+ 
0.4 mM IPTG, 
10 µM FAD 37°C 4 h 
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After expression, cells were harvested by centrifugation at 3500g for 15 minutes and cell 
pellets resuspended in buffer A plus 0.1 mg/ml lysozyme, 1 mM phenylmethylsulfonyl 
fluoride (PMSF) and left on ice for 5 minutes, followed by an incubation at 37°C for 10 
minutes. To rupture the cells, lysates were freeze-thawed three times (15 minutes at -
80°C, 10 minutes at 37°C) before being passed twice through a French Press machine at a 
stable pressure of 1000 psi. Unbroken cells were then removed by centrifugation at 
3500g for 5 minutes at 4°C, and the supernatant subjected to another centrifugation at 
21000g for 30 minutes at 4°C. The new supernatant containing soluble protein material 
was kept on ice and the pellet containing broken membranes and inclusion bodies was 
resuspended in buffer B and kept at RT. At this point, the solubility of the expressed 
protein was checked by SDS-PAGE and Coomassie staining to reveal which fraction the 
protein was in. If the protein was largely in the supernatant, then it was purified following 
protocol (i) or (ii) depending on whether it contained a His or GST tag; if it was insoluble, 
then it was purified from inclusion bodies following either protocol (iii) or (iv).  
 
i. Soluble His-tagged proteins. The soluble supernatant was loaded onto a column 
containing equilibrated Ni-NTA beads plus 10 mM imidazole. The flowthrough was 
drained and the beads washed with buffer A plus 15 mM imidazole (wash 1). Beads 
were then washed again but with 50 mM Tris-HCl pH 7.4, 50 mM NaCl, 10% glycerol, 
25 mM imidazole (wash 2). His-tagged proteins were eluted in 50 mM Tris-HCl pH 7.4, 
50 mM NaCl, 25% glycerol and 250 mM imidazole.  
 
ii. Soluble GST-tagged proteins. Equilibrated Glutathione Sepharose 4B beads 
(equilibrated in binding buffer) were added to the soluble supernatant and incubate 
for at least 30 minutes at 4°C. The supernatant plus beads were then transferred to a 
column and the flowthrough drained. Beads were then washed three times in binding 
buffer (washes 1-3). GST-tagged proteins were eluted three times in elution buffer.  
 
iii. Insoluble His-tagged proteins. The pellet was resuspended in buffer B  and 5 mM 
DTT added before homogenisation of the pellet and incubation at 30°C for 1 hour, 
followed by centrifugation at 21000g for 30 minutes at 4°C to remove aggregates. The 
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supernatant was kept and diluted with buffer B from 8 M urea to 6 M urea by adding 
buffer A. 10 mM imidazole was then added and the supernatant loaded onto a 
column with equilibrated Ni-NTA beads. The flowthrough was drained and the beads 
washed with buffer A, 6 M urea and 10 mM imidazole (wash 1). Beads were washed 
again but with buffer A, 4M urea and 10 mM imidazole (wash 2), followed by a third 
wash with buffer A, 2 M urea and 20 mM imidazole (wash 3). A final wash with buffer 
A and 20 mM imidazole (wash 4) was carried out before elution in buffer A and 200 
mM imidazole.  
 
iv. Insoluble GST-tagged proteins. The pellet was resuspended in buffer B  and 5 mM 
DTT added before homogenisation of the pellet and incubation at 30°C for 1 hour, 
followed by centrifugation at 21000g. The supernatant was kept and diluted 10 times 
with renaturing buffer then incubated at 4°C for 3-16 hours, followed by 
centrifugation at 21000g for 30 minutes at 4°C to remove aggregates. Equilibrated 
Glutathione Sepharose 4B beads were added to the supernatant (equilibrated in 
binding buffer) and incubated for at least 30 minutes at 4°C. The supernatant plus 
beads were then transferred to a column and the flowthrough drained. Beads were 
washed three times in binding buffer (washes 1-3) before three consecutive elutions 
in elution buffer.  
 
Cleavage of GST 
Thrombin was used to cleave GST from fusion proteins when required; this was done 
either during the purification process or after purification. Cleavage during purification 
happened at the elution stage; instead of releasing GST fusion proteins from Glutathione 
Sepharose beads with reduced glutathione, the protein of interest was released by the 
addition of Thrombin at 1u/100 µg estimated protein for 16 hours at 4°C. Whereas after 
purification, GST fusion proteins were exchanged into a buffer suitable for cleavage – PBS 
– followed by the addition of Thrombin at 1u/100 µg protein for 16 hours at 4°C. Cleaved 
GST was then removed by the addition of Glutathione Sepharose beads for 3 hours at 4°C 
with the flowthrough then containing the protein of interest without GST.  
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2.2.1.7. ÄKTA FPLC 
  
  
After each purification, proteins were analysed for their purity, estimated molecular 
weight and oligomeric state using an ÄKTA Fast Protein Liquid Chromatography (FPLC) 
machine (GE Healthcare), with UNICORN 6.3 software. Proteins were exchanged into 
buffers suitable for use in the ÄKTA, and the ÄKTA was equilibrated in the same buffer – 
all buffers were degassed prior to use. All aggregated proteins were removed from 
protein samples prior to injection into the machine by centrifugation at 16000g for 5 
minutes at 4°C. Each injected sample contained around 100 µg protein which was then 
passed through a Superdex 200 10/300 GL (GE Healthcare) gel filtration column to 
separate proteins and complexes based on molecular weight. Sample protein mixes of 
known molecular weights (Table 2.5) were also passed through the column to generate a 
standard curve and equation (Figure 2.1) which was then used to calculate the 
approximate molecular weights of proteins of interest.  
  
Table 2.5. List of ÄKTA protein standards.  
  
Analysis of protein standards using an ÄKTA FPLC with a Superdex 200 10/300 GL gel filtration 
column. VE – retention volume in ml; VO – void volume at which Blue dextran elutes. The VE/VO 
ratio is calculated for each sample protein and used to generate the standard curve and equation 
shown in Figure 2.1.  
ÄKTA protein standards 
Protein Mr (Da) Retention volume (ml) (VE) VE/VO 
Blue dextran 2000000 8.8 (=VO) 1 
Thyroglobulin 660000 9.7 1.1 
Ferritin 440000 10.5 1.19 
Aldolase 158000 12.6 1.43 
Conalbumin 75000 13.9 1.58 
Ovalbumin 44000 15.1 1.72 
Carbonic anhydrase 29000 16.3 1.85 
Ribonuclease A 13700 17.6 2 
Aprotinin 6500 19.3 2.19 
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Figure 2.1. Mr standard curve for ÄKTA protein standards. Graph shows the standard 
curve and equation generated by analysed protein standards using a Superdex 200 10/300 GL gel 
filtration column. Protein samples of unknown molecular weight can be approximated using the 
equation shaded in grey. Mr (Da) – molecular weight in Daltons; VE/VO – retention volume in ml 
divided by the void volume calculated from Blue dextran (see Table 2.5). Blue dashed line 
represents Mr (Da); solid black line represents the exponential Mr (Da).  
  
2.2.1.8. Radiolabelled protein production 
  
35S-methionine labelled precursor proteins were synthesised using a TNT® SP6 Quick 
Coupled Transcription/Translation System (Promega) following the manufacturer’s 
protocol. Plasmids whereby gene expression is under the control of the SP6 polymerase 
promoter were used – pSP64 and pSP65. The radioactive reaction mixes were incubated 
at 30°C for 90 minutes shielded by foil, followed by centrifugation at 55000rpm in a 
TLA100 rotor for 15 minutes at 4°C to separate precursors from ribosomes.  
  
2.2.1.9. Tris-Tricine SDS-PAGE, western blotting and 
autoradiography 
  
Tris-Tricine SDS gels were prepared following the protocol by Schägger 2006, and all 
samples were resuspended in 2 X Laemmli sample buffer -/+ β-mercaptoethanol and 
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boiled at 95°C for 5 minutes prior to loading into wells. Gels were run at 60-180 V for 60-
120 minutes and were then either soaked in Coomassie buffer for 5 minutes followed by 
destaining in destain buffer to detect proteins, or transferred onto nitrocellulose 
membranes using a Bio-Rad Semi-Dry Transfer System at a constant 25 V for 25 minutes. 
Prior to western blotting or autoradiography, membranes were soaked in Ponceau buffer 
for 2-3 minutes to stain the transferred proteins and check whether the transfer was 
successful. The Ponceau stain was then removed by soaking the membranes in dH2O. For 
western blotting, membranes were blocked in a 5% milk solution at RT for at least one 
hour. After blocking, membranes were washed three times in TBST for 5 minutes before 
the addition of primary antibodies (diluted to working concentrations of 1:500-2000 in 1-
5% milk – see Table 7.4) for 1-3 hours at RT or overnight at 4°C. Unbound primary 
antibodies were removed and membranes were washed three times in TBST for 5 
minutes before the addition of secondary antibodies (diluted to 1:10000 in 1% milk for 
Horseradish Peroxidase (HRP)-labelled antibodies or dH2O for fluorescently-labelled 
antibodies) for 1 hour at RT. Unbound secondary antibodies were removed and 
membranes were washed twice in TBST for 5 minutes before a final wash in dH2O for 5-10 
minutes. HRP-labelled antibodies were detected using X-ray films whilst fluorescently-
labelled antibodies were detected using a LI-COR Odyssey CLx quantitative fluorescence 
imaging system. For autoradiography, membranes were placed into a cassette directly 
after removal of the Ponceau stain and left for 2-3 days before being visualised by a 
digital Phosphoimager (Fujifilm FLA-7000). 
  
2.2.1.10. Silver staining 
SDS-PAGE gels were fixed in 50% (v/v) methanol and 10% (v/v) acetic acid for 30 minutes 
at RT before being washed twice in dH2O for 15 minutes per wash. Gels were then soaked 
in 0.005% (w/v) sodium thiosulfate for 30 minutes at RT before being transferred into 
cold 0.1% silver nitrate. After another 30 minutes, gels were washed in dH2O for no more 
than 30 seconds before soaking in 0.036% (v/v) formaldehyde and 2% (w/v) sodium 
carbonate. After 1-2 minutes, the solution was then poured off and the gels were soaked 
in 50 mM EDTA for 15 minutes. This protocol was kindly provided by Esther Nuebel.  
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2.2.2. In organello assays  
  
2.2.2.1. Isolation of yeast mitochondria and peroxisomes 
  
Isolation of mitochondria only 
Mitochondria were isolated and purified as described in Glick 1991 from wild-type D273-
10B, wild-type BY4741, gpx3∆ and ypl107w∆ yeast. Cells were grown in liquid YPLac at 
30°C to promote mitochondrial respiration and proliferation of mitochondria – this 
medium does not allow yeast to produce energy by glycolysis in the cytoplasm, thus the 
only cells that survive are those that have functional mitochondria (Turcotte et al., 2010). 
After isolation, mitochondria were stored at -80°C in breaking buffer plus 10 mg/ml fatty 
acid free BSA to stabilise the mitochondrial membranes. Mitochondrial protein 
concentration was measured by reading the absorbance at 280 nm using a UV 
spectrophotometer and the equation: mg/ml = A280/0.12 x 10.  
  
Isolation of mitochondria and peroxisomes from the same yeast culture 
Mitochondria and peroxisomes were isolated and purified following the protocol 
published in Current Protocols in Cell Biology, volume 1, 3.8.32 ‘Isolation of oleate-
induced peroxisomes using sucrose step gradients’ (Rieder and Emr, 2001) with the 
exception that Nycodenz step gradients were used instead of sucrose (as described in 
Ohdate and Inoue, 2012). Wild-type D273-10B, galMia40 and gpx3∆ yeast were grown in 
liquid YPOle media at 30°C to induce peroxisomal proliferation. After isolation, both 
mitochondria and peroxisomes were stored separately at -80°C in breaking buffer plus 10 
mg/ml fatty acid free BSA.  
  
2.2.2.2. Mitochondrial import assay 
  
Purified recombinant His-tagged proteins or radiolabelled precursors were used in 
mitochondrial import assays. All His-tagged proteins, and radiolabelled proteins requiring 
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denaturing/reducing treatment before import, were precipitated in 2 volumes 
ammonium sulphate for 30 minutes on ice and pelleted by centrifugation at 25000g for 
30 minutes at 4°C. Proteins were resuspended in either native buffer, reducing buffer or 
denaturing/reducing buffer and incubated for 30-90 minutes at 4-30°C (or ice for native 
buffer) depending on the protein (see Table 2.6). Afterwards, proteins were incubated 
with isolated mitochondria (following a rule of 6.25 μg His-tagged protein or 5 μl 
radiolabelled protein with 50 μg mitochondria) in an import reaction mix containing 1 X 
Import buffer plus 50% (w/v) mitochondria, 2 mM ATP and 2.5 mM NADH for 10-30 
minutes at 30°C followed by centrifugation at 15000g for 5 minutes at 4°C. Mitochondria 
pellets were resuspended in Breaking buffer plus 0.1 mg/ml Trypsin and left on ice to 
digest unimported proteins. A control import reaction whereby 1% (v/v) Triton-X-100 was 
added at this stage was carried out for each assay to solubilise the mitochondrial 
membranes and allow the protease to destroy imported as well as unimported material. 
After 30 minutes, 1 mM SBTI was added and incubated on ice for a further 10 minutes to 
inhibit Trypsin. Mitochondria were then pelleted by centrifugation at 15000g for 5 
minutes at 4°C, and resuspended in 2 X Laemmli sample buffer with β-me, then analysed 
by SDS-PAGE and visualised either by western blotting using anti-His or digital 
autoradiography using a Phosphoimager (Fujifilm FLA-7000) to detect His-tagged proteins 
and radiolabelled proteins, respectively. 
 
Table 2.6. Treatment conditions for proteins prior to their mitochondrial import  
 
 
Treatment conditions for mitochondrial import 
Protein Buffer Temp Time 
All Gpx3 proteins Native buffer Ice n/a Denaturing and reducing buffer 30°C 90 minutes 
Pex11 (radiolabelled) Native buffer Ice n/a 
CytcHis Native buffer Ice n/a 
Ybr124w-3Met 
Native buffer Ice n/a 
Reducing buffer 30°C 30 minutes 
Denaturing and reducing buffer 30°C 60 minutes 
Ypl107w 
Native buffer Ice n/a 
Reducing buffer Ice 30 minutes 
Denaturing and reducing buffer Ice 30 minutes 
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2.2.2.3. Mitochondrial localisation assay 
  
Radiolabelled proteins were produced and imported into mitochondria as described in 
Sections 2.2.1.1 & 2.2.2.2 respectively. After treatment with Trypsin/SBTI to remove 
unimported material, the following protocols were used to determine which subcellular 
compartment the imported material resides in and whether it is likely a soluble, 
peripheral membrane or integral membrane protein. 
 
Mitoplasting 
To create mitoplasts (mitochondria without their outer membrane), mitochondria were 
resuspended in 1 X import buffer at a protein concentration of 5 mg/ml, and then diluted 
nine times in a hypotonic mitoplast buffer (-/+ 0.1 mg/ml Proteinase K (PK)) to a final 
concentration of 0.5 mg/ml and incubated on ice for 20 minutes, followed by the addition 
of 2 mM PMSF for 10 minutes to inactivate PK. Samples were then centrifuged at 16000g 
for 5 minutes at 4°C; supernatants contained soluble IMS proteins, whereas pellets 
contained mitoplasts along with fragments of the outer membrane.  
 
Carbonate extraction 
To separate soluble from membrane-bound proteins, 0.1 M ice-cold sodium carbonate 
was added to intact mitochondria after import at a final protein concentration of 0.5 
mg/ml, and incubated on ice for 30 minutes. Samples were then centrifuged at 55000rpm 
using a TLA100 rotor for 30 minutes at 4°C; supernatants contained soluble mitochondrial 
proteins, whereas pellets contained membrane bound proteins.   
 
Urea extraction 
To extract peripherally associated membrane proteins, mitoplasting was carried out 
followed by extraction with urea. After mitoplasting, as described above, mitoplasts were 
resuspended in 1 x breaking buffer plus either 3 M urea or 5 M urea and incubated on ice 
for 30 minutes. Samples were then centrifuged at 55000rpm using a TLA100 rotor for 30 
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minutes at 4°C; supernatants contained peripheral-associated proteins, whereas pellets 
contained integral membrane proteins.   
  
2.2.2.4. Pulldown assay using His-tagged proteins 
  
His-tagged protein were imported into mitochondria as described in Section 2.2.2.2, 
followed by solubilisation of mitochondrial membranes using 1% n-Dodecyl β-D-maltoside 
(DDM) in solubilisation buffer for 30 minutes on ice. For pulldown experiments, 375 μg 
precursor protein and 3mg of isolated mitochondria were used. Solubilised mitochondrial 
membranes were pelleted by centrifugation at 16000g for 30 minutes. The supernatant 
containing the released mitochondrial proteins was kept. 10 mM imidazole was added to 
the supernatant before loading onto Ni-NTA beads which were equilibrated in 
solubilisation buffer plus 10 mM imidazole for five minutes at RT. The supernatant was 
left binding to the Ni-NTA beads for 30 minutes, 4°C, and rotating 360°. The beads were 
then centrifuged at 5000g for one minute and the flow through discarded. Wash buffer 1 
(solubilisation buffer, 20 mM imidazole) was added to the beads for 10 minutes, 4°C, 
rotating 360°, and followed by centrifugation at 5000g for one minute. The flow through 
from wash 1 was discarded. Wash buffer 2 (solubilisation buffer, 40 mM imidazole) was 
added to the beads for 10 minutes, 4°C, rotating 360°. Finally, to elute the bound material, 
300-400 mM imidazole in solubilisation buffer was added to the beads and left to rotate 
360° at 4°C for 30 minutes. Beads were then centrifuged at 5000g for one minute and the 
eluates kept; 1/3 (equivalent to 800 μg mitochondria) was analysed by SDS-PAGE and 
western blotting, the remaining 2/3 was sent for mass spectrometry analysis. In case the 
elution buffer did not successfully elute all of the bound material, 2 X sample buffer plus 
β-me was added to the beads, vortexed, centrifuged at 16000g for five minutes, vortexed, 
boiled at 95°C for five minutes, and frozen at -20°C. See Figure 3.7 for an illustration of 
the pulldown. The control for this experiment consisted of repeating the above protocol 
without the import of His-tagged proteins. Control eluates were also analysed by SDS-
PAGE followed by western blotting and mass spectrometry. 
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2.2.2.5. Complex immunoprecipitations 
  
Method I – endogenous protein Co-IP 
Isolated wild-type mitochondria from D273-10B yeast were solubilised as described in 
Section 2.2.2.4. The supernatant containing soluble mitochondrial proteins was then split 
into multiple 1.5 mL tubes so that each tube contained 50 µg of solubilised material (at a 
concentration of 1 µg/µl), along with 1.2 mL IP buffer, plus either 4 µl undiluted anti-Gpx3, 
4 µl undiluted anti-Cytc, 4 µl undiluted pre-immune serum (PI) or nothing (extra control). 
Tubes were then rotated at 360° for two hours at 4°C. Afterwards, 30 µl of pre-
equilibrated protein A beads were added to each tube and left rotating at 360° for a 
further hour at 4°C. Protein A beads were equilibrated in IP buffer with the addition of 3% 
BSA for 30 minutes shaking at RT, followed by a mild spin at 3000g for one minute before 
resuspension in fresh IP buffer. The tubes were then spun at 3000g for one minute and 
the supernatant removed. The beads were resuspended in 1.5 mL fresh IP buffer and 
spun again. To elute any bound material, the beads were resuspended in 20 µl 2 X sample 
buffer without β-me and then vortexed, boiled for five minutes, followed by a final vortex 
and spin at 16000g for 5 minutes at RT. The elutions step was repeated twice and the 
supernatants combined. Samples were then analysed by SDS-PAGE and visualised by 
western blotting using anti-Gpx3 or anti-Cytc.  
 
Method II – radiolabelled Co-IP 
Radiolabelled Gpx3 and Cytc were produced following the protocol described in Section 
2.2.1.8 and imported into isolated wild-type mitochondria from D273-10B yeast as 
described in Section 2.2.2.2. Mitochondria were then solubilised as described in Section 
2.2.2.4. After this, the Co-IP protocol was the same as that described above, apart from 
the visualisation which was carried out by digital autoradiography. 
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2.2.2.6. BN-PAGE 
  
Gel and sample preparation 
6-16% Bis-Tris gradient gels were made on the same day as use. Separate 6% and 16% Bis-
Tris gel solutions were made fresh by adding the appropriate amount of BN acrylamide 
solution in 0.5 x BN gel buffer (plus 14.5% glycerol in the 16% solution) and mixed using a 
gradient mixer on a stir plate, followed by the addition of a stacking solution (4% Bis-Tris, 
0.5 x BN gel buffer). For samples of 50-100 µg mitochondria, mitochondria were first 
washed in 1 x breaking buffer and centrifuged at 16000g for 5 minutes at 4°C. The 
supernatant was removed and mitochondrial pellets were resuspended in 45 µl ACA750, 
followed by the addition of 5 µl 10% (w/v) DDM which was freshly made in dH2O from a 
powdered stock. Samples were incubated on ice for 5 minutes then centrifuged at 16000g 
for 10 minutes at 4°C. Supernatants were transferred to new tubes and 2.5 µl of 5% serva 
blue solution were added. Samples were kept on ice until loading. 
 
Gel running and visualisation 
Everything at this stage was carried out in a cold room at 4°C. The gel tank was prepared 
by filling the out chamber with 1 x anode buffer and the inner chamber with 1 x cathode 
buffer (plus 0.02% Coomassie G250 – dark blue). Samples were loaded into wells, along 
with a native protein marker (Amersham HMW Calibration Kit for Native Electrophoresis). 
Gels were run at 100 V (4-10 mA) for around 45 minutes, until the dye front had moved a 
third of the gel length down. The 1 x cathode buffer (dark blue) was then removed and 
replaced with 1 x cathode buffer (plus 0.002% Coomassie G250 – light blue), and gels 
were run at 250 V (15 mA) for a further 2-3 hours until the dye front was at the bottom of 
the gel. For Coomassie staining, gels were incubated in BN-PAGE Coomassie stain for 1-12 
hours, followed by multiple washes in BN-PAGE destaining buffer. For digital 
autoradiography and western blotting, gels were soaked in 1 x cathode buffer and then 
transferred to Polyvinylidene fluoride (PVDF) membranes, which had been pre-soaked in 
100% methanol then soaked in 1 x cathode buffer, using a Bio-Rad Semi-Dry Transfer 
System at a constant 25 V for 3 hours. After transfer, membranes were either visualised 
using a Phosphoimager (Fujifilm FLA-7000) or incubated with antibodies, as described in 
Section 2.2.1.9. This BN-PAGE protocol was kindly provided by Andrew Mclean. 
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2.2.3. In vitro assays 
  
2.2.3.1. In vitro binding assay using Ni-NTA beads 
  
Isolated mitochondria or peroxisomes were lysed in 1 ml solubilisation buffer for 30 
minutes on ice followed by centrifugation at 16000g for 30 minutes at 4°C. His-tagged 
proteins were precipitated in 2 volumes saturated ammonium sulphate for 30 minutes on 
ice and pelleted by centrifugation for 30 minutes at 25000g at 4°C followed by 
resuspension in lysis buffer plus 10 mM imidazole. A 20 μg amount of His-tagged protein 
(0.02 μg/μl) was added to 20 μl equilibrated Ni-NTA beads for 30 minutes at 4°C, rotating 
at 360°. Beads were centrifuged at 3000g for 1 minute followed by the addition of 1 mg 
solubilised mitochondrial (or peroxisomal proteins) plus 10 mM imidazole for 60 minutes 
at 4°C, rotating 360°. Beads were centrifuged again at 3000g for 1 minute, then washed 
three times in 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 10 mM imidazole, and 1 mM PMSF 
for 5-10 min per wash at 4°C, rotating 360°, followed by a final wash in 50 mM Tris-HCl pH 
7.4, 150 mM NaCl, 20 mM imidazole, and 1mM PMSF. Beads were then incubated in 50 
mM Tris-HCl pH 7.4, 150 mM NaCl and 300-400 mM imidazole for 30 minutes at 4°C, 
rotating 360°, followed by a final centrifugation to collect eluates containing His-tagged 
proteins and interaction partners. Samples were analysed by SDS-PAGE/western blotting.  
  
2.2.3.2. In vitro protein-protein interaction assay 
  
Proteins were precipitated in 2 volumes ammonium sulphate and resuspended in 50 mM 
Tris-HCl pH 8.0 before the addition of either 20 mM DTT or 200 µM H2O2 for 30 minutes 
at 30°C or RT, respectively. Per interaction, 50 μg of each protein were incubated 
together in 1 ml 50 mM Tris-HCl pH 8.0 for the desired amount of time at 30°C followed 
by TCA precipitation. TCA was added to a 10% final concentration for 20 minutes on ice 
then centrifuged at 16000g for 20 minutes at 4°C. Precipitates were then washed in 100% 
ice cold acetone, centrifuged again, air dried and resuspended in ETS buffer plus 15 mM 
AMS for 30 minutes at 30°C, followed by another 30 minutes at 37°C. 6 X Laemmli sample 
buffer (-βme) was added and samples were analysed by SDS-PAGE and western blotting.  
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2.2.4. In vivo assays 
  
2.2.4.1. Yeast growth, drop tests and sensitivity assays 
  
Liquid growth assays 
Individual yeast colonies were grown overnight at 30°C in liquid YPD then diluted the next 
morning to an OD600nm of 0.05 in each required media, i.e. liquid YPD, YPLac, YPGly or 
YPOle. Cells were then incubated at 30°C and cell density was measured (at OD600nm) 
every 2 hours until 16 hours had been reached.  
 
Drop tests 
Individual yeast colonies were grown overnight at 30°C in liquid YPD then diluted the next 
morning to an OD600nm of 0.1 in autoclaved dH2O. Serial dilutions were then made to 0.01, 
0.001 and 0.0001, and 2.5 μl from each were spotted onto YPD, YPLac and YPGly plates. 
Plates were then incubated for 48 hours at 30°C.  
 
H2O2 sensitivity assay 
Individual yeast colonies were grown overnight at 30°C in liquid YPD then diluted the next 
morning to an OD600nm of 0.1 in autoclaved dH2O and 400 μl spread onto individual YPD 
plates. Once dried, a 5 μl drop of 8.8 M H2O2 was spotted onto the centre of each plate. 
Plates were left to dry again and then incubated for 24 hours at 30°C. Diameters of the 
clear ‘halo’ zones were measured in mm using a ruler.  
 
Diamide sensitivity assay 
Individual yeast colonies were grown overnight at 30°C in liquid YPD then diluted the next 
morning to an OD600nm of 0.1 in autoclaved dH2O. Serial dilutions were then made to 0.01, 
0.001 and 0.0001, and 2.5 μl from each were spotted onto YPD plates containing either 0, 
2.0 or 2.5 mM diamide. Plates were then incubated for 72 hours at 30°C. 
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2.2.4.2. Immunofluorescence assay 
  
Part I – parasite transient transfection 
Plasmids suitable for expression in T. gondii were transfected into lysed T. gondii (host 
cells were human foreskin fibroblasts, which were obtained from ATCC (cat no. CRC1041)). 
Parasites were resuspended in cytomix (350 μl per transfection) and transferred to 
cuvettes suitable for electroporation. Plasmid DNA was then added at a concentration of 
1 μg/μl (50 μg total DNA required per transfection). Cuvettes were then shock pulsed at 
1700V and the parasites placed in petri dishes containing host cells and DMEM–
Dulbecco's Modified Eagle Medium (GIBCO).  
 
Part II – Immunofluorescence preparation 
After 24-48 hours, when the parasites had lysed, all media was removed from the dishes 
and 3.7-4% (v/v) paraformaldehyde (PFA) was added for 20 minutes at RT. PFA was then 
removed and the dishes were washed three times with PBS before adding blocking buffer 
for 20 minutes at RT. Blocking buffer was then removed and primary antibodies (anti-myc 
at 1:1000 in blocking buffer) were added for 1 hour at RT. Primary antibodies were 
removed and the dishes washed three times in PBS for 5 minutes per wash before adding 
secondary antibodies (anti-mouse 680 (red) or 488 (green) at 1:500 in blocking buffer). 
After incubation in the dark for 45 minutes at RT, the secondary antibodies were removed 
and the dishes washed three times in PBS for 5 minutes. Glass slides were removed from 
the bottom of the dishes containing the host cells and parasites, and mounted on slides 
suitable for confocal microscopy using DAPI-fluoromount-G (Invitrogen).  
 
Part III – Confocal microscopy 
Slides were visualised using a DeltaVision microscope (RT deconvolution, Olympus 
Uplan/Apo) at 100x zoom using SoftWoRx 5.5 and analysed using ImageJ. 
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2.2.5. Mass spectrometry 
  
Eluates were sent to the Glasgow Polyomics facility for mass spectrometry analysis. First, 
the eluates containing His-tagged proteins and their interacting proteins were digested 
with Trypsin using the filter-aided sample preparation (FASP) protocol. The digested 
peptides were then separated by RP-UPLC on C18, followed by analysis using a Bruker 
Amazon Speed ion trap (ESI-TRAP) to collect MS and MS/MS data. This data was then 
searched using the Mascot search engine against a Saccharomyces database (database: 
NCBInr 20150301, taxonomy: S. cerevisiae) with the following analysis criteria: fixed 
modifications (carbamidomethyl); variable modifications (oxidation); mass values 
(monoisotopic); protein mass (unrestricted); peptide mass tolerance (-/+ 0.4 Da); 
fragment mass tolerance (-/+ 0.4 Da); maximum missed cleavages (1); and MudPIT 
scoring with a significance threshold of p<0.05. 
 
2.2.6. Circular dichroism 
  
Circular dichroism measurements were obtained using a Jasco J-810 spectropolarimeter 
at 20°C and was carried out by Dr Sharon Kelly at the University of Glasgow. A 0.02cm 
pathlength quartz cuvette was used to measure far UV spectra between the 190 – 250 nm 
wavelength range. A 0.2cm pathlength quartz cuvette was used to measure near UV 
spectra between the 250 – 320 nm wavelength range. The scan rate was 10 nm/minute 
with 1 nm bandwidth and a two second response time. Three spectra were recorded from 
each sample and averaged, and all spectra were corrected for cell pathlength and protein 
concentration. 
  
2.2.7. Electron microscopy 
Individual yeast colonies were grown overnight at 30°C in liquid YPD then diluted the next 
morning to an OD600nm of 0.05 in fresh liquid YPD. Once the cells reached an OD600nm of 
0.7-1.0, they were washed twice in PBS at 4°C and centrifuged at 3000g for 5 minutes. 
After this, the cells were fixed in 2% glutaraldehyde, 1 mM CaCl2 and 0.1 M sodium 
cacodylate pH 7.2 for 30 minutes at 4°C followed by centrifugation at 3000g for 5 minutes 
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at RT. Cells were then washed three times in 0.1 M sodium cacodylate for 5 minutes per 
wash at RT, followed by centrifugation at 3000g for 5 minutes. Pelleted cells were 
resuspended in 50 mM Tris-HCl pH 7.4, 5 mM MgCl2, 1.4 M sorbitol, 0.5% (v/v) 2-
mercaptoethanol and 0.15 mg/ml Zymolyase 20T (AMS Biotechnology Europe) and 
incubated for 15 minutes at RT. After removal of the cell wall by Zymolyase, the cells 
were washed four times in 0.1 M sodium cacodylate buffer for 5 minutes at RT before a 
final centrifugation at 3000g for 5 minutes. At this point, the cells were handed over to 
Margaret Mullin at the Electron Microscopy Facility (University of Glasgow) who followed 
an electron microscopy protocol designed for the visualisation of yeast membrane 
structures published by Bauer et al. (2001). A transmission electron microscope (TEM) 
was used. 
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3. Identifying mitochondrial protein interactors of yeast Gpx3 
  
3.1. Introduction 
  
Gpx3 is a thiol peroxidase in S. cerevisiae with a well-established role as a major H2O2 
sensor in the cytosol. The reaction that Gpx3 catalyses is: Gpx3(-SH) + H2O2 → Gpx3(-SOH) 
+ 2H2O; the sulphenylated form of Gpx3 can then form transient conjugates with other 
proteins via intermolecular disulphides, or, form an intramolecular disulphide bond Gpx3 
(S-S). The oxidised form of Gpx3(S-S) is then reduced by Thioredoxin. The most 
characterised partner of Gpx3 within the cytosol is the transcription factor Yap1, its 
interaction with Gpx3 results in its nuclear accumulation and subsequent activation of 
more than 70 stress response genes, as explained in Chapter 1, Section 1.6  (Delaunay et 
al., 2002; Veal et al., 2003; Ma et al., 2007; Okazaki et al., 2007; Ouyang et al., 2011). 
However, additional functions are either known or hypothesised to exist based on 
interactome data using whole yeast cell extracts; these include roles in metabolism and 
protein homeostasis, some of which have been investigated in more detail (Kho et al., 
2006; Lee et al., 2007; Lee et al., 2008; Tarassov et al., 2008; Lee et al., 2009; Lee et al., 
2011). 
  
The majority of Gpx3 interaction partners identified in these studies were predominantly 
cytosolic; only four exhibit mitochondrial localisation (Alo1, Grx2, Tfa1 and Tdh2) (Lee et 
al., 2008; Tarassov et al., 2008), though it cannot be inferred in which cellular 
compartment these interactions occur. At the time, it was thought that Gpx3 was solely 
cytosolic; it was not until 2012 that Gpx3 was found within an IMS fraction during a 
proteomics analysis by Vögtle et al. (2012) and later confirmed by Kritsiligkou et al. (2017). 
This raises the question as to what the role of Gpx3 is in the IMS – the smallest, but highly 
redox active, mitochondrial subcompartment.  
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Only two of the proteins previously identified are likely interactors of the IMS pool of 
Gpx3 based on their sub-mitochondrial localisation: Alo1 and Grx2. Alo1 is an integral 
outer membrane (OM) protein that catalyses the final step in dehydro-A-arabinono-1,4-
lactone synthesis, an enantiomer of ascorbate that is protective against oxidative stress 
(Kenney et al., 1979). Glutaredoxin 2 (Grx2) is a glutathione-dependent disulphide 
oxidoreductase known to reside in the IMS in small amounts but it is largely found in the 
cytosol (Kojer et al., 2015). There is no current evidence to suggest the other two 
interactors of Gpx3, Tfa1 and Tdh2, localise to the IMS. 
 
Work carried out in our lab previously and during the course of this PhD identified Mia40, 
an oxidoreductase that is a key player of the oxidative folding mitochondrial protein 
import machinery, as an interactor of Gpx3 (Kritsiligkou et al., 2017). In these studies, it 
was shown that one role of the IMS-localised Gpx3 is to maintain the redox state of 
Mia40 in the IMS, promoting efficient mitochondrial protein import via the Mia40 
pathway. However, additional interaction partners are still thought to exist. It has also 
been shown that an N-terminally extended version of Gpx3 exists, denoted as N18Gpx3, 
which leads to more efficient targeting of Gpx3 to the IMS, and an increased affinity to 
mitochondrial membranes (Vögtle et al., 2012; Kritsiligkou et al., 2017; Tokatlidis, 
unpublished obs.). The work in this chapter has investigated such additional putative 
protein interactors of Gpx3 and also of N18Gpx3. Identifying these will help elucidate 
their roles within the IMS. 
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3.2. Aims 
  
In this chapter, the aim was to identify protein partners of the H2O2 sensor Gpx3 and 
N18Gpx3 in the mitochondrial IMS in order to elucidate their function(s) in the IMS. 
Whilst much is known about the role of Gpx3 in the cytosol (see Chapter 1, Section 1.6), 
for example its interaction with Yap1, very little is understood about Gpx3 in the IMS. As 
an initial screening method, pulldowns from mitochondrial fractions were performed 
after import of His-tagged Gpx3/N18Gpx3 proteins and putative partners were identified 
by mass spectrometry. Cysteine trap mutant forms of Gpx3 and N18Gpx3 whereby the 
resolving cysteine was mutated to alanine (C82A) were also used in order to capture 
mixed disulphide intermediates and identify partner proteins that rely on intermolecular 
disulphide bonds. Once a list of putative proteins had been generated, in vitro binding 
assays were carried out to help confirm some of these partners. The interaction between 
Gpx3 and one such partner, Cytochrome c (Cytc), was investigated further using in vitro 
interaction assays and immunoprecipitations. 
  
Alternative approaches were also sought, including expression of an endogenously tagged 
Gpx3 in yeast (Gpx3-TAP) and the expression of yeast plasmids harbouring tagged 
versions of Gpx3 (Gpx3-V5). The aim was to confirm that these tagged versions were 
successfully expressed in yeast and that the tags did not affect their mitochondrial 
localisation. If confirmed, mitochondria would be isolated from these strains and 
pulldowns would be performed. 
  
Finally, the mitochondrial import of two proteins with unknown localisation and function 
that were identified in the mass spectrometry data analysis was tested – Ybr124w and 
Ypl107w.     
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3.3. Results 
  
3.3.1. Purification of Gpx3 and N18Gpx3 proteins 
   
To begin, recombinant Gpx3 and N18Gpx3 proteins were expressed and purified from E. 
coli with a C-terminal 6xHistidine (His) tag for use in subsequent pulldown and in vitro 
binding assays. GPX3 had previously been cloned by a former lab member into a pET-24 
vector (Novagen) which includes a multiple cloning site followed by a sequence encoding 
a 6xHis tag (Chatzi, unpublished obs.). Here, the N18GPX3 sequence was cloned in a 
similar manner and both constructs were sent for sequencing to ensure that no 
mutations had arisen during the cloning process, or within storage. Both the pET-24/GPX3 
and pET-24/N18GPX3 plasmids contained the correct gene sequences with no mutations, 
deletions or insertions (sequencing data not shown). The plasmids were then transformed 
into BL21 (DE3) E. coli for bacterial expression and induced using IPTG. Proteins were 
purified by affinity chromatography using Ni-NTA columns, either from the soluble 
(supernatant) or insoluble (pellet containing inclusion bodies from which the protein was 
extracted after denaturation) fractions after cell disruption, depending on their solubility. 
 
As Gpx3 had previously been expressed and purified a former lab member the optimal 
conditions were already determined and it was known to be an easily expressed, soluble 
protein (Chatzi, unpublished obs.). Following a pre-established protocol as described in 
Chapter 2, Section 2.2.1.6, a fresh stock of Gpx3 was purified for use in subsequent 
experiments (Figure 3.1A). In addition, single cysteine mutants of Gpx3 were purified 
using the same conditions after site-directed mutagenesis of the pET-24/GPX3 plasmid to 
create pET-24/GPX3C36S, pET-24/GPX3C64S, and pET-24/GPX3C82A (Figures 3.1B, 3.1C & 
3.1D). These proteins were purified further using an ÄKTA Fast Protein Liquid 
Chromatography (FPLC) machine (AKTA pure) to remove contaminants and to assess their 
oligomeric state (see Appendices, Section 7.1).  
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Figure 3.1. Expression and purification of His-tagged Gpx3 proteins. Purification of (A) 
Gpx3His, (B) Gpx3C32SHis, (C) Gpx3C64SHis, and (D) Gpx3C82AHis from the supernatant fraction 
of IPTG-induced DE3 E. coli cells (Coomassie stained SDS-PAGE gels; all samples loaded with b-me). 
–IPTG – no induction; +IPTG – induction/protein expression; P – pellet; S – supernatant; Fth – flow 
through; W1 – wash 1; W2 – wash 2; W3 – wash 3; EL – eluate. Asterisks indicate purified proteins 
of interest. 
  
In parallel, the optimal conditions for expression of the extended N18Gpx3His protein 
were determined by transforming the pET-24/N18GPX3 plasmid in DE3 E. coli, inducing 
with IPTG (0.1 - 1 mM IPTG), and incubating at different temperatures (18 - 37°C). There 
were no differences in expression levels when titrating IPTG and/or changing the 
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temperature as the N18Gpx3His protein expressed well under all conditions nor were 
there any differences in solubility (data not shown). Based on this, the expression 
conditions were kept the same as for Gpx3His, see Table 2.4, and the strongest 
expressing colony out of three was selected for the full purification process (Figures 3.2A 
& 3.2B). Interestingly, in comparison to Gpx3His the presence of the N18 extension 
resulted in a larger proportion of N18Gpx3His remaining in the insoluble fraction after 
solubilisation. Given that data from Kritsiligkou et al. (2017) suggests that the N18 tends 
to cause association of Gpx3 to the mitochondrial membrane, the recombinant N18Gpx3 
proteins could be more ‘sticky’ and might have the ability to bind to bacterial membranes 
when cells are ruptured, thus causing their precipitation within inclusion bodies.  
  
Another observable difference when comparing the expression and purification of 
Gpx3His to N18Gpx3His was that in the latter there were two bands with molecular 
weights both similar to the expected size of N18Gpx3His that were both induced and 
eluted at the final purification step (see asterisks in Figures 3.2A & 3.2B). This suggested 
that both versions must carry the C-terminal His tag - this was confirmed by western 
blotting using an antibody against the His tag itself (data not shown). Based on this, it was 
hypothesised that the two species were due to translation of both Gpx3His and 
N18Gpx3His from the pET-24/N18GPX3 plasmid, as it was possible that translation was 
occurring from both start methionines. 
  
To test this, the pET-24/N18GPX3 plasmid was mutated via site-directed mutagenesis to 
change the normal start methionine of Gpx3 (M20) to an alanine, thus eliminating the 
possibility of expressing an unwanted translation product. When the mutated plasmid 
pET-24/N18M20LGPX3 was expressed in E. coli, one single species was observed and 
N18M20LGpx3His was purified; this time from insoluble inclusion bodies (Figure 3.2D) as 
attempts to purify the protein from the soluble fraction yielded nothing (Figure 3.2C). 
However, upon closer inspection, the purified N18M20LGpx3His protein still appears as a 
doublet (Figure 3.2D, EL lane). It is possible that the doublet in this case was only visible 
due to the low amount of protein in the elution as the two bands appear to be more 
similar in size than before. 
90 
 
  
Figure 3.2. Expression and purification of His-tagged N18Gpx3 and N18Gpx3M20L 
proteins. (A) Induction of pET-24/N18GPX3 using 0.4 mM IPTG in three DE3 E. coli colonies 
labelled #1-3. Purification of (B) N18Gpx3His and (C) N18M20LGpx3His from the supernatant 
fractions of IPTG-induced DE3 E. coli cells. (D) Purification of N18M20LGpx3His from inclusion 
bodies (pellet fraction). –IPTG – no induction; +IPTG – induction/protein expression; P – pellet; S – 
supernatant; Fth – flow through; W1 – wash 1; W2 – wash 2; W3 – wash 3; EL – eluate. All images 
are Coomassie stained SDS-PAGE gels and all samples were loaded with b-me. Asterisks indicate 
purified proteins of interest. 
 
An alternative explanation for the presence of two bands is that even though the M20L 
mutation eliminates the possibility of a second translation initiation product, there is still 
the potential for degradation of the N18 which is potentially cleaved due to its predicted 
unstructured nature. One further hypothesis is that the two bands are due to different 
91 
 
redox states of the purified proteins. To investigate how their redox state might affect 
their migration on SDS-PAGE gels, both the N18M20LGpx3His and Gpx3His purified 
proteins were treated with either a reducing or oxidising agent, DTT and H2O2 
respectively, and compared to non-treated samples (Figures 3.3A & 3.3B). Gpx3C82AHis 
was used as a control as it lacks the ability to form an intra-molecular disulphide bond 
(Figure 3.3B). In addition, N18M20LGpx3His was treated with the alkylating agent AMS, 
4’acetamido-4’-maleimidylstilbene-2,2’-disulphonic acid, which reacts with reduced thiols 
(-SH) and increases protein molecular weight by ~0.5 kDa for every –SH present. From 
these treatments, it was concluded that the doublets present when running 
N18M20LGpx3His and Gpx3His on SDS-PAGE gels are the result of a combination of 
reduced/oxidised species, despite the presence of the strong reducing agent b-me in 
previous gels (Figures 3.1 & 3.2). 
 
 
Figure 3.3. Thiol redox state of purified Gpx3 and N18Gpx3 proteins. Gel shift assays 
using AMS to investigate the thiol redox state of (A) purified N18M20LGpx3His and (B) purified 
Gpx3His and Gpx3C82AHis. (-) no treatment with DTT or H2O2; AMS – AMS addition to sample not 
treated with DTT or H2O2. Both images are Coomassie stained SDS-PAGE gels and all samples were 
loaded without b-me. ‘red’ – reduced thiol state; ‘ox’ – oxidised thiol state. 
  
For the import experiments that followed, the redox state of the purified proteins was 
not an issue because all proteins were denatured and reduced prior to import. This 
treatment ensures that the proteins are completely import-competent. Post-import, the 
proteins are localised in the IMS where they can adopt their native folded structure. A 
depiction of all Gpx3/N18Gpx3 variant proteins purified can be seen in Figure 3.4. 
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disulphide bond 
disulphide bond 
disulphide bond 
disulphide bond 
  
Figure 3.4. Schematic of all Gpx3 proteins purified. M – methionine residue; H- histidine 
residue; C – cysteine residue; S – serine residue. Red indicates where an amino acid has been 
mutated. Dotted lines represent disulphide bonds. 
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3.3.2. Mitochondrial import of Gpx3 and N18Gpx3 
  
Before moving on to pulldown assays it was crucial that the purified proteins, Gpx3His 
and N18M20LGpx3His, could be imported into wild-type yeast mitochondria following a 
standard import protocol (Section 2.2.2.2, illustrated within Figure 3.7). As seen in 
Figures 3.5A & 3.5B, both His-tagged proteins were successfully imported and protease 
protected.  
 
Figure 3.5. Import of purified Gpx3His and N18M20LGpx3His. The purified proteins (A) 
Gpx3His and (B) N18M20LGpx3His were treated with DTT & urea and presented to isolated wild-
type yeast mitochondria for 20 minutes under standard import conditions, followed by a protease 
treatment using trypsin to destroy unimported material (M). As a control, samples were also 
treated with trypsin in combination with a detergent, Triton-X-100, to solubilise the mitochondria 
and destroy both unimported and imported material (Tx). Western blots were used to probe for 
His-tagged proteins (using anti-His), and for a positive/loading control protein (using anti-Mia40 
against mitochondrial intermembrane space assembly protein). 5% corresponds to 5% of the 
Gpx3His/N18M20LGpx3His used for the import reaction.  
  
Import assays were also performed using radiolabelled versions of both Gpx3 and 
N18M20LGpx3 to confirm that they could both be imported when produced in this 
manner (ready for their use in later immunoprecipitation experiments). GPX3 and 
N18M20LGPX3 had been previously cloned into pSP64 vectors by a former lab member 
which are suitable for use with an in vitro coupled transcription and translation kit 
(Promega) that incorporates 35S-methionine (35S-met) (Chatzi, unpublished obs.). 
Radioactively-labelled precursors were synthesised on ribosomes shortly before import, 
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and again both Gpx3 and N18M20LGpx3 were successfully imported into mitochondria 
and protease protected (Figure 3.6). In addition, these experiments show that the import 
of both proteins happens very quickly, within a matter of seconds, and that pre-treatment 
of the precursors with DTT and urea results in a more efficient import. In comparison to 
Gpx3, the N18Gpx3 variant goes in quite substantially in its native state. This could mean 
that one function of the N18 extension is to draw the protein into mitochondria even 
when it is folded.  
 
 
Figure 3.6. Import of radiolabelled Gpx3 and N18M20LGpx3. Gpx3 and N18M20LGpx3 
were synthesised as radiolabelled precursors and imported into isolated wild-type yeast 
mitochondria. Precursors were either imported straight after translation, (A) native Gpx3 import 
and (C) native N18M20LGpx3 import, or following treatment with DTT and urea, (B) 
denatured/reduced Gpx3 and (D) denatured/reduced N18M20LGpx3. Import reactions were 
stopped after increasing time points: 15’’ – 15 seconds; 30’’ – 30 seconds; 1’ – one minute; 2’ – 
two minutes; and 10’ – ten minutes. All import reactions were treated with trypsin to destroy 
unimported material, and a combination of Triton-X-100 and trypsin as a negative control (Tx). 10% 
corresponds to 10% of the precursor used for each import reaction. Radiolabelled precursors 
were detected by digital autoradiography; western blots were probed for Porin1 (using anti-Por1) 
as a positive/loading control.  
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3.3.3. In organello affinity pulldown assays to identify Gpx3 
interactors 
  
In order to identify interactors of Gpx3 specifically within mitochondria, pulldown assays 
were performed using mitochondrial isolates rather than whole cells, to minimise the 
likelihood of detecting cytosolic partners. Pulldown assays were initially carried out using 
wild-type Gpx3His and the cysteine trap mutant Gpx3C82AHis to allow for optimisation of 
the assay. The proteins were imported into isolated yeast mitochondria, followed by 
solubilisation of mitochondria under non-denaturing conditions and pulldown of His-
tagged proteins plus interacting partners using Ni-NTA beads. An experimental flowchart 
is shown in Figure 3.7 and described in detail in Section 2.2.2.4. The detergent n-Dodecyl 
b-D-maltoside (DDM) was chosen as it had been used in previous lab experiments where 
it was found to efficiently solubilise mitochondria whilst allowing the isolation of IMS 
complexes such as the Tim9-Tim10 complex.  
 
Figure 3.7. Illustration of the pulldown assay. Purified His-tagged proteins are reduced and 
denatured in DTT and urea, and presented to isolated wild-type yeast mitochondria under 
standard import conditions. Mitochondria are then treated with the protease trypsin to remove 
unimported His-tagged proteins before solubilisation with DDM under native conditions to 
solubilise the mitochondrial membranes without affecting (in theory) protein-protein interactions. 
Mitochondrial proteins that are released into the supernatant are the ones that have been 
solubilised and are then collected and passed through Ni-NTA beads. Bound proteins that remain 
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after subsequent wash steps are eluted using high concentrations of imidazole are putative 
interactors for Gpx3His and are sent for mass spectrometry analysis. 
  
In theory, the pulldown eluates should contain mitochondrial interacting partners of 
Gpx3His and Gpx3C82AHis, including the His-tagged proteins themselves. However, Ni-
NTA beads are known for having problems of non-specific binding of proteins; thus, the 
results were analysed with caution and alternative tagging methods were explored (see 
Section 3.3.6). In order to eliminate non-specifically bound proteins from the mass 
spectrometry data, control pulldowns whereby no His-tagged precursors were imported 
were performed. Any proteins detected in control eluates were removed from the list of 
potential interactors.  
 
The cysteine trap mutant Gpx3C82AHis is a very specific and useful tool that was used in 
parallel to Gpx3 for two reasons: (i) to trap mixed disulphide intermediates which would 
increase the chance of detecting partners, see Figure 3.8; and (ii), to differentiate 
between partner proteins that interact with Gpx3 via intermolecular disulphide bonds vs 
other types of interaction that do not rely on covalent bonding, i.e. driven by mainly 
hydrophobic or electrostatic interactions. Although it is possible, and likely, that a 
combination of protein-protein interaction types occurs for each partner protein, those 
that interact in a transient manner may be missed when using the wild-type version of 
Gpx3.  
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Peroxidatic 
cysteine (C36) 
Mutated resolving 
cysteine (C82A) 
Potential 
interactors 
Mixed disulphide intermediates 
that cannot resolve 
Elution of Gpx3His + interactors 
which are then trypsin digested and 
analysed by mass spectrometry, or, 
separated using a reducing agent 
and analysed by western blotting 
Figure 3.8. Illustration of how Gpx3C82AHis traps mixed disulphide intermediates. 
Potential partners of Gpx3 that interact via an initial disulphide bond with Gpx3’s peroxidatic 
cysteine (C36) will be unable to resolve when the resolving cysteine of Gpx3 is mutated (C82A), 
thus they will stay trapped as mixed disulphide intermediates. In this assay, Gpx3C82AHis 
becomes bound to Ni-NTA beads along with its interactors which are then eluted together and 
either released by trypsin digestion before mass spectrometry analysis, or, separated using a 
reducing agent such as DTT before SDS-PAGE and western blot analysis.   
  
Before sending samples for mass spectrometry analysis, the pulldown assay was 
optimised to reduce the amount of non-specific binding as after the first pulldown 
attempt it was clear that there was a huge number of proteins in the final eluate (Figure 
3.9). It was first reasoned that a large proportion of these might not have been 
successfully removed during the wash step of the assay. Therefore, in proceeding 
attempts the wash step conditions were altered accordingly, with the ultimate goal to be 
able to reproduce specific patterns of bands in the elution lanes (detected via silver 
staining). 
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Figure 3.9. Gpx3His pulldown assay – first attempt. Gpx3His was denatured and reduced 
using DTT and urea before being presented to isolated wild-type yeast mitochondria under 
standard import conditions, followed by treatment with trypsin to remove unimported material 
(M) plus a control import treated with trypsin plus Triton-X-100 (Tx). Mitochondria were then 
solubilised in 1% DDM and separated by centrifugation into the supernatant (S), containing 
soluble proteins, and the pellet (P), containing membrane fragments. Soluble proteins were 
passed through Ni-NTA beads and a sample of unbound material from the flow through (Fth) was 
collected. Ni-NTA beads were washed once (W) and bound material eluted (EL) with 200 mM 
imidazole. (A) Western blot analysis of pulldown samples using anti-His to probe for Gpx3His and 
anti-Mia40 as a positive IMS control. 5% corresponds to 5% of the Gpx3His used for the import 
reaction. Each lane is equivalent to 50µg mitochondria except for the final elution lane which is 
equivalent to 800µg (to increase signal intensity). (B) Silver stain analysis of pulldown samples to 
detect proteins in elution lanes. * - predicated location of eluted Gpx3His. 
  
As there were no problems with the import of the His-tagged proteins, and their binding 
to the Ni-NTA beads, the conditions changed were solely aimed at reducing the amount 
of non-specific binding. Many Gpx3His pulldowns were carried out whereby the 
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conditions detailed in Table 3.1 were changed, either individually or in combination of 
two or more (see Figure 3.10 for some of these attempts). Unfortunately, no matter how 
many conditions were changed there was still a worryingly large number of proteins 
detected in the eluates. Furthermore, western blot analysis showed that after only two 
washes, Gpx3His started to elute along with other potential interactors - in this case, 
Mia40. However, the fact that Mia40 was detected in both the initial pulldown (Figure 3.9) 
and during optimisation pulldowns (Figure 3.10), suggested that the experiment was 
successful at identifying interactors as it was already suspected at the time that Mia40 
was an interactor of Gpx3 in the IMS (now published in Kritsiligkou et al., 2017). 
 
 
 
 
 
 
 
  
Table 3.1. Pulldown assay optimisation conditions. ‘First attempt’ lists the initial 
equilibration, wash and elution conditions tested. ‘Optimisation’ shows the range of conditions 
tested. Refer to Section 2.2.2.4 for full details. 
 First attempt Optimisation 
Imidazole in equilibration (mM) 5 5-10 
Number of washes 1 2-4 
Length of washes (min) 10 10-15 
Imidazole in washes (mM) 20 0-40 
Imidazole in elution (mM) 200 200-300 
Elution with EDTA no yes/no 
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Figure 3.10. Optimisation of Gpx3His pulldown conditions. Gpx3His pulldown as 
previously described but with the following exceptions: (A, B, C, & D) Ni-NTA equilibration with 5 
mM imidazole and an additional wash with 40 mM imidazole before an elution with 300 mM 
imidazole; and (E & F) Ni-NTA equilibration with 15 mM imidazole, wash 1 and wash 2 with 0 mM 
imidazole, wash 3 with 20 mM imidazole, wash 4 with 40 mM imidazole and elution with 10 mM 
EDTA. A & B are western blots where anti-His was used to probe for Gpx3His and anti-Mia40 as a 
positive mitochondrial control; C & D shows the same experiment analysed by silver staining, and 
with a trial elution with EDTA or boiling at 95°C. 2.5% - 2.5% of Gpx3His used for import; M – 
import; Tx – Triton-X-100 control; S – supernatant; P – pellet; Fth – flow through; W1-4 – washes 
1-4; EL – eluates; and c.EL – control eluate (no Gpx3His import). Each lane is equivalent to 50µg 
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mitochondria except for some lanes which are equivalent to 800µg (to increase signal intensity). * 
- predicted location of eluted Gpx3His. 
  
The final conditions were decided upon based on retaining the maximum amount of His-
tagged protein and interactors, whilst removing as much non-specific material as possible 
(Table 3.2). Pulldown experiments were then carried out for both Gpx3His and the trap 
mutant Gpx3C82AHis, and liquid fractions (collected after the final elution) were sent for 
mass spectrometry analysis along with a control ‘mock’ pulldown – no His-tagged protein 
import. Any proteins detected in the control dataset were removed from the list of 
potential interactors. Mass spectrometry data from these and subsequent pulldowns are 
analysed in the next results section. 
 
 
 
 
 
 
 
Table 3.2. Final conditions after pulldown optimisation. This table lists the conditions 
used in pulldowns where liquid eluates were sent for mass spectrometry analysis. Refer to Section 
2.2.2.4 for full details. 
 
 
 
 
 
 Final 
Imidazole in equilibration (mM) 5 
Number of washes 2 
Length of washes (min) 10 
Imidazole in washes (mM) 20/40 
Imidazole in elution (mM) 300 
Elution with EDTA no 
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3.3.4. Mass spectrometry analysis of Gpx3 pulldown eluates  
  
Initially, two samples were sent for liquid chromatography-mass spectrometry (LC-MS) 
analysis to check whether proteins could be successfully identified in pulldown elutions. 
These two samples were from a pulldown using Gpx3C82AHis as bait, and a ‘mock’ 
pulldown where no His-tagged protein was imported. Although the hit list was small, the 
peptides identified were nearly all mitochondrial. Based on this, the pulldown 
experiments were repeated multiple times: twice using Gpx3His, thrice using 
Gpx3C82AHis, thrice using N18M20LGpx3His, each time alongside a ‘mock’ control, and a 
hit list was generated (Table 3.3, see Section 2.2.5 for analysis criteria).   
  
As expected from the western blot data in Figures 3.9A and 3.10A, Mia40 was identified 
in pulldowns using either Gpx3His or Gpx3C82AHis as bait. However, it was only 
recognised as a significant hit by the MASCOT search program (refer to analysis criteria) 
when Gpx3His was used. Gpx3 and Mia40 are known to be transient interaction partners 
and Gpx3 can re-oxidise Mia40 via its cysteine residues (Kritsiligkou et al., 2017). 
Interestingly, the IMS electron carrier Cytochrome c (Cytc) was also found in nearly all 
datasets using both Gpx3His, Gpx3C82AHis and N18M20LGpx3His; however, it was 
present in 2 out of 5 control datasets but these datasets also contained hits for the 
endogenous version of Gpx3. As the mass spectrometry data could not differentiate 
between Cytochrome c isoform 1 (Cyc1) and Cytochrome c isoform 2 (Cyc7) due to their 
sequence similarity as paralogs, the term Cytc is used throughout. Frustratingly, untagged 
Gpx3 appears to have a slight binding affinity to Ni-NTA beads which could mean that 
some true partner proteins are being missed as all protein hits present in the controls 
were removed from the list. The exception to this was Cytc as it also plays a role in the 
MIA oxidative folding pathway along with Mia40 and Gpx3 in the IMS, and encouragingly 
it was not found in a control pulldown using mitochondria isolated from a gpx3∆ strain. 
Thus, further work was warranted to confirm whether Cytc could indeed be a true hit. 
This thesis does not investigate the interaction between Gpx3 and Mia40 as ongoing work 
was being carried out by other members of the lab (Chatzi, Kritsiligkou and Tokatlidis, 
unpublished obs.).  
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Table 3.3. Hits identified by mass spectrometry.  
Bait Systematic 
name 
Standard 
name 
MW Unique 
peptides 
Total 
peptides 
 
Total 
number 
of hits 
Sequence 
Coverage 
Description 
Gpx3His YKL192C Acp1 13.9 1 1 1 13.6% Acyl carrier protein (mitochondrial matrix) 
Gpx3His/ 
N18M20Gpx3His 
YFL039C Act1 41.7 1 1 1 3.2% Structural protein of the cytoskeleton 
(cytoplasm) 
Gpx3His YGR234W Yhb1 44.6 1 1 1 4.3% Nitric oxide oxidoreductase involved in 
nitrosative and oxidative stress response 
(cytosol, nucleus and mitochondrial matrix) 
Gpx3His/ 
Gpx3C82AHis 
YML054C Cytb2* 65.5 6 6 6 15.1% Cytochrome b2 (L-lactate cytochrome-c 
oxidoreductase) (IMS) 
Gpx3His/ 
Gpx3C82AHis 
YEL030W Ecm10* 70.1 1 6 6 12.8% Heat shock protein (Hsp70 family), localises to 
mitochondrial nucleoids (mitochondrial matrix) 
Gpx3His/ 
Gpx3C82AHis 
YKL195W Mia40 44.5 1 1 1 4.0% Component of the mitochondrial 
intermembrane space MIA oxidative folding 
pathway (IMS) 
Gpx3His/ 
Gpx3C82AHis/ 
N18M20LGpx3His 
YHR023W Myo1* 22.4 2 14 31 7.8% Type II myosin heavy chain involved in 
cytokinesis and cell separation (cytoplasm) 
Gpx3His/ 
Gpx3C82AHis/ 
N18M20LGpx3His 
YJR048W/ 
YEL039C 
Cyc1/7** 12.2/ 
12.5 
1 2 2 24.8% Cytochrome c isoforms 1 and 2, both involved in 
IMS electron transfer (IMS) 
Gpx3C82AHis YOR317W Faa1 77.9 1 1 1 1.9% Long chain fatty acyl-CoA synthetase 
(mitochondrial OM) 
Gpx3C82AHis YDR375C Bcs1 51.1 1 1 1 3.7% Protein translocase and chaperone involved in 
assembly of Complex III (mitochondrial IM) 
Gpx3C82AHis/ 
N18M20LGpx3His 
YOR201C Mrm1 46.4 3 3 4 7.5% Mitochondrial rRNA methyltransferase 
(mitochondrial matrix) 
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N18M20LGpx3His YAL047C Spc72 72.1 2 4 8 10.1% Gamma-tubulin small complex receptor 
involved in astral microtubule formation and 
stabilisation (cytoplasm) 
N18M20LGpx3His/ 
Gpx3C82AHis 
YIL125W Kgd1* 114.4 1 1 1 1.6% Subunit of the mitochondrial alpha-
ketoglutarate dehydrogenase complex 
(mitochondrial matrix) 
N18M20LGpx3His/ 
Gpx3His 
YBR244W Gpx2* 18.4 1 3 15 19.1% Phospholipid hydroperoxide glutathione 
peroxidase (cytoplasm, nucleus, mitochondrial 
OM and IM) 
N18M20LGpx3His/ 
Gpx3C82AHis 
YOR127W Rga1* 112.8 2 4 21 10.1% GTPase-activating protein (cytoplasm) 
N18M20LGpx3His/ 
Gpx3His 
YDR120C Trm1* 64.1 3 7 8 17.5% tRNA methyltransferase (nucleus, mitochondrial 
matrix) 
 
This table includes hits that were identified as significant or *non-significant but present in multiple bait datasets from LC/MS analysis of pulldown eluates as 
described in Section 3.3.3. Mia40 was found to be significant in one dataset (Gpx3His) but non-significant in another (Gpx3C82AHis), thus those that were present in 
one or more dataset were included despite being deemed non-significant. Refer to Materials and Methods, Section 2.2.5, for a detailed description of how the mass 
spectrometry analysis was carried out. ** Cyc1/7 was included in the hit list as even though one of the peptide hits was present in a control dataset (where no His-
tagged protein was used), endogenous Gpx3 was also present as it appears to have a slight affinity to bind non-specifically to the Ni-NTA beads. As both Cyc1/7 and 
Gpx3 are present within the IMS, and both are known to interact with Mia40 (Bien et al., 2010; Kritsiligkou et el., 2017), it is plausible that they are interactors. 
Where a protein was found in more than one dataset the number of unique hits, total hits and percentage sequence coverage represents the one with the most hits 
or the largest sequence coverage. 
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Apart from Mia40 and Cytc, Cytochrome b2 (Cytb2) was the only other IMS protein listed 
in Table 3.3; none of the others are known to localise to the IMS. Some are found in the 
OM/IM which could in theory have domains that stick out into the IMS, some are 
cytosolic/cytoplasmic which are likely due to slight contamination in the isolated 
mitochondrial fractions, and some localise to the mitochondrial matrix. One explanation 
for matrix proteins is that during the solubilisation process to break the mitochondrial 
membranes, soluble proteins from the IMS and matrix are ‘mixed’ together, and 
therefore free to interact with the His-tagged Gpx3 proteins before their binding to Ni-
NTA beads. The only way around this would be to isolate only the mitochondrial IMS 
during the solubilisation by breaking only the OM. Different concentrations of the 
detergent Triton-X-100 were tested but unfortunately none were successful even when a 
very low percentage (0.01%) was used as the matrix protein Hsp70 was present in the 
soluble fraction (Figure 3.11). Other detergents should be tested such as digitonin, DDM 
and CHAPS, or the OM broken by hyperosmotic shock. However, this approach will only 
allow partners that bind to the completely soluble Gpx3 (not the pool that associates to 
the membrane) and those that are soluble themselves as those that are not will not be 
released into the supernatant.  
 
 
 
 
 
 
 
Figure 3.11. Solubilisation of mitochondrial proteins to isolate intermembrane 
space proteins. Isolated wild-type yeast mitochondria were solubilised in buffers containing 
increasing amounts of the detergent Triton-x-100: 0.01%, 0.05%, 0.02% and 0.1%. T – total 
mitochondrial protein before solubilisation; P – pellet fraction; S – soluble fraction. Western blots 
were used to probe for a soluble matrix protein (using anti-Hsp70 against mitochondrial heat 
shock 70 protein), and two soluble intermembrane space proteins (Erv1 - sulphydryl oxidase 1, 
and Tim10 – translocase of the inner membrane 10). 
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Most importantly though, due to the non-specific binding capacity of the Ni-NTA beads 
used in these pulldown assays, and the lack of reproducible hits for the majority of 
putative partners, alternative approaches using different tags were sought and no more 
samples were sent for mass spectrometry analysis. The data gathered here simply 
became a collection of potential hits that would act as a rudimentary starting point rather 
than a conclusive list of mitochondrial Gpx3 interactors, for example, Cytc. Therefore, 
whilst work was ongoing to create different tagged versions of Gpx3, the putative 
interaction between Gpx3 and Cytc was investigated using a combination of in vitro 
binding assays, in vitro interaction assays and immunoprecipitations (see Section 3.3.5).  
  
Separate to the search for Gpx3 interactors, the mass spectrometry data revealed a 
number of proteins with unknown localisation and unknown function, some of which are 
very small in molecular weight. In theory, and rather excitingly, these proteins could be 
previously unidentified mitochondrial proteins. Section 3.3.7 explores the mitochondrial 
import of two such proteins.   
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3.3.5. Investigating the potential interaction between Gpx3 and 
Cytc 
  
3.3.5.1. In vitro binding assays using His-tagged Gpx3 proteins 
   
An alternative attempt to eliminate non-specific binding of non-Gpx3 interactors to Ni-
NTA beads was to completely saturate the beads with purified Gpx3His, Gpx3C82AHis, 
N18M20LGpx3His and N18M20LGpx3C82AHis. Whilst excess His-tagged protein was 
binding to the beads, mitochondria were solubilised and the soluble proteins then passed 
over the saturated beads, washed then eluted (Figure 3.12). Eluates were analysed by 
western blotting to probe for the two suspected Gpx3 interactors - Mia40 and Cytc.  
 
Figure 3.12. Illustration of the in vitro binding assay. Purified His-tagged proteins are 
reduced in a buffer containing DTT, or left native, and presented in excess to Ni-NTA beads. In 
parallel, mitochondria are solubilised with 1% n-Dodecyl b-D-maltoside (DDM) to break the 
mitochondrial membranes under native conditions. Mitochondrial proteins that are released into 
the supernatant are collected and passed through Ni-NTA beads. Bound proteins that remain 
after subsequent wash steps are eluted using high concentrations of imidazole and analysed by 
western blotting and/or silver staining. 
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The results from this assay provide further evidence that Mia40 is an interactor of Gpx3 
as Mia40 co-eluted with Gpx3His (Figure 3.13B), Gpx3C82AHis (Figure 3.13G) and 
N18M20LGpx3C82AHis (Figure 3.13G). However, Mia40 did not always co-elute/the band 
detected was extremely faint (Figures 3.13C, 3.13D & 3.13E) which suggests that its 
interaction with Gpx3 may be transient. Cytc was very rarely detected (only Figure 3.13B) 
despite a vast abundance of both Gpx3 and Cytc in each assay. It could be that this in vitro 
assay does not represent the physiological conditions required for an interaction between 
Gpx3-Cytc and/or the interaction is transient, or that they are not true partners. Neither 
Mia40 nor Cytc were present in ‘mock’ assays where no His-tagged protein was bound to 
Ni-NTA beads prior to the addition of soluble mitochondrial proteins. Another possibility 
is that an interaction between Gpx3 and Cytc might occur when both are associated with 
the IM of mitochondria, and thus they are unable to interact in this assay as membrane 
proteins are retained in the insoluble pellet fraction. As can be seen in Figure 3.13A, Cytc 
is found both in the pellet and supernatant fractions after solubilisation.  
  
Interestingly, in the repeat experiment shown in Figure 3.13G Thioredoxin 1 (Trx1, a small 
protein found in both the cytosol and the IMS) co-eluted with the extended cysteine trap 
mutant, N18M20LGpx3C82AHis. This was a serendipitous finding as the antibody against 
Trx1 was only used as an extra control. However, it would make sense as Trx1 in the 
cytosol is important in recycling Gpx3 when Gpx3 becomes disulphide bonded upon stress. 
This finding could be of importance if it can be confirmed by additional methods, such as 
by isothermal titration calorimetry (ITC), a method which has previously been used to 
analyse the interaction between Gpx3 and Mia40 (Chatzi, Kritsiligkou and Tokatlidis, 
unpublished obs.). This would lend additional support to a functional role of Gpx3 in the 
IMS. In Chapter 5, Section 5.3.4, a similar result was found when in vitro binding assays 
were carried out with solubilised peroxisomal proteins. 
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Figure 3.13. In vitro binding assays to detect Gpx3 interactors. In vitro binding assays 
using His-tagged versions of Gpx3. (A) Solubilisation of isolated wild-type yeast mitochondria 
using 1% DDM. T – total mitochondrial protein; P – pellet fraction; S – soluble fraction. The 
purified proteins Gpx3His (B), N18M20LGpx3His (C), Gpx3C82AHis (D & G) and 
N18M20LGpx3C82AHis (E & G), and Gpx3C82AHis (E & G), were bound to Ni-NTA beads and 
mitochondrial proteins from the soluble fraction shown in A were passed over. Unbound material 
can be seen in the flow throughs (Fth) and co-eluted material in the eluates (EL). W – indicates the 
third and final wash before elution with imidazole. (F) CONTROL – control assay where no His-
tagged protein was bound to Ni-NTA beads prior to addition of mitochondrial proteins. NOTE: G is 
a repeat of D, E and F. Western blots were probed using anti-His against all His-tagged proteins 
and anti-Mia40 and anti-Cytc against the putative interactors Mia40 and Cytc. Anti-Trx1 (against 
Thioredoxin 1) was used as an additional IMS control in G. 
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3.3.5.2. Reciprocal in vitro binding assay using CytcHis 
   
CYC1, the gene encoding Cytochrome c isoform 1, was cloned into a pET-24 vector which 
contains a C-terminal sequence for a 6xHis tag. To purify the protein, pET-24/CYC1 was 
transformed into DE3 E. coli, induced using IPTG, and purified from the soluble fraction 
using Ni-NTA beads following the same protocol used for Gpx3His (Figure 3.14A). A 
reciprocal in vitro binding assay was then carried out using CytcHis bound to Ni-NTA 
beads instead of Gpx3His, and endogenous Gpx3 was detected in the eluate fraction 
(Figure 3.14B). No Gpx3 was found in the eluate from the control ‘mock’ assay (Figure 
3.14C). These data suggest that Gpx3 and Cytc can interact in vitro as recombinant 
proteins. 
  
Unfortunately, attempts to repeat this assay to confirm the result were hindered by the 
fact that the purified CytcHis protein aggregated within a few days of purification. We 
concluded that the purification method used was not suitable to obtain a fully folded 
CytcHis protein as the protein is known to be prone to aggregation when it lacks its heme 
prosthetic group. Instead, Cytc was obtained from Sigma-Aldrich in a lyophilised form 
which was resuspended into buffers suitable for performing in vitro interaction assays 
with Gpx3. This version of Cytc lacks a tag and therefore could not be used to repeat the 
in vitro binding assay. 
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Figure 3.14. Purification of CytcHis and in vitro binding assay to detect Cytc 
interactors. (A) CytcHis was purified from the supernatant fraction of IPTG-induced DE3 E. coli 
cells after transformation and expression of a pET-24/CYC1 plasmid. Cells were induced with 0.4 
mM IPTG for 4 hours at 37°C. Coomassie stained SDS-PAGE gel; samples loaded with b-me. –IPTG 
– no induction; +IPTG – induction/protein expression; P – pellet; S – supernatant; Fth – flow 
through; W1 – wash 1; W2 – wash 2; EL – eluate. (B) In vitro interaction assay using CytcHis 
saturated to Ni-NTA beads. Soluble mitochondrial proteins were passed over and unbound 
material removed in the flow through (Fth). Beads were washed three times (W – third and final 
wash) before elution with imidazole (EL). (C) CONTROL – control assay where no His-tagged 
protein was bound to Ni-NTA beads prior to the addition of mitochondrial proteins. Western blots 
were probed using anti-Cytc, anti-Gpx3 and anti-Mia40 to detect CytcHis (and the endogenous 
Cytc), Gpx3 and Mia40.  
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3.3.5.3. In vitro interaction assays between Gpx3 and Cytc 
   
To further investigate Cytc as a potential interactor of Gpx3, in vitro interaction assays 
were carried out using purified Gpx3His and Cytc (purchased from Sigma-Aldrich). As 
nothing was known about the redox state of either protein during their potential 
interaction, Gpx3His was either oxidised or reduced prior to incubation with Cytc that had 
been reduced or oxidised respectively (Figure 3.15). This assay indicates a strong physical 
interaction between the two as a suspected mixed intermediate with a molecular weight 
shift compatible with one Gpx3 monomer and one Cytc monomer was found. Western 
blotting confirmed a Gpx3-Cytc intermediate as both antibodies (anti-Gpx3 and anti-Cytc) 
detected the same band of around 32 kDa (Figure 3.16). This interaction was independent 
of whether Gpx3/Cytc was oxidised or reduced prior to their incubation together. This 
result is interesting but we do not yet have an explanation for this interaction. It is 
worthwhile pursuing in the future given the importance of Cytc in the oxidative folding 
pathway and in lipid peroxidation in mitochondria.   
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Figure 3.15. Gpx3 interaction with Cytc in vitro. (A) In vitro interaction between Gpx3His 
oxidised (Gpx3ox) and reduced Cytc (Cytcred). (B) In vitro interaction between Gpx3red and 
Cytcox. Images shown are coomassie stained SDS-PAGE gels. Gpx3/Cytc were oxidised with 10 µM 
H2O2 for 30 mins or reduced with 20 mM DTT for 30 mins. The first four lanes show the 
oxidised/reduced proteins before their incubation together. bf – controls where the 
oxidised/reduced proteins were incubated alone in the reaction buffer for 30 mins. Proteins were 
incubated together and the reactions stopped after 10 mins, 20 mins and 30 mins. AMS was used 
in all samples to detect shifts in redox state.  
114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16. Confirmation of a mixed intermediate between Gpx3-Cytc in vitro. 
Western blots using antibodies against Gpx3 (anti-Gpx3) and Cytc (anti-Cytc) to confirm the 
suspected mixed intermediate between one Gpx3 monomer and one Cytc monomer in both the in 
vitro interaction assays using (A) Gpx3ox and Cytcred and (B) Gpx3red and Cytcox. NOTE: Markers 
were accidentally loaded in the same lane as the first samples which were detected by the 
secondary antibody. 
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Rather than observing the presence of a mixed intermediate between Gpx3-Cytc in this 
assay, it was expected that the results would be interpreted by changes in redox state 
during incubation. However, this proved challenging in this experiment for two reasons: (i) 
in Figure 3.15B, Gpx3 becomes oxidised in the buffer alone control, and (ii) the difference 
between oxidised and reduced Cytc is difficult to see as the difference in molecular 
weight after AMS treatment is minimal. Therefore, it is unknown whether the mixed 
intermediate is the result of oxidised Gpx3 (that formed during the incubation time) 
interacting with Cytc (of unknown redox state), rather than the initial reduced Gpx3.  
  
As it could not be determined whether the reduction of Cytc using 20 mM DTT for 30 
minutes was enough to reduce the protein, attempts to reduce Cytc were carried out 
using varying concentrations of DTT or b-mercaptoethanol. The results were not 
conclusive as shifts were still difficult to detect in each case (Figure 3.17).  
 
 
 
 
 
 
 
 
 
 
Figure 3.17. Reduction of Cytc in vitro. Purified Cytc (Sigma-Aldrich) was subjected to the 
following treatments: 200 µM H2O2, 20 mM DTT, 50 mM DTT, 20 mM b-me, and 50 mM b-me. 
The first lane shows Cytc in its native form, i.e. after resuspension in 50 mM HEPES-KOH pH 7.4. 
No differences can be seen between the un-treated, oxidised or reduced samples. Monomers, 
dimers and trimers are detected in all samples.  
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Next, to test whether the interaction between Gpx3-Cytc is dependent upon a mixed 
disulphide bond, single cysteine mutants of Gpx3 (Gpx3C32SHis, Gpx3C64S and 
Gpx3C82AHis) were incubated with Cytc. Note that the only cysteines known to be 
involved in Gpx3 disulphide bond formation are its peroxidatic cysteine (C32) and its 
resolving cysteine (C82); no function for C64 has been reported despite its location within 
a highly conserved hydrophobic region (Figure 3.18). Surprisingly, the only cysteine 
mutant that had an effect on the Gpx3-Cytc mixed intermediate was C64S (Figure 3.19). 
As this cysteine residue is not known to be involved in disulphide bond formation, we 
thought that the C64S mutation might be causing a change in protein structure/folding 
that could be affecting a hydrophobic interaction between Gpx3-Cytc, as the cysteine 
residue C64 lies within a hydrophobic region. 
  
 
Figure 3.18. S. cerevisiae Gpx3 multiple sequence alignment. Clustal Omega (Version 
1.2.4) was used to align Gpx3 homologs from Saccharomyces cerevisiae (Gpx3), Caenorhabditis 
elegans (Gpx-2), Drosophila melanogaster (PHGpx), and Homo sapiens (GPX4).* (asterisk) – single, 
fully conserved residue. : (colon) – conservation between groups of strongly similar properties. . 
(period) – conservation between groups of weakly similar properties. Red residues include 
Cysteines (including U for selenocysteine in GPX4). Blue residues show the conserved hydrophobic 
region in which the C64 of Gpx3 sits.  
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Figure 3.19. Gpx3 single cysteine mutant interactions with Cytc in vitro. Coomassie 
stains showing in vitro interaction assays between His-tagged Gpx3 cysteine mutants and Cytc ((A) 
Gpx3ox and Cytcred, (B) Gpx3C36Sox and Cytcred, (C) Gpx3C64Sox and Cytcred, and (D) 
Gpx3C82Aox and Cytcred) for 10 mins, 20 mins and 30 mins. All Gpx3 variants were oxidised with 
10 µM H2O2 for 30 mins; Cytc was reduced with 20 mM DTT for 30 mins. The first four lanes show 
the oxidised/reduced proteins before their incubation together. bf – controls where the 
oxidised/reduced proteins were incubated alone in the reaction buffer for 30 mins. AMS was used 
in all samples to detect shifts in redox state. 
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To investigate this idea, circular dichroism (CD) spectroscopy was used to assess the 
structure of Gpx3His and all three cysteine mutants (Figure 3.20). The far UV spectra 
shown in Figure 3.20A indicates that all four proteins contain the expected b-sheet and 
a-helices of Gpx3, and that their secondary structures do not appear to be hugely 
affected by any of the single cysteine mutants. However, there are some slight 
differences as the red and pink lines indicating Gpx3C36SHis and Gpx3C82AHis 
respectively do not precisely follow those of Gpx3His (blue) and Gpx3C64SHis (green). 
This is likely attributable to the fact that C36 and C82 are involved in forming the 
intramolecular disulphide bond in Gpx3 which, when absent, may affect the stability of its 
secondary structure. The near UV spectra shown in Figure 3.20B indicates more subtle 
differences in their tertiary structures. Based on this data, it remains unclear why the 
C64S cysteine mutant is the only one that affects the interaction between Gpx3 and Cytc.  
 
Furthermore, the interaction between Gpx3 and Cytc does not appear to be affected by 
the presence of the reducing agent b-mercaptoethanol, increasing concentrations of NaCl 
(which generally affect electrostatic interactions) or changes to temperature (which 
generally affect hydrophobic interactions) (data not shown).  
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Figure 3.20. CD spectra of Gpx3 cysteine mutants. (A) Far UV CD spectra of Gpx3His 
(blue), Gpx3C36SHis (red), Gpx3C64SHis (green) and Gpx3C82AHis (pink). A 0.02cm pathlength 
quartz cuvette was used to measure spectra and corrected for concentration. (B) Near UV CD 
spectra of Gpx3His (blue), Gpx3C36SHis (red), Gpx3C64SHis (green) and Gpx3C82AHis (pink). A 
0.2cm pathlength quartz cuvette was used to measure spectra. All spectra were corrected for cell 
pathlength, buffer effect and protein concentration.  Mol. Ellip  – molar ellipticity; HT – high 
tension.   
 
 
 
A 
B 
b-sheet 
a-helices 
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3.3.5.4. Immunoprecipitations to detect Gpx3-Cytc in organello 
  
The assays in Sections 3.3.5.1 - 3 were all aimed at characterising the interaction between 
Gpx3 and Cytc in vitro. However, in order to provide convincing evidence that there is a 
physiological relevance to a Gpx3-Cytc interaction it must be confirmed in organello/in 
vivo. Various protein complex immunoprecipitation (Co-IP) protocols were tried using 
isolated wild-type yeast mitochondria: (i) solubilisation of mitochondria followed by Co-
IPs using either anti-Cytc or anti-Gpx3 to detect endogenous protein interactions; and (ii) 
import of radiolabelled Gpx3 or Cytc followed by solubilisation of mitochondria and Co-
IPs using anti-Cytc or anti-Gpx3, respectively. 
  
The first method was unsuccessful due to the strong cross-reactivity of the secondary 
antibody with the precipitating heavy chain antibodies (from the primaries) – both 
primary antibodies were raised in rabbits and thus required the same secondary anti-
rabbit. Therefore, we could not tell whether there was a signal for either Gpx3 or Cytc in 
the eluates as any signal would have been masked (data not shown). To circumvent this, 
the second approach involved importing radioactive Gpx3 or Cytc prior to the Co-IPs so 
that their signals could instead be visualised by autoradiography thus eliminating 
antibody cross-reactivity. After import, mitochondria were solubilised in 0.16% DDM 
followed by the addition of either anti-Gpx3, anti-Cytc, pre-immune serum (PI) or nothing 
(control). After two hours, pre-equilibrated protein A beads (pA) were added and left to 
bind for a further hour. Unbound material was then washed off and the remaining 
proteins eluted using a combination of boiling, vortexing and centrifuging (refer to 
Section 2.2.2.5 for detailed methodology). However, neither Gpx3 or Cytc could be 
detected co-eluting with each other using this method (data not shown). One explanation 
could be that the amounts of radiolabelled protein interacting with any endogenous 
proteins are too low to be detected thus a positive control is required. Due to the time 
limitations of this study, the IP protocol was not successfully optimised and no conclusive 
results were gathered from these experiments. It was always imperative that a 
combination of methods was kept in the pipeline which is why different tagging/pulldown 
methods were also pursued throughout the project – these are discussed in the next 
section. 
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3.3.6. Alternative tags  
  
Due to consistently high levels of non-specifically bound proteins when binding His-
tagged proteins to Ni-NTA beads, two different approaches were sought: a yeast strain 
endogenously expressing a Gpx3-TAP fusion protein, and expression of a V5-tagged Gpx3 
recombinant protein in yeast from a transformed plasmid. Both of these methods differ 
from the ones previously described in this chapter as they are in vivo techniques that, in 
addition to hopefully removing unwanted false positive interactors, are much more 
representative of the physiological conditions within yeast. 
 
3.3.6.1. Gpx3-TAP 
   
The first method is a two-step affinity purification that relies on the binding of the Gpx3-
TAP to Immunoglobulin G (IgG) beads, followed by cleavage of the TAP tag with the 
Tobacco Etch Virus (TEV) protease to release Gpx3 along with protein partners. As the 
TAP tag also consists of Protein A and a calmodulin-binding peptide (CBP) which is not 
cleaved by the TEV protease, the cleaved Gpx3-TAP can then re-bound to a Calmodulin 
resin. After a few wash steps, Gpx3 and its interactors can be eluted using ethylene 
glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA). 
  
One main caveat of this method is that the TAP tag itself is large in size at 21 kDa; Gpx3 is 
only 19 kDa. Therefore, two problems might exist: (i) the TAP tag interferes with the 
interaction of partner proteins with Gpx3, and/or (ii) the TAP tag prevents mitochondrial 
import. Thus, the starting point was to test whether Gpx3-TAP was present within 
mitochondria isolated from a yeast strain expressing an endogenously C-terminally TAP-
tagged version of Gpx3 (strain purchased from GE Healthcare). Unfortunately, only a very 
small amount of Gpx3-TAP could be detected in isolated mitochondria (Figure 3.21) which 
suggests the TAP tag is affecting the import of Gpx3 into mitochondria. This method was 
no longer pursued as it is crucial that Gpx3 is within the IMS in a high enough amount in 
order to identify mitochondrial interactors. Instead, a smaller V5 tag was selected to try 
to alleviate this problem. 
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Figure 3.21. Mitochondria isolated from a Gpx3-TAP yeast strain vs wild-type 
mitochondria. Mitochondria were isolated from both Gpx3-TAP and wild-type BY4741 yeast, 
and 100µg samples were loaded onto an SDS-PAGE gel followed by western blotting using anti-
Gpx3. Endogenous Gpx3 (19 kDa) can be detected in wild-type mitochondria, but it is unclear 
whether Gpx3-TAP (40 kDa) is found within mitochondria as only one weak band was detected in 
Gpx3-TAP that was not present in the wild-type lane. NOTE: there are lots of non-specific bands 
present in the western blot when using anti-Gpx3. Anti-TAP did not detect any differences 
between the two (data not shown). 
 
 
3.3.6.2. Gpx3-V5 
   
The V5 tag was chosen next due to its small size of only 14 amino acids, adding roughly 
1.4 kDa in molecular weight. This is substantially smaller than the 21 kDa TAP tag 
previously tried, and only marginally larger than the 6xHis tag at 1 kDa which has been 
successfully used before. Therefore, the V5 tag is unlikely to interfere with mitochondrial 
import. Upon successful import of Gpx3-V5, the next step would be to perform a 
pulldown assay whereby an Anti-V5 Agarose Affinity Gel (Sigma) is used instead of Ni-NTA 
beads. The gel is made up of agarose beads conjugated to a monoclonal anti-V5 antibody 
which allows Gpx3-V5 to bind along with its interactors.  
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As an endogenously expressing Gpx3-V5 yeast strain does not exist, a yeast expression 
plasmid (pSF-TEF1-COOH-V5, Oxford Genetics) was obtained and attempts to insert the 
GPX3 gene to the 5’ side of the V5 sequence were made. Unfortunately, these clonings 
were not successful within the timeframe of this thesis and further optimisation of the 
cloning protocol is required. When successful, the plasmid will be transformed into gpx3D 
yeast to allow for constitutive expression of Gpx3-V5 from the strong TEF1 promoter 
present within the plasmid, without the presence of endogenous un-tagged Gpx3. If 
Gpx3-V5 is found to localise within the mitochondrial IMS, then pulldowns will be 
performed using isolated mitochondria and samples sent for mass spectrometry analysis.  
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3.3.7. Import of Ybr124w and Ypl107w 
   
When searching the mass spectrometry data in Section 3.3.4, we uncovered a number of 
small proteins with unknown functions and localisations which could be of interest to 
general mitochondrial proteome studies (Table 3.4). Although none of these were 
putative Gpx3 interactors (with the exception of one, Ypl107w), it was still interesting to 
pursue their potential mitochondrial localisation. Small proteins are often missed during 
mass spectrometry analysis due to their small fragment sizes and limited cleavage by 
trypsin, and new proteins are continually being added to the mitochondrial proteome.  
  
Table 3.4. Potential mitochondrial proteins based on mass spectrometry analysis of 
mitochondria isolated from S. cerevisiae. 
  
Standard 
name 
Systematic 
name* 
MW 
(kDa) 
Cysteine motifs Description Human 
homolog 
- Ybr124w 13.2 …CX3C…CX9C… Unknown No 
- Ydr193w 13.7 None Unknown No 
- Ygl024w 12.2 …CX5CX13CX16C… Unknown No 
- Yor293c-a 6.1 None Unknown No 
- Ypl107w 28.6 …CCX3CX2C… Unknown hOXLD-1 
- Ypr010c-a 7.9 None Unknown No 
  
*Reserved name agreed upon by the yeast community (SGD). Human homologs were searched 
for using BLASTP (NCBI). No standard names had been given to these proteins when the mass 
spectrometry data was analysed in 2015. MW – molecular weight in kDa. 
  
Three of these proteins were chosen for further investigation based on the presence of 
cysteine motifs which could act as mitochondrial targeting signals and/or be important 
redox motifs: Ybr124w, Ygl024w and Ypl107w. Ybr124w is a 119 amino acid (aa), 13 kDa 
protein of unknown function which is inviable when knocked out, although this is 
probably due to its overlap with an essential gene located on the opposite strand.  It also 
contains a potential transmembrane domain (UniProtKB entry - P38269). A MITOPROT 
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prediction gives a score of 0.07 (7%) probability that it is targeted to mitochondria. 
Ybr124w is conserved across Saccharomyces species. Ygl024w is a non-essential 111aa, 12 
kDa protein of unknown function with a MITOPROT score of 0.39 (39%), and is predicted 
to be a membrane protein based on sequence analysis (UniProtKB entry - P53190). No 
homologs exist. Ypl107w is a non-essential 248aa, 29 kDa protein with a highly conserved 
oxidoreductase-like domain (see InterPro entry IPR019180/Pfam entry PF09791), and a 
MITOPROT score of 0.92 along with a predicted a 26-amino acid N-terminal cleavable 
presequence. Its human homolog is hOXLD-1, oxidoreductase-like domain-containing 
protein 1. A C-terminal GFP tagged version of Ypl107w has been found to localise to 
mitochondria in a high-throughput study (Huh et al., 2003). 
  
YBR124W and YPL107W were cloned into pSP64 vectors for subsequent use with an in 
vitro coupled transcription and translation, TNT, kit (Promega) to produce radiolabelled 
precursors. Unfortunately attempts to clone YGL024W into pSP64 failed after multiple 
attempts. The transcription and translation of Ybr124w and Ypl107w was tested prior to 
import but no signal was detected for Ybr124w (autoradiography image not shown). This 
was likely due to the fact that Ybr124w only contains one methionine residue which 
would not produce a strong enough radioactive signal. Therefore, we re-cloned YBR124W 
with a C-terminal sequence encoding three extra methionines.  
  
The radiolabelled import of Ybr124w-3Met and Ypl107w into isolated wild-type yeast 
mitochondria was tested under various conditions (‘native’ precursors vs treatment of 
precursors with either DTT or DTT and urea). The results show that Ybr124w-3Met cannot 
be imported into mitochondria in its native state, i.e. immediately after translation 
(Figure 3.22A); its import after reduction with 20 mM DTT (Figure 3.22D) or denaturation 
and reduction with 20 mM DTT and 8 M urea (Figures 3.22B & 3.22C) are unclear as the 
Triton-X-100/protease controls failed to cleave the Ybr124w precursor. This could be due 
to aggregation of the protein upon import which could result in it being inaccessible to 
cleavage by the protease.  In contrast, the results of Ypl107w indicate that it can be 
successfully imported into mitochondria, regardless of its precursor pre-treatment, as it is 
protease-protected upon import (Figure 3.22E). Chapter 5 goes on to investigate Ypl107w. 
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Figure 3.22. Import of radiolabelled Ybr124w and Ypl107w. Ybr124w-3Met and Ypl107w 
were synthesised as radiolabelled precursors and imported into isolated wild-type yeast 
mitochondria. (A) native Ybr124w import, (B) denatured/reduced Ybr124w import, (C) repeat 
denatured/reduced Ybr124w import using PK instead of trypsin, (D) reduced Ybr124w import, (E) 
Three Ypl107w imports: native, reduced, and denatured/reduced. All import reactions (M) were 
stopped after 30 minutes and then treated with trypsin or proteinase k, PK, to destroy 
unimported material, or a combination of Triton-X-100 and trypsin, or Triton-X-100 and PK, as a 
negative control (Tx). 5% corresponds to 5% of the precursor used for each import reaction. 
Radiolabelled precursors were detected by digital autoradiography; western blots were probed 
for Porin1 (using anti-Por1) or Hsp70 (using anti-Hsp70) as positive loading controls. Note: Three 
methionines were added to Ybr124w during the cloning process as the endogenous sequence 
does not encode enough methionines to detect a radioactive signal. * - Ypl107w. 
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In addition to the small proteins listed in Table 3.4, one other was also highlighted as a 
potential mitochondrial protein: Xrr1. Xrr1/Ymr087w is a 32 kDa protein that has been 
labelled as a putative ADP-ribose-1”-monophosphatase with a possible role in tRNA 
splicing (Kumaran et al., 2005). Its localisation is currently unknown but it was found in 
the majority of mass spectrometry datasets which suggests it could be mitochondrial. A 
radiolabelled import assay could address this in future.  
  
3.4. Discussion 
  
In this chapter, various Gpx3 and N18Gpx3 recombinant proteins were successfully 
expressed and purified from E. coli, including: Gpx3His, Gpx3C36SHis, Gpx3C64SHis, 
Gpx3C82AHis, N18Gpx3His, N18M20LGpx3His and N18M20LGpx3C82AHis (Figures 3.1, 
3.2, 3.3 & 3.4). The purpose of purifying these proteins was to identify putative 
interactors of both Gpx3 and N18Gpx3 within the mitochondrial IMS in order to help 
elucidate their function/s. Although prior work has shown that an amino acid N-terminal 
extension of 18 amino acids can bolster Gpx3’s mitochondrial import (Kritsiligkou et al.,  
2017), it is not yet known whether this extended version has a different interactome. Nor 
is it known which proteins Gpx3 interacts with outside of the cytosol, apart from Mia40 
(Kritsiligkou et al., 2017). To tackle this, we first confirmed that the His-tagged proteins 
were capable of import into isolated yeast mitochondria (Figure 3.5). From there, an in 
organello pulldown assay using Ni-NTA affinity beads was thoroughly optimised in order 
to minimise the amount of non-specific binding which would later reduce the number of 
false positives (Figures 3.7, 3.9 & 3.10, and Tables 3.1 & 3.2). The success of this assay 
was determined by the co-elution of its only known mitochondrial interactor, Mia40, with 
His-tagged Gpx3 (Figures 3.9 & 3.10). Based on this, repeat pulldowns were performed 
and five eluates from pulldowns using either Gpx3His, N18M20LGpx3His, or the cysteine 
trap mutant Gpx3C82AHis as bait were sent for mass spectrometry analysis. Control 
‘mock’ pulldown eluates where no His-tagged protein was used were also performed to 
capture non-specifically bound proteins.  
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Although the pulldown assay and mass spectrometry analysis was fraught with problems 
despite optimisation (low reproducibility between datasets, high numbers of proteins in 
control eluates, and the presence of endogenous Gpx3 in some of the control datasets), a 
putative hit list was generated which would act as a starting point for further 
investigation (Table 3.3). The majority of these hits are not known to localise to the 
mitochondrial IMS and are therefore unlikely to be true interactors, i.e. mitochondrial 
matrix proteins and nuclear proteins; however, three IMS proteins were found: Mia40, 
Cytc (Cyc1/7), and Cytb2. Given that both Mia40 and Cytc play a role in the MIA oxidative 
folding pathway within the IMS, and that Mia40 is already a known interactor of Gpx3, we 
decided to focus on characterising the potential interaction between Gpx3 and Cytc – an 
abundant IMS electron carrier. Alternatively, one possible explanation for Gpx3 
interacting with proteins outside the IMS could be that after solubilisation of 
mitochondria, Gpx3 starts redox relays with proteins in close proximity, like it does with 
Yap1 in the cytosol (Gutscher et al., 2009). Thus, it may be challenging to identify a 
reproducible list of proteins. 
  
To investigate Gpx3-Cytc, a combination of in vitro and in vivo assays was carried out. 
Firstly, an assay similar to the in organello pulldown was performed whereby His-tagged 
Gpx3 proteins were bound in excess to Ni-NTA beads in an attempt to minimise non-
specific binding. Solubilised mitochondrial proteins were then added, washed and eluted 
along with recombinant Gpx3 (Figure 3.12). The assay was reasoned to be successful due 
to the detection of Mia40, but Cytc was rarely detected (Figure 3.13). It could be that Cytc 
is a very transient interactor of Gpx3, or that the assay does not represent the 
physiological conditions required for an interaction to occur. Unexpectedly, Trx1 was 
found to co-elute with Gpx3 which itself warrants a future investigation as Trx1 also 
localises to the IMS (Vögtle et al., 2012; Manganas, Cárdenas-Rodriquez and Tokatlidis, 
unpublished obs.). Control pulldowns could be carried out to investigate whether this 
interaction occurs when galMia40, cytcD or trx1D mitochondria are used.  
  
Moving on, CytcHis was purified from E. coli for use in a reciprocal in vitro binding assay 
and an initial result suggests that endogenous Gpx3 can interact with CytcHis (Figure 
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3.14). However, this assay could not be repeated due to aggregation of the recombinant 
CytcHis protein which occurred quickly after its purification. This prompted us to 
purchase Cytc from Sigma-Aldrich (sourced from S. cerevisiae) and continue on with in 
vitro interaction assays using only purified His-tagged Gpx3 proteins and Cytc (no tag 
available). Interestingly, these assays indicate a strong molecular interaction between 
Gpx3 and Cytc that results in a mixed intermediate (Figures 3.15 & 3.16); this 
intermediate most likely comprises one Gpx3 monomer and one Cytc monomer based on 
predicted molecular weight and western blot analysis. These in vitro interaction assays 
were then carried out using the single cysteine mutants of Gpx3 (Gpx3C36SHis, 
Gpx3C64SHis and Gpx3C82AHis) in order to determine whether any of these cysteine 
residues are required for its interaction with Cytc. Based on what is known about Gpx3’s 
interaction with Yap1 in the cytosol, we expected that the peroxidatic and resolving 
cysteine mutants, Gpx3C36SHis and Gpx3C82AHis, would abolish or enhance their 
interactions with Cytc, respectively. This was not the case. The only cysteine mutant that 
affected the interaction was Gpx3C64SHis – a cysteine residue which is not known to be 
involved in disulphide bond formation – as the band detected by Coomassie staining was 
‘weaker’ when compared to that seen for wild-type Gpx3His and the other cysteine 
mutants (Figure 3.19). Although little is known about the function of C64, it is highly 
conserved across homologs and lies within a hydrophobic region (Figure 3.18). We 
therefore thought that the C64A mutation might be causing a structural change in Gpx3 
which might be affecting a potential hydrophobic interaction with Cytc.  
  
To test this theory, we carried out a circular dichroism (CD) analysis on Gpx3His, 
Gpx3C36SHis, Gpx3C64SHis and Gpx3C82AHis, and also looked at the ÄKTA data 
generated previously from their purifications (Figure 3.20 and Appendices Figures 7.1, 
7.2, 7.3 & 7.4). The CD spectroscopy data indicates that all four proteins are folded in 
terms of their secondary structure; however, there may be some subtle differences 
between tertiary structures which could be further assessed by nuclear magnetic 
resonance (NMR). The ÄKTA data does not indicate any substantial differences in 
oligomeric state between Gpx3His and Gpx3C64SHis as both proteins are largely found as 
monomers under native conditions. Further analysis on these cysteine mutant proteins is 
required in order to elucidate how Gpx3 is interacting with Cytc (at least in this in vitro 
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assay). That aside, we cannot be fully certain that this interaction actually exists in yeast 
until in vivo/in organello experiments provide ‘real-life’ evidence. 
  
Confirming a Gpx3-Cytc interaction in vivo and in organello proved challenging for a 
number of reasons. Firstly, an endogenously His-tagged Gpx3 yeast strain failed to 
express the protein at levels sufficient enough to carry out experiments (Chatzi, 
unpublished obs.), and yeast plasmids expressing Gpx3-myc also failed to express the 
protein at sufficient levels (Chatzi, unpublished obs.). Due to this, and the low abundance 
of endogenous Gpx3 in the IMS, it was not possible to carry out in vivo assays using whole 
yeast cells. Instead, we decided to try in organello immunoprecipitations via a number of 
ways including: (i) IPs to detect endogenous mitochondrial Gpx3 and Cytc; and (ii) IPs to 
detect radiolabelled Gpx3 and Cytc after their import into mitochondria. Frustratingly, 
neither of these methods proved successful but for different reasons. The former had 
problems with heavy chain antibody cross-reactivity which would have masked a 
potential signal. Future Co-IPs could avoid this problem by covalently attaching the 
primary antibodies to protein A beads or by probing with a light-chain specific antibody. 
In contrast, the latter method used here likely did not work due to low amounts of 
radiolabelled protein, much lower than endogenous protein levels, which could have 
hindered their detection. Future Co-IPs via this method should aim to increase the 
amount of radiolabelled material present upon import and perhaps optimisation of the 
binding procedure. On the other hand, it is possible that the reason this method did not 
show an interaction could simply be because the two proteins do not interact in organello, 
or that their interaction is transient, or that their interaction depends upon specific 
physiological conditions which were not replicated. Therefore, it is crucial that, alongside 
continued efforts to optimise these in organello Co-IPs, alternative approaches are 
pursued to express tagged Gpx3 proteins at levels sufficient enough to work with whole 
yeast cells. 
  
Mitochondria were isolated from a Gpx3-TAP tagged yeast strain in the hopes that 
enough of the protein would be found inside the mitochondrial IMS in order to carry out 
pulldown assays with an alternative method. Unfortunately, the TAP tag appears to affect 
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the mitochondrial import of Gpx3 as only very small amounts of Gpx3-TAP were detected 
in isolated mitochondria (Figure 3.21). Clonings are still ongoing to clone GPX3 into a pSF-
TEF1-COOH-V5 plasmid which will be transformed into yeast cells to express Gpx3-V5; it is 
hoped that the V5 tag will not affect mitochondria import as it is much smaller in size. 
  
Finally, we identified a list of potential mitochondrial proteins of unknown function from 
the mass spectrometry data that had previously not been associated with the organelle: 
Ybr124w, Ydr193w, Ygl024w, Yor293c-a, Ypl107w and Ypr010c-a. Out of the six proteins, 
three of them have interesting cysteine motifs (Table 3.4), of which two are similar to the 
twin cysteine motifs responsible for mitochondrial IMS targeting via the MIA oxidative 
folding pathway – Ybr124w and Ygl024w. Ypl107w’s cysteine motif, although not 
resembling any known targeting signals, may have an important functional role. 
Furthermore, out of these six proteins only one has an identifiable human homolog – 
Ypl107w (the human homolog is OXLD-1). Therefore, we focused on Ybr124w, Ygl024w 
and Ypl107w. YBR124W and YPL107W were successfully cloned into pSP64 vectors 
(YGL024W was not), and mitochondrial import assays were carried out to determine 
whether they could be imported into isolated mitochondria. Radiolabelled Ybr124w could 
not be detected in mitochondria, whereas Ypl107w could (Figure 3.22). Thus, the next 
chapter goes on to investigate Ypl107w in more detail.  
  
NOTE: Towards the end of this study, a paper was published by Morgenstern et al. (2017) 
which identified both Ypl107w and Ypr010c-a in mitochondria as part of a large proteome 
study; the authors named these proteins Dpc25 and Min8, respectively. 
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4. Ypl107w: a putative oxidoreductase of unknown function 
 
4.1. Introduction 
  
In S. cerevisiae, Ypl107w is a non-essential 29 kDa protein of unknown function (Giaever 
et al., 2002). It contains a predicted mitochondrial targeting signal at its N-terminus 
(Section 3.3.7) and four cysteine residues which are all located within a highly conserved, 
oxidoreductase-like, N-terminal domain (see InterPro entry IPR019180/Pfam entry 
PF09791). The exact function of this domain is not yet known.  
  
Prior to the work presented in this chapter, little literature existed on Ypl107w; most 
came from the systematic data analysis of null mutants. Large-scale studies have found 
ypl107w∆ cells to be less resistant to oxidative stress induced by H2O2 (Brown et al., 2006), 
less resistant to hyperosmotic stress induced by salt (Yoshikawa et al., 2009), and less 
competitively fit in minimal media (Breslow et al., 2008). In addition, ypl107w∆ cells have 
also been shown to exhibit a small defect in vacuolar fragmentation (Michaillat and 
Mayer, 2013), and a decreased resistance to the oncology drug elesclomol which targets 
the mitochondrial respiratory chain (Blackman et al., 2012; Nagai et al., 2012). Notably 
though, a C-terminally GFP-tagged version of Ypl107w exhibited mitochondrial 
localisation during a high-throughput study (Huh et al., 2003), and a paper by Hacioglu et 
al. (2010) predicted Ypl107w as a thiol oxidoreductase based on the presence of a CXXC 
redox motif and a predicted helical structure immediately downstream (–CXXC-a). 
  
Like Ypl107w, barely any literature exists on any of its homologs other than some of their 
associations with mitochondria. The mouse homolog, oxidoreductase-like domain-
containing protein 1 (OXLD-1), was identified by mass spectrometry in a mitochondrial 
proteomics analysis and was found to be expressed in the following tissues: adipose, large 
intestine and stomach (Pagliarini et al., 2008; Calvo et al., 2016). As a result, OXLD-1 is 
now listed in both the mouse and human MitoCarta 2.0 databases which each contain 
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1158 proteins with evidence of mitochondrial localisation. Additionally, the 
Schizosaccharomyces pombe fission yeast homolog, known as P31B10.02, was found to 
localise to mitochondria when C-terminally tagged with yellow fluorescent protein, YFP 
(Matsuyama et al., 2006). 
  
Earlier in Chapter 3, Ypl107w was identified in one of the mass spectrometry datasets 
after analysis of an eluate containing putative N18M20LGpx3His interactors (Section 
3.3.4). An initial import experiment whereby a radiolabelled version of Ypl107w was 
synthesised and presented to mitochondria indicated that Ypl107w could be successfully 
imported (Figure 3.22). This result prompted further investigation to confirm the 
localisation of Ypl107w and to start probing its function within mitochondria.  
  
Since starting this work, Ypl107w has been confirmed to reside within yeast mitochondria 
in a large-scale mitochondrial proteomics study (Morgenstern et al., 2017). The authors 
renamed the protein Dpc25, for delta-psi dependent mitochondrial import and cleavage 
protein of ~25 kDa, as they observed a defect in import when membrane potential was 
abolished and a cleavable sequence upon successful import. Morgenstern et al. (2017) 
also performed a BN-PAGE analysis on isolated mitochondria after radiolabelled import of 
Ypl107w/Dpc25 to detect complexes; however, the results were inconclusive. Despite this 
evidence appearing nearly two years after my work on this protein began, the results 
shown here add to the literature and provide a more detailed analysis of Ypl107w. The 
protein will be referred to throughout this chapter as Ypl107w (which is its systematic 
gene name in the yeast database) and not Dpc25, as this was not known prior to the work. 
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4.2. Aims 
  
In this chapter, the first aim was to perform a thorough bioinformatics analysis of 
Ypl107w and its homologs, and confirm its mitochondrial localisation within S. cerevisiae 
which was previously suggested by the mass spectrometry data shown in Section 3.3.4 
using standard import and localisation assays. Given the highly conserved OXLD domain 
within Ypl107w, it is of importance to unravel the localisation and function of this protein 
as it may help us understand the role of OXLD domains across many organisms. Once the 
localisation of Ypl107w was confirmed, the next aim was to perform a BN-PAGE analysis 
to determine whether Ypl107w is part of any larger complexes within mitochondria, and 
whether any of the respiratory chain complexes are affected when Ypl107w is absent in a 
ypl107wD yeast strain. Furthermore, the predicted N-terminal mitochondrial targeting 
signal of Ypl107w (N26) was deleted and its effect on import assessed.  
  
A second aim was to carry out a more extensive phenotypic analysis of ypl107wD cells to 
determine whether the absence of Ypl107w results in any growth defects that could be 
attributed to impaired mitochondrial function. In addition, steady-state levels of 
mitochondrial proteins were compared between mitochondrial isolates from wild-type 
and ypl107wD yeast. 
  
Based on the growth defects observed when ypl107wD cells were grown in non-
fermentable carbon sources, a final aim was to assess the import of the human homolog, 
OXLD-1, with the intention of expressing OXLD-1 in ypl107wD yeast and determining 
whether it can rescue these growth defects. If successful, this would provide evidence for 
the first time as to whether OXLD-1 is a real functional homolog of Ypl107w.   
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4.3. Results 
 
4.3.1. Bioinformatics analysis of Ypl107w and its homologs 
   
To begin, a multiple sequence alignment between Ypl107w in S. cerevisiae and its 
homologs in various model organisms was performed using Clustal Omega (Sievers et al., 
2011). The alignment shown in Figure 4.1 clearly highlights a conserved domain present 
in all homologs – ‘…PX2CCX2GCX2CVWX2YX3L…’. This domain has been annotated as 
‘oxidoreductase-like domain, N-terminal’ (InterPro - IPR019180), and is present in more 
than 2000 proteins across 749 species (Pfam - PF09791; Finn et al., 2016). This includes 
614 eukaryotic species and 135 bacterial species (Figure 4.2). A profile hidden Markov 
Model, profile HMM, which represents the oxidoreductase-like domain within these 
proteins is shown in Figure 4.3. It is striking to note that although there are so many 
proteins containing this domain, absolutely nothing is known about the function of any of 
these proteins.  
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Figure 4.1. S. cerevisiae Ypl107w multiple sequence alignment. Clustal Omega (Version 
1.2.4) was used to align Ypl107w homologs from Saccharomyces cerevisiae, Schizosaccharomyces 
pombe, Mus musculus, Bos Taurus, Homo sapiens, Caenorhabditis elegans and Drosophila 
melanogaster. Green – hydroxyl + sulphydryl + amine + G; Red – small (small + hydrophobic, 
including aromatic – Y); Pink – basic - H; Blue – acidic. * (asterisk) – single, fully conserved 
residue. : (colon) – conservation between groups of strongly similar properties. . (period) – 
conservation between groups of weakly similar properties.  
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Figure 4.2. Graphical representation of the oxidoreductase-like family across 
species. Sunburst representation of species containing the oxidoreductase-like, N-terminal 
domain (Finn et al., 2016). There are 749 species in total; 614 eukaryota and 135 bacteria. The 
domain is absent from archea, viruses and viroids. (Pfam – PF09791). 
 
 
 
Figure 4.3. Profile HMM for oxidoreductase-like protein family. A graphical 
representation of the profile hidden Markov model, profile HMM, for the oxidoreductase-like 
protein family (Pfam – PF09791) (Wheeler et al., 2014). Height of stack – a measure of the 
invariance of the column; Height of letter – frequency at that position. 
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As the Mitoprot/targeting analysis of Ypl107w predicted a cleavable N-terminal 
mitochondrial targeting sequence of around 26 amino acids, a secondary structure 
prediction was carried out on both Ypl107w and hOXLD-1 (Figure 4.4).  Ypl107w and 
hOXLD-1 contain multiple predicted alpha helical structures both with one close to the N-
terminus which could act as a potential mitochondrial targeting signal.  
 
 
 
 
 
 
 
 
Figure 4.4. Secondary structure prediction for Ypl107w and hOXLD-1. Secondary 
structure predictions for (A) Ypl107w and (B) hOXLD-1 were carried out using the online PSIPRED 
prediction tool (Jones, 1999; Buchan et al., 2013). 
 
A B 
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In addition to the secondary structure predictions, an ion binding prediction for Ypl107w 
was carried out using IonCom (Hu et al., 2016). IonCom is a composite binding-site 
prediction tool that searches for 13 small ligands, including nine metal ions and four acid 
radical ions: Zn2+, Cu2+, Fe2+, Fe3+, Ca2+, Mg2+, Na+, K+; and CO32-, NO2-, SO42- , and PO43-, 
respectively. The tool predicted potential binding sites for Zn2+ and Na+ - no binding sites 
were detected for the others (Figure 4.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Small ligand binding-site prediction for Ypl107w. IonCom results predict 
putative binding sites for Zn2+ (A & B) and Na+ (C & D) (Hu et al., 2016). Predicted residues 
involved in binding are shown in red. Note that the structures shown in Panels A and C are also 
predictions generated by IonCom. 
  
Moving on from sequence and structural analysis, nearly all of the known genetic and 
physical interactors of Ypl107w and OXLD-1 were compiled together and analysed using 
Gene Ontology Term Finders. In addition, any literature relating to gene expression and 
regulation was also analysed. 
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Although YPL107W itself is not an essential gene, there are 75 known genetic interactors 
of YPL107W, of which 23 (31%) are associated with mitochondria either by localisation or 
function and are listed in Table 4.1 (Costanzo et al., 2010; Costanzo et al., 2016). Here, 
genetic interactors are defined when a deletion of YPL107W in combination with the 
deletion of another gene results in either a deleterious or beneficial phenotype, and are 
classified as either negative or positive. Nearly of all YPL107W’s interactors are negative; 
only two are positive. A Gene Ontology (GO) search for both process and function was 
carried out by inputting these 23 mitochondrial-associated genetic interactors using the 
GO Term Finder, Version 0.83, which is available on the yeast genome database website 
(www.yeastgenome.org). Three processes and two functions were highlighted: processes 
include mitochondrial tRNA thio-modification, mitochondrial organisation and protein 
lipoylation; functions include sulphurtransferase and oxidoreductase activity (Table 4.2).  
 
Table 4.1. YPL107W genetic interactors associated with mitochondria.  
  
Genes that show either a positive or negative genetic interaction when knocked out in 
combination with YPL107W (Costanzo et al., 2010; Costanzo et al., 2016).  
Mitochondrial Genetic Interactions with YPL107W 
Systematic name Standard name Function/Process +/- 
YAL046C BOL3 Mitochondrial Fe/S cluster transfer - 
YDR375C BCS1 Assembly of Complex III + 
YOR125C CAT5 Ubiquinone biosynthesis - 
YNR041C COQ2 Ubiquinone biosynthesis + 
YNL052W COX5A Subunit of complex IV - 
YOR065W CYT1 Subunit of complex III - 
YMR207C HFA1 Acetyl-coenzyme A carboxylase - 
YOL095C HMI1 ATP-dependent DNA helicase - 
YLR239C LIP2 Lipoyl ligase - 
YOR196C LIP5 Lipoic acid biosynthesis - 
YKL053C-A MDM35 Mitochondrial organisation - 
YOR350C MNE1 Mitochondrial splicing - 
YDR116C MRPL1 Subunit of mitochondrial ribosome - 
YOR354C MSC6 Mitochondrial translation - 
YCL017C NFS1  Fe/S cluster biogenesis & thiol modification of tRNAs - 
YGR231C PHB2 Subunit of prohibitin complex/life span regulation + 
YLL041C SDH2 Fe/S protein subunit of succinate dehydrogenase - 
YDL033C SLM3 tRNA-specific-2-thiouridylase - 
YHR008C SOD2 Manganese superoxide dismutase - 
YKR042W UTH1 Cell wall biogenesis & oxidative stress response - 
YDR049W VMS1 Mitochondrial protein degradation - 
YDL120W YFH1 Mitochondrial Fe/S assembly - 
YMR241W YHM2 Mitochondrial citrate and oxoglutarate carrier - 
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Table 4.2. Gene Ontology search for YPL107W genetic interactors.  
  
All mitochondrial-associated YPL107W genetic interactors were entered into the Gene Ontology 
Search Finder (available at www.yeastgenome.org). Interactors were searched separately for 
process or function. 
  
In addition to searching for genetic interactors of YPL107W, genes with similar expression 
profiles were generated using SPELL, Serial Pattern of Expression Levels Locator (Hibbs et 
al., 2007). SPELL searches through 11449 microarrays from 386 published studies for 
genes with similar expression patterns to the query input – in this case YPL107W. A list of 
the top 19 genes similar to YPL107W can be seen in the Appendices, Table 7.1. A GO 
Term Finder search of these 19 genes for process and function found no significant 
ontology terms apart from eight of the genes share ‘biological process unknown’ and 12 
share ‘molecular function unknown’. Although no genetic interactors are known for any 
of the YPL107W homologs, there are some large-scale studies that identified putative 
physical interactors of the human homolog, hOXLD-1 (Huttlin et al., 2015 and Huttlin et 
al., 2017). Those that are localised within mitochondria are listed in Table 4.3 - 38/49 are 
mitochondrial.  A GO search using these 38 putative interactors brought up a huge list of 
processes and functions which can be seen in the Appendices, Table 7.2. Interestingly, in 
S. cerevisiae, although physical partners have not been fully captured, the mitochondrial 
matrix Hsp70, Ssc1, is listed as a potential protein interactor (Böttinger et al., 2015). 
Gene Ontology Term Finder 
Process 
Cluster 
frequency 
Background 
frequency 
P-value Genes annotated to term 
mitochondrial tRNA 
thio-modification 2/23, 9% <0.1% 
0.00175 
 NFS1, SLM3 
mitochondrion 
organisation 7/23, 30% 3.7% 
0.00235 
 
NFS1, SLM3, BCS1, PHB2, MDM35, 
YHM2, HMI1 
protein lipoylation 2/23, 9% 0.1% 0.01744  LIP2, LIP5 
Function 
Cluster 
frequency 
Background 
frequency 
P-value Genes annotated to term 
sulphurtransferase 
activity 3/23, 13% 0.1% 
7.17E-05 
 NFS1, SLM3, LIP5 
oxidoreductase activity 5/23, 22% 4% 0.03764  YFH1, SOD2, SDH2, COX5A, CAT5 
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Table 4.3. hOXLD-1 physical interactors associated with mitochondria.  
  
All mitochondrial-associated hOXLD-1 putative physical interactors are listed, along with a brief 
description of their function (Huttlin et al., 2015; Huttlin et al., 2017). 
  
 
 
Human hOXLD-1 Mitochondrial Physical Interaction Partners 
Standard name Description 
AARS2 Alanine tRNA ligase 
ACADVL Acyl-CoA dehydrogenase 
ACOT9 Acyl-CoA thioesterase 
ACSF3 Acyl-CoA synthetase 
AK4 Adenylate kinase 
ALAS1 5-aminolevulinate synthase 
ALDH5A1 Succinate-semialdehyde dehydrogenase 
ATPAF2 ATP synthase mitochondrial F1 complex assembly 
AUH Methylglutaconyl-CoA hydratase 
CARS2 Cysteinyl-tRNA synthetase 
CPT2 Carnitine O-palmitoyltransferase 
DBT Lipoamide acyltransferase 
FMC1 Assembly/stability of ATP synthase 
GLDC Glycine dehydrogenase 
GLS Glutaminase 
GRPEL2 Essential component of PAM complex 
HIBCH 3-hydroxyisobutryl-CoA hydrolase 
HSD17B8 Estradiol 17-beta-dehydrogenase 
IBA57 Putative transferase, maturation of mitochondrial 4Fe-4S proteins 
MGME1 Mitochondrial genome maintenance 
MMAB Adenosyltransferase 
MRPP3 Catalytic ribonuclease component of mitochondrial ribonuclease P 
MTG2 Mitochondrial ribosome-associated GTPase 
MTIF2 Mitochondrial translation initiation factor 
MUT Methylmalonyl-CoA mutase 
NARS2 Asparaginyl-tRNA synthetase 
NDUFAF5 Complex I assembly factor 
NDUFAF7 Complex I assembly factor 
PDSS2 Decaprenyl-disphophate synthase subunit 
POLG DNA polymerase submit gamma 
POLRMT RNA polymerase 
PUS1 tRNA pseudouridine synthase 
SIRT3 NAD-dependent protein deacetylase 
TRMT2B tRNA methyltransferase 
TRMT61B tRNA methyltransferase 
TSFM Translation elongation factor 
UQCC1 Ubiquinol-cytochrome-c reductase complex assembly factor 
UQCC2 Ubiquinol-cytochrome-c reductase complex assembly factor 
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4.3.2. Import and localisation of Ypl107w 
  
The import of Ypl107w was initially tested at the end of Chapter 3, Section 3.3.7, where it 
was found to successfully import into isolated mitochondria (Figure 3.22). Further assays 
were carried out to assess whether Ypl107w import is dependent on membrane potential, 
along with two extra controls (no mitochondria/no precursor added to reactions). These 
extra controls were to confirm that the band detected by autoradiography in the import 
reaction lanes are imported into mitochondria and not protease-resistant aggregates, and 
that the bands are specific to the radiolabelled precursors.  The results shown in Figures 
4.6A & 4.6B indicate that Ypl107w import requires membrane potential, as no band is 
detected when membrane potential is abolished by CCCP and valinomycin, and the extra 
controls confirm its import. Su9-DHFR was used as a control protein that requires 
membrane potential as it is cleaved after import into the matrix (Figure 4.6C). These 
results suggest that Ypl107w is also targeted to the matrix; however, a localisation assay 
was required to provide evidence for this. 
  
To investigate the suspected matrix localisation of Ypl107w, a mitochondrial localisation 
assay was used to detect which subcompartment Ypl107w resides in after import, and 
whether or not it is soluble (refer to Chapter 2, Section 2.2.2.3 for methodology). The 
results show that Ypl107w is found within ‘mitoplasts’, the inner mitochondrial 
membrane/matrix fraction after osmotic shock, and that it is protease protected (Figure 
4.7). Carbonate extraction revealed that Ypl107w is a soluble protein. Control antibodies 
against proteins from various mitochondrial subcompartments and different associations 
with membranes were used to compare against Ypl107w. The soluble matrix protein 
Cpn10 showed the same localisation pattern as Ypl107w, providing further evidence that 
Ypl107w is likely to be a soluble, matrix protein. 
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Figure 4.6. Import of radiolabelled Ypl107w and Su9-DHFR. Ypl107w and Su9-DHFR 
were synthesised as radiolabelled precursors and imported into isolated wild-type yeast 
mitochondria. (A) Ypl107w import straight after translation (native), (B) Ypl107w import after 
treatment with 20 mM DTT and 8 M urea to reduce and denature the precursor, and (C) Control 
Su9-DHFR import (native). Import reactions were stopped after 30 minutes. DY - membrane 
potential. All import reactions were treated with trypsin to destroy unimported material (M), and 
a combination of Triton-X-100 and trypsin as a negative control (Tx). Extra controls whereby no 
mitochondria (No mitos) or no precursor (No Ypl/Su9) were added to the import reaction. 5% 
corresponds to 5% of the precursor used for each import reaction. Radiolabelled precursors were 
detected by digital autoradiography. * -  Ypl107w. Pre – premature Su9-DHFR, i – IMS stalled Su9-
DHR intermediate (incompletely cleaved in transition), Mat – mature Su9-DHFR (cleaved after 
import into matrix). 
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Figure 4.7. Radiolabelled Ypl107w localisation after mitochondrial import. Ypl107w 
was synthesised as a radiolabelled precursor and imported into isolated wild-type yeast 
mitochondria straight after translation. The import reaction was stopped after 30 minutes and 
treated with trypsin to destroy unimported material (M), and a combination of Triton-X-100 and 
trypsin as a negative control (Tx). Osmotic shock to rupture the OM, mitoplasting (MP), resulted in 
pellets (P) containing the matrix/IM and supernatants (S) containing IMS proteins, -/+ proteinase 
K (PK). Carbonate extraction (CE) to separate insoluble from soluble proteins from intact 
mitochondria after Ypl107w import: (P) – insoluble proteins associated with mitochondrial 
membranes; and (S) – soluble proteins. Top panel - analysis by autoradiography to detect 
radiolabelled Ypl107w. Bottom panel - analysis by western blotting to detect mitochondrial 
proteins from different subcompartments: anti-Mia40 (IMS/IM); anti-Por1 (integral OM); anti-
Erv1 (soluble IMS); anti-Cytc (soluble IMS); and anti-Cpn10 (soluble matrix). 5% corresponds to 5% 
of the precursor used for each import reaction. Radiolabelled precursors were detected by digital 
autoradiography. * - Ypl107w. 
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As most matrix proteins contain cleavable sequences at their N-terminus, the next step 
was to delete the suspected targeting sequence in Ypl107w and test its import capacity. 
YPL107W was subcloned into a pSP64 vector without its first 78 base pairs to create a 
plasmid which would translate a truncated protein lacking the first 26 amino acids of 
Ypl107w - N26∆Ypl107w.  This vector was then used to produce a 35S-labelled precursor 
and presented to isolated wild-type yeast mitochondria following the import assay 
described above (Figure 4.8). The results show that Ypl107w cannot be imported without 
its N26 sequence. Thus, its mitochondrial targeting signal must lie within this region. 
Altogether, the evidence indicates that Ypl107w is a soluble, mitochondrial matrix protein 
with an N-terminal mitochondrial targeting signal that requires both its targeting signal 
and membrane potential for import. 
 
 
 
 
 
 
 
 
 
 
Figure 4.8. Import of radiolabelled N26∆Ypl107w and Ypl107w. N26∆Ypl107w and 
Ypl107w were synthesised as radiolabelled precursors and imported into isolated wild-type yeast 
mitochondria. Import reactions were stopped after 20 minutes then treated with trypsin to 
destroy unimported material (M), and a combination of Triton-X-100 and trypsin as a negative 
control (Tx). 5% corresponds to 5% of the precursor used for each import reaction. Radiolabelled 
precursors were detected by digital autoradiography. * - Ypl107w/N26∆Ypl107w (size difference 
not detectable); ** - Unknown, could be translation from a downstream Met. Anti-Hsp70 was 
used as a loading control and control for successful Tx/trypsin treatment. 
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4.3.3. BN-PAGE analysis 
   
As the evidence points strongly in favour of Ypl107w as a true mitochondrial protein, 
based on mass spectrometry data, import and localisation assays, the next step was to 
determine whether Ypl107w is part of a complex (or complexes). Blue native PAGE (BN-
PAGE) was performed to isolate native protein complexes after radiolabelled import of 
Ypl107w into isolated wild-type mitochondria. Unfortunately, the results (after multiple 
tries and using different solubilisation methods) were not clear as no sharp bands could 
be detected other than one that is assumed to be the monomeric form of Ypl107w 
(Figures 4.9A & 4.9B). However, upon closer inspection there are several ‘smears’ that 
might indicate the presence of Ypl107w within multiple different complexes of varying 
molecular weights. These remain to be verified and the BN-PAGE protocol requires 
further optimisation. 
  
In parallel to the work carried out in Sections 4.3.2 and 4.3.3, a phenotypic approach was 
taken to provide a more detailed analysis of yeast cells lacking Ypl107w (ypl107wΔ). 
Growth assays, drop tests, and H2O2 and diamide sensitivity assays were used to gather 
information that could potentially relate Ypl107w to a role in mitochondrial function.  
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Figure 4.9. BN-PAGE analysis of Ypl107w after radiolabelled import. Ypl107w was 
synthesised as a 35S-labelled precursor and imported into isolated wild-type yeast mitochondria. 
The import reaction was stopped after 20 minutes then treated with trypsin to destroy 
unimported material. Three lanes containing increasing amounts of isolated mitochondria after 
import were loaded into a 6-16% gel (50 µg, 100 µg and 150 µg) to help detect complexes that 
might not be apparent in lesser amounts. Ypl107w after transcription and translation was loaded 
as a control. (A) and (B) are repeats of the same experiment. * - Ypl107w (monomer?). Brackets 
indicate potential complexes. Note: Ypl107w is a 29 kDa protein (predicted 25 kDa after cleavage 
upon import). 
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4.3.4. Growth assays and drop tests 
   
The first phenotypic analysis that was performed was to check for growth defects 
between the yeast mutant ypl107wD which lacks the entire open reading frame (ORF) for 
Ypl107w and the wild-type BY4741 strain. This ypl107wD mutant is in the BY4741 genetic 
background and was obtained from GE Healthcare. These yeasts were grown in 
fermentable (YPD - glucose) and non-fermentable media (YPLac - lactate; and YPGly - 
glycerol) over a period of 16 hours. The results indicate that yeast lacking Ypl107w 
struggle to grow on non-fermentable media which suggests that they have impaired 
mitochondrial function (Figure 4.10). Non-fermentable media is also known as respiration 
media as they force the cells to use only aerobic respiration to produce ATP.  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. Growth of ypl107wD vs wild-type yeast. Growth curves for ypl107wD and 
wild-type BY4741 in (A) the fermentable media YPD, and the non-fermentable mediums (B) YPLac 
and (C) YPGly. YPD – yeast extract, peptone and glucose. YPLac - yeast extract, peptone and lactic 
acid. YPGly – yeast extract, peptone and glycerol. Blue lines indicate wild-type yeast; red dashed 
lines indicate ypl107wD yeast. Three colonies from each strain were grown to stationary phase in 
YPD before diluting to OD600nm: 0.05 in each media, and measured every hour for 16 hours.  
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Drop tests were also performed alongside the growth curves. Agar plates were made 
containing the same fermentable and non-fermentable carbon sources and ypl107wD 
yeast were compared to wild-type, along with various positive and negative controls 
(Figure 4.11). The results of these drop tests indicate that ypl107wD do not exhibit 
growth defects on the fermentable media YPD (as expected), but that they were slightly 
sensitive to growth on the non-fermentable media YPLac (as shown in the growth curves). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4.11. Yeast drop tests in fermentable vs non-fermentable media. Yeast were 
grown to stationary phase in liquid YPD media overnight then serially diluted in the morning and 
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spotted onto plates containing fermentable media (A and B) YPD, and non-fermentable media (C 
and D) YPLac and (E and F) YPGly. YPD – yeast extract, peptone and glucose/dextrose. YPLac - 
yeast extract, peptone and lactic acid. YPGly – yeast extract, peptone and glycerol. Plates were 
incubated for 48 hours at 30°C. These are representative images from three repeat assays. 
BY4741 is the representative wild-type background strain for gpx3D and ypl107wD. W303 is the 
representative wild-type background strain for trr1D and trx1/2D. 
  
Interestingly, ypl107wD yeast grown on YPLac plates turned brown in colour, whereas all 
the other strains stayed their typical white/cream colour (Figure 4.12). The reason for this 
colour change is entirely unknown. This colour change was also observed when the 
ypl107wD yeast strain was grown on standard YPD plates but only after storage at 4°C for 
a few weeks. Thus, it appears that the brown colour phenotype is exacerbated by growth 
in a non-fermentable carbon source. On observation under a light microscope, ypl107wD 
yeast appeared to have a petite phenotype in comparison to BY4741 yeast (data not 
shown). 
 
 
 
 
 
  
Figure 4.12. Colour of wild-type vs ypl107wD yeast grown on non-fermentable 
media. Yeast were grown to stationary phase in liquid YPD media overnight then serially diluted 
in the morning and spotted onto plates containing the non-fermentable media YPLac (yeast 
extract, peptone and lactic acid). Plates were incubated for 48 hours at 30°C. BY4741 is the 
representative wild-type background strain for ypl107wD. BY4741 yeast cells remained their 
typical white/cream colour (top row) whereas the mutant ypl107wD yeast turned brown (bottom 
row).  
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4.3.5. Hydrogen peroxide and diamide sensitivity assays 
  
As a high-throughput study found that ypl107wD yeast have a decreased resistance to 
oxidative stress when exposed to 3 mM H2O2 (Brown et al., 2006), a H2O2 sensitivity assay 
(also known as a halo assay) was performed where H2O2 was spotted onto the middle of a 
YPD agar plate containing yeast cells (refer to Chapter 2, Section 2.2.4). The results 
shown in Figures 4.13 and 4.14 indicate that the ypl107wD strain obtained from GE 
Healthcare is more sensitive to H2O2 than the wild-type control, along with the positive 
controls trr1D and gpx3D, as they produced larger clear zones in comparison to their wild-
type background strains. The trr1D mutant was chosen as a positive control based on 
prior evidence by Hacioglu et al (2010) who found that a trr1D yeast strain exhibited a 
large halo when grown on plates spotted with H2O2. Similarly, yeast lacking Gpx3 are 
known to be more sensitive to H2O2 (Ma et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13. H2O2 sensitivity assay - plates. Yeast were grown to stationary phase in liquid 
YPD media, diluted to OD600nm: 0.1 and then spread onto YPD plates.  Plates were then spotted 
with 5µl 8.8 M H2O2 in the centre and left to grow for 24 hours at 30°C. Wild-type strains are 
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BY4741          yplD          gpx3D         W303         trr1D        trx1/2D 
shown in the left panels; trr1D is in the W303 genetic background and gpx3D and ypl107wD are in 
the BY4741 background. Positive controls that are known to be sensitive to H2O2 are trr1D and 
gpx3D. These are representative images from four repeat assays. The diameters of the clear zones 
were measured from four repeats; the results of all four are shown in Figure 4.14. 
 
 
 
 
 
 
 
 
 
 
  
Figure 4.14. H2O2 sensitivity assay - diameters. Yeast were grown to stationary phase in 
liquid YPD media, diluted to OD600nm: 0.1 and then spread onto YPD plates. A 5µl drop of 8.8 M 
H2O2 was placed onto the centre of each plate. Once dried, plates were incubated for 24 hours at 
30°C. The diameter of the clear zone, ‘halo’, was measured. The diameters shown here are the 
mean of four repeat assays for each yeast strain. Error bars represent standard error of the mean. 
BY4741 is the representative wild-type background strain for gpx3D and ypl107wD. W303 is the 
representative wild-type background strain for trr1D and trx1/2D.   
  
In addition to H2O2, the alternative thiol oxidising agent diamide was used to test for 
oxidant sensitivity in the ypl107wD strain. Yeast cells were spotted onto YPD plates 
containing either 0, 2.0 or 2.5 mM diamide and grown for 3 days at 30˚C. The results 
indicate that ypl107w∆ and gpx3∆ are slightly more sensitive than wild-type yeast to 2.0 
mM diamide; no yeast strains were able to grow with 2.5 mM diamide (Figure 4.15). This 
assay should be repeated using lower concentrations of diamide. 
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 Figure 4.15. Diamide sensitivity assay. Yeast were grown to stationary phase in liquid YPD 
media overnight before being serially diluted in the morning and spotted onto plates containing 
either 0, 2.0 or 2.5 mM diamide. Plates were left to grow for 3 days at 30°C. Wild-type BY4741, 
gpx3D and ypl107wD on YPD with (A) no diamide, (B) 2.0 mM diamide, and (C) 2.5 mM diamide. 
These are representative images from three repeat assays. 
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4.3.6. Steady-state protein levels in ypl107wD mitochondria 
  
Mitochondria from ypl107wD yeast were isolated by density gradient centrifugation and 
analysed by western blotting. Various mitochondrial proteins were probed and their 
expression levels were compared to mitochondria from the wild-type BY4741 strain. The 
results suggest that Gpx3 and Cytc levels are lower in ypl107wD mitochondria, whilst Erv1 
and Tim11 levels are higher (Figure 4.16); quantifications are shown in Figure 4.17 and 
repeat western blots which indicate the same findings can be seen in the Appendices, 
Figure 7.5. It is not known why these levels are different in the mutant strain; however, 
one could hypothesise that Erv1 is upregulated when the levels of Gpx3 and Cytc are 
down in order to compensate for their absence in the Mia40 oxidative folding pathway, 
but this remains to be investigated. Tim11 is a small 11 kDa protein of the IM that is 
subunit e of the mitochondrial ATP synthase complex (ATPase) (Arnold et al., 1997). 
Although not essential for ATPase function, it is involved in dimerisation and stability of 
the complex (Devenish et al., 2000). One hypothesis to explain why Tim11 is upregulated 
could be that it is compensating for defects in respiratory chain activity (potentially 
caused by the lack of Ypl107w) by stabilising ATPase in order to maintain adequate ATP 
production. It would be interesting to determine the individual activities of all the 
respiratory chain complexes in WT vs ypl107wD mitochondria. 
  
Intriguingly, an odd band pattern against Tom22 was detected in ypl107wD mitochondria; 
although three bands are detected in the wild-type BY4741 and it is unclear which is 
specifically recognising Tom22, all three are different in the mutant strain. The reason for 
this is unknown, however, it could be evidence for the loss of Ypl107w function affecting 
mitochondrial transport. 
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Figure 4.16. Comparison of protein levels in wild-type BY4741 vs ypl107wD 
mitochondria. Mitochondria were isolated from yeast grown to mid-log phase in media 
containing the non-fermentable carbon source lactic acid. After density gradient centrifugation, 
purified mitochondria (pure mitos) were separated by SDS-PAGE and analysed by western blotting 
to detect various mitochondrial proteins. Antibodies against OM proteins include: anti-Por1, anti-
Tom40, anti-Tom70, anti-Tom22 and anti-Tom20. IMS proteins include: anti-Mia40, anti-Gpx3, 
anti-Erv1, anti-Cytc and anti-Tim10. IM proteins include: anti-Tim11, anti-Tim23 and anti-Tim44. 
Anti-Hsp70 was used as a matrix protein marker.  
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BY4741                  ypl107wD   BY4741                  ypl107wD   
BY4741                  ypl107wD   BY4741                  ypl107wD   
 
Figure 4.17. Quantification of protein levels in wild-type BY4741 vs ypl107wD 
mitochondria. Quantification of western blot band density from Figure 4.16 was performed 
using Image J 1.48v. The y-axis represents the relative density of bands when normalised against a 
control protein which was probed for on the same blot; (A) Gpx3 was normalised against Mia40, 
(B) Cytc against Por1, and (C) Erv1 and (D) Tim11 against Tom40. Error bars show the standard 
error of the mean. 
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4.4. Discussion 
  
At the start of this project very little was known about Ypl107w other than its potential 
mitochondrial localisation based on fluorescent tagging of the protein (Huh et al., 2003) 
and some phenotypic data on a ypl107w∆ yeast strain collected during high-throughput 
studies (Brown et al., 2006; Yoshikawa et al., 2009; Breslow et al., 2008; Blackman et al., 
2012; Michaillat and Mayer, 2013). These studies indicate that ypl107w∆ yeast cells are 
less fit and are less resistant to H2O2, salt and the drug elesclomol which targets the 
respiratory chain, and, have a small defect in vacuolar fragmentation. However, no study 
to date has exclusively focused on Ypl107w or any of its homologs.  
  
Bioinformatics analysis on Ypl107w revealed that, for every organism checked, a homolog 
exists; its human homolog is hOXLD-1 (Figure 4.1). Furthermore, a highly conserved 
domain within Ypl107w known as ‘oxidoreductase-like domain, N-terminal’ is present in 
over 2000 proteins from 749 species (InterPro – IPR019180; Pfam – PF09791; Finn et al., 
2016), but nothing is known about the function of any of these (Figures 4.2 & 4.3). A 
mitochondrial targeting predictor tool, MITOPROT, predicts a cleavable N-terminal 
targeting sequence comprising the first 26 amino acids of Ypl107w, and a secondary 
structure prediction of Ypl107w predicts the presence of an alpha-helical structure within 
this region (Figure 4.4). Together, this is suggestive of a classical N-terminal mitochondrial 
matrix targeting signal that is cleaved upon import. Finally, an ion binding predictor tool 
predicted Zn2+ and Na+ binding sites (Figure 4.5). In order to test these predictions, 
Ypl107w would need to purified and structurally characterised using a range of 
techniques to determine whether it can bind metal ions, and if so, which ones and what 
its oligomeric state is. Unfortunately, attempts to purify Ypl107w within the duration of 
this PhD were not successful as the protein was highly prone to aggregation (data not 
shown). Future work to optimise purification conditions is required. Finally, the potential 
interaction between Ssc1 and Ypl107w should be explored as this may be of importance 
to the role of Ypl107w in the mitochondrial matrix. However, as Ssc1 is involved in the 
refolding import of matrix proteins after entry through the TIM23-PAM complex (Horst et 
al., 1997), it could be that their interaction is purely to help facilitate the folding of 
Ypl107w within the matrix. 
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Switching from biochemistry to genetics, a search revealed that out of 75 known genetic 
interactions, 23 of these are genes associated with mitochondria; 20 negative and 3 
positive (Table 4.1). Inputting these 23 genes into a Gene Ontology Term Finder tool 
highlighted three processes (mitochondrial tRNA thio-modification, mitochondrial 
organisation and protein lipoylation) and two functions (sulphurtransferase and 
oxidoreductase activity), see Table 4.2. Furthermore, a search for genes with similar 
expression patterns using SPELL, Serial Pattern of Expression Levels Locator (Hibbs et al., 
2017), generated a list of the top 19 genes; however, no significant ontology terms were 
found other than biological process and molecular function unknown (Appendices, Table 
7.1). Moving back to biochemistry and switching to hOXLD-1, 49 physical interaction 
partners are listed by Huttlin et al. (2015, 2017), of which 38 are mitochondrial proteins 
(Table 4.3). A GO term finder tool found a vast number of significant ontology terms – 
mostly related to metabolism but also mitochondrial gene expression, mitochondrial 
organisation, mitochondrial RNA processing and mitochondrial translation (Appendices, 
Table 7.2). Based on these data, could Ypl107w and its homologs be involved in 
mitochondrial organisation by regulating mitochondrial gene expression and translation, 
and/or by helping to assemble the respiratory complexes? 
  
To begin our experimental exploration of Ypl107w, its import into mitochondria was 
confirmed by synthesising a radiolabelled precursor and presenting it to isolated wild-
type yeast mitochondria; upon import Ypl107w was protease-protected (Figure 4.6). Its 
import was also dependent on membrane potential. A localisation assay was then carried 
out to assess which mitochondrial subcompartment the protein resides in, and the results 
of the assay suggest that Ypl107w is a soluble, matrix protein (Figure 4.7). Next, the 
predicted mitochondrial targeting sequence of Ypl107w was confirmed by checking the 
import of Ypl107w without its N-terminal 26 amino acids (N26DYpl107w) which, as 
expected, was not successful (Figure 4.8). Future import assays using mitochondria 
isolated from mutant strains defective in different import pathway components could be 
carried out to establish which pathway Ypl107w follows, for example: tom40-ts, tim23-ts, 
galMia40 and galErv1 yeast (refer to Chapter 1 for a description of the various 
mitochondrial import pathways). If the import of Ypl107w was shown to be dependent on 
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the presence of the TIM23 complex, this would provide further clarification that Ypl107w 
resides in the mitochondrial matrix. 
 
Soon after these experiments were completed, a paper was published by Morgenstern et 
al. (2017) reporting an additional 82 high-confidence mitochondrial proteins, one of 
which was Ypl107w. After carrying out their own import experiments on a multitude of 
these new proteins, they gave Ypl107w its standard name, Dpc25, which stands for delta-
psi dependent mitochondrial import and cleavage protein of ~25 kDa. Although the 
timing of their paper was unfortunate, it did provide reassuring evidence in an 
independent study that is in complete agreement with our own, and it only encouraged 
us to probe Ypl107w in more detail. Thus, the next aim was to determine whether 
Ypl107w is part of any complexes.    
  
A BN-PAGE analysis was performed to isolate native protein complexes after radiolabelled 
import of Ypl107w into wild-type mitochondria. The initial results, although unclear, 
suggest that Ypl107w may be part of multiple complexes (Figure 4.9) but the BN-PAGE 
analysis requires more extensive optimisation in order to detect clearer, sharper bands. 
Morgenstern et al. (2017) also attempted BN-PAGE on Ypl107w, however, akin to ours 
they could not provide any clear evidence of the presence of the protein in distinct 
complexes. One hypothesis behind the presence of multiple ‘smeary’ bands in our BN-
PAGE could be that Ypl107w is a chaperone/assembly protein and thus might interact 
with lots of proteins and complex subunits. An additional hypothesis is that it is natively 
unfolded when produced via the TNT system (or when expressed in bacteria) which leads 
to aggregation of the protein as it is not tightly folded, thus it can then falsely interact 
with many other proteins. We also tried to determine whether any of the respiratory 
chain complexes were affected in ypl107w∆ mitochondria by performing BN-PAGE 
followed by Coomassie staining on wild-type vs ypl107w∆ mitochondria. The results were 
unclear (data not shown) and this assay should be repeated using antibodies against the 
yeast respiratory chain complexes. Sadly, these were not available in the lab and could 
not be commercially bought. Another method would be to analyse protein partners of 
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Ypl107w by carrying out pulldowns and analysing by mass spectrometry or 
immunoprecipitations with or without the use of crosslinkers.  
  
Parallel phenotypic experiments found that ypl107wD yeast exhibit growth defects when 
grown in non-fermentable carbon sources, including lactic acid and glycerol, when 
compared to glucose (Figures 4.10 & 4.11), and, that ypl107wD  yeast colonies turn 
brown after growth on plates containing lactic acid (Figure 4.12). We also confirmed the 
previous finding that ypl107wD yeast have a decreased resistance to H2O2 (Brown et al., 
2006; Figures 4.13 & 4.14). As Ypl107w is a bona fide mitochondrial protein (Figure 4.6; 
Morgenstern et al., 2017), it would make sense that a null mutant would display growth 
defects that are likely attributed to impaired mitochondrial function. 
  
A similar sensitivity assay using diamide instead of H2O2 did not yield any conclusive 
results as the wild-type BY4741 strain was also affected by the concentrations of diamide 
used (Figure 4.15); this assay could be repeated using lower concentrations.  However, it 
is important to note that H2O2 and diamide exert very different physiological effects; H2O2 
and diamide both induce a Yap1-dependent antioxidant response (refer to Chapter 1, 
Section 1.6) but diamide drastically alters the cellular balance of GSH and GSSG in a non-
specific manner. Thus, it would be interesting to use fluorescent sensors to measure the 
levels of H2O2 in the mitochondrial matrix (and also the cytosol as a control) in both 
ypl107wD  and wild-type cells. 
 
Mitochondria isolated from wild-type and ypl107wD yeast by density gradient 
centrifugation were analysed by western blotting after SDS-PAGE and the levels of various 
mitochondrial proteins were quantified (Figures 4.16 & 4.17).  Intriguingly, less Gpx3 and 
Cytc were found in ypl107wD mitochondria but the reason for this is currently unknown. 
Given that Gpx3 and Cytc are putative mitochondrial partners and Ypl107w was a 
putative hit in the mass spectrometry data when N18M20LGpx3His was used as bait 
(Section 3.3.7), it would be interesting to investigate whether there is a link, direct or 
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indirect, between all three proteins. In vitro interaction assays and immunoprecipitations 
could be used to help to elucidate which proteins are interacting and under what 
conditions. It would also be of importance to check whether any other cytochrome 
proteins are affected in ypl107wD mitochondria; for this, more antibodies are required. In 
addition, matrix protein levels need to be assessed due to the localisation of Ypl107w in 
the mitochondrial matrix but again more antibodies are needed. Another perhaps more 
suitable method would be to send isolated mitochondria for quantitative mass 
spectrometry analysis. Furthermore, future work should aim to measure the 
mitochondrial membrane potential in ypl107w∆ mitochondria by using a membrane 
potential sensitive probe, 3,3’-dipropylthiadicarbocyanine iodide - DiSC(3), and oxygen 
consumption calculated using a Clarke electrode. 
   
Finally, future work must address the question whether the human homolog hOXLD-1 can 
be (i) imported into yeast mitochondria, and (ii) rescue any of the phenotypic defects 
observed in the ypl107wD yeast strain. This work will be essential in uncovering whether 
hOXLD-1 is a real functional homolog of Ypl107w, and, together with parallel work in 
human cells, could provide instrumental information on proteins containing a highly 
conserved ‘oxidoreductase-like domain’ of which no literature exists. 
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5. Investigating Gpx3 in peroxisomes 
 
5.1. Introduction 
  
Peroxisomes are highly dynamic organelles in respect to their size, shape, protein content 
and abundance (Smith and Aitchison, 2013). Researchers are still trying to pinpoint 
exactly which proteins localise to peroxisomes, and under what conditions, but it is clear 
that the peroxisomal proteome continuously changes in response to the cellular 
metabolic environment and new proteins are regularly being identified (Yifrach et al., 
2016).  
 
In 2012, a study investigating the role of Gpx1 in S. cerevisiae peroxisomes also identified 
Gpx3 in the peroxisomal matrix due to cross-reactivity of anti-Gpx1 with Gpx3 (Ohdate 
and Inoue, 2012). It was found that Gpx1 exhibits peroxidase activity in peroxisomes, and 
when absent peroxisome biogenesis and growth in oleic acid media is compromised.  
Oleic acid induces peroxisome proliferation by inducing the transcription of genes 
required for fatty acid β-oxidation; a response mediated by the Pip2-Oaf1 transcription 
factor complex upon binding to the oleate response element (ORE) present within target 
genes (Rottensteiner et al., 1996; Rottensteiner et al., 1997; and Karpichev et al., 1997). 
These phenotypes were not rescued by expression of a peroxidatic cysteine mutant, 
Gpx1C36S, whereas expression of resolving cysteine mutants could. This indicates that the 
function of Gpx1 in peroxisomes relies on the ability of Gpx1 to form disulphide bonds. 
The authors suggested that Gpx1 might be involved in the redox regulation of Pex11; 
however, the literature points towards a potential interaction between Gpx3 and Pex11 
(Tarassov et al., 2008). No experiments were undertaken to investigate the role of Gpx3 
in peroxisomes.  
  
Pex11 is a highly abundant 27 kDa peroxisomal membrane protein required for 
peroxisomal fission (Erdmann and Blobel, 1995; Marshall et al., 1995), fatty acid oxidation 
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(van Roermund et al., 2000), establishing mitochondria-peroxisome contact sites via the 
ERMES complex (Mattiazzi Usaj et al., 2015), and transferring metabolites across the 
peroxisomal membrane (Mindthoff et al., 2016). The function of Pex11 in peroxisome 
proliferation depends upon the oligomeric state of the protein; monomeric Pex11 is 
required for proliferation whilst dimeric Pex11 inhibits organelle division (Marshall et al., 
1995). An upstream sequence analysis of Pex11 reveals a possible 17-amino acid N-
terminal extension with similarities to the N18 of Gpx3 (see later Figure 5.12).  
  
Based on the evidence that Gpx3 and Pex11 are potential interactors (Tarassov et al., 
2008) and the localisation of Gpx3 in both organelles (Ohdate and Inoue, 2012), the 
question as to whether the two are entwined in organelle cross-talk is apparent. 
Furthermore, the involvement of Pex11 in the ERMES complex (Mattiazzi Usaj et al., 2015) 
and ‘mislocalisation’ of Pex11 to mitochondria in the absence of peroxisomes (Mattiazzi 
Usaj et al., 2015; Wróblewska et al., 2017) are also suggestive of a potential link between 
the two proteins.  
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5.2. Aims 
  
The initial aim of this chapter was to confirm the presence of Gpx3 in peroxisomes, and 
determine whether the N-terminally extended version of Gpx3 (N18Gpx3) is present also 
in peroxisomes. To do this, peroxisomes and mitochondria were isolated in tandem and 
steady-state protein levels were assessed by western blotting (Figures 5.2 & 5.4). The 
results were unexpected and suggested that alongside the presence of Gpx3 in both 
organelles, Trx1, Trx2, Erv1 and Mia40 (albeit a shorter version) may also reside in 
peroxisomes.  
  
Based on this, four new objectives emerged: (i) to look for potential peroxisomal 
targeting signals in the suspected dually-localised proteins, (ii) to confirm the presence of 
a shorter form of Mia40 in peroxisomes and analyse its targeting signal, (iii) to determine 
peroxisomal interaction partners of Gpx3, (iv) to investigate the import of Pex11 and 
N17Pex11 in mitochondria, and (v) to test whether Gpx3 and Pex11 are interactors. 
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5.3. Results 
  
5.3.1. Isolation of mitochondria and peroxisomes confirms the 
presence of Gpx3 in both organelles 
 
As it is known that a pool of Gpx3 resides in the mitochondrial IMS, and that an N-
terminal extension of 18 amino acids boosts its mitochondrial targeting capacity, it was 
questioned whether the same targeting signal might be responsible for peroxisomal 
import. First, the presence of Gpx3 within mitochondria and peroxisomes in yeast was 
confirmed by isolating both organelles from the same yeast culture. Yeast cells were 
grown in 0.12% oleic acid to induce peroxisome proliferation, followed by fractionation 
and separation of organelles by density gradient centrifugation (Figure 5.1). Gpx3 was 
detected in both mitochondria and peroxisomes (Figure 5.2).  
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Isolation of yeast mitochondria and peroxisomes. Yeast were grown in 
media containing 0.12% oleic acid for 12-16 hours to induce peroxisome proliferation before 
purifying both mitochondria and peroxisomes using Nycodenz density gradient centrifugation. 
Mitochondria were collected from the 10%-23% gradient interface; peroxisomes were collected 
from the 23%-35% interface. Refer to Chapter 2, Section 2.2.2.1 for detailed methodology. 
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Figure 5.2. Yeast Gpx3 localises to both mitochondria and peroxisomes. (A) 
Nycodenz gradient after density centrifugation to show the separation of mitochondria (Mito) and 
peroxisomes (Pero) from yeast grown to mid-log phase in 0.12% oleic acid. (B, C & D) Western 
blots to detect cytosolic, peroxisomal or mitochondrial proteins in (T) total yeast cell extract 
before fractionation, crude organelles before density centrifugation (CO), purified mitochondria 
(M) and purified peroxisomes (P). Antibodies against the following proteins were used: Ssa1 - 
cytosolic; Trr1 - cytosol/IMS; Por1 - OM; Hsp70 – matrix; Pex11 – peroxisomal membrane; Gpx3 – 
cytosol/IMS; Trx1 – cytosol/IMS; Mia40 – IMS; Tom40 – OM; Erv1 - IMS; Cpn10 – matrix; and Trx2 
– cytosol. NOTE: Cross-reactivity between anti-Trx1 and anti-Trx2 is likely as the two paralogous 
proteins are very similar in amino acid sequence (89% similarity). * - Gpx3. ** - possible N18Gpx3. 
  
Under oleic acid growth conditions, a strong band using anti-Gpx3 (denoted with an 
asterisk) is detected in the peroxisomal fraction, and there appears to be more Gpx3 in 
peroxisomes than mitochondria, but this would need to be accurately quantified and 
compared to non-oleic acid conditions (Figure 5.2C). Two distinct bands are detected in 
the mitochondrial fraction; the top band (asterisk) may represent the N18Gpx3 version, 
although this cannot be confirmed by western blotting alone. The bottom band (double 
asterisk) is likely to represent the wild-type version which is the more predominant band 
in the peroxisomal fraction. Although not entirely clear, the western blot suggests that 
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the N-terminal extension of 18 amino acids which boosts mitochondrial import of Gpx3 is 
not required for peroxisomal import. Note that there is a band with high intensity that 
runs higher in molecular weight, at around 25 kDa, when anti-Gpx3 is used. It is not 
known what this band represents as it is too large to be the N18Gpx3 version of Gpx3, but 
it is absent in gpx3D yeast (see later Figure 5.6). Saturation of anti-Gpx3 with purified 
recombinant Gpx3 would also show specificity.  
  
What is also clear from the western blots shown in Figure 5.2 is that there is a degree of 
mitochondrial contamination in the isolated peroxisomal fractions as other mitochondrial 
proteins are detected in peroxisomes. The majority of these are detected to a much 
lesser extent than in the mitochondrial fraction which suggests they are weak 
contaminants, for example: Porin1, Tom40 and Cpn10. However, this is a common 
problem with density gradient centrifugation - 100% pure fractions are extremely unlikely 
as some organelles may break or stick together during the isolation protocol. The yeast 
cytosol was successfully removed as the cytosolic protein Ssa1 was only detected in total 
yeast cell extracts, and never in the organelle fractions (Figure 5.2B). Marker antibodies 
against other cellular components would need to be used to assess the true purity of the 
fractions but it can be assumed that they are largely enriched for the expected organelles 
based on organelle density. 
  
An antibody against a peroxisomal membrane protein, anti-Pex11, was sourced from 
Santa Cruz Biotechnology and used as a control for the enrichment of peroxisomes. 
Intriguingly, two bands were detected in the crude organelle fraction; one of which 
appears to be enriched in the mitochondrial fraction and the other in the peroxisomal 
fraction (Figure 5.2C). It could be that Pex11 is dually localised to both peroxisomes and 
mitochondria via a non-canonical start site resulting in an N-terminal extension akin to 
Gpx3 that targets Pex11 to mitochondria. Section 5.3.7 investigates this possibility.  
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Surprisingly, Erv1 also appears to localise to both mitochondria and peroxisomes as a 
strong band was detected in the peroxisomal fraction when probing using anti-Erv1 
(Figure 5.2D). Likewise, Trx1 and Trx2 were detected in peroxisomes (Figures 5.2C & 5.2D) 
but the antibodies against either one may recognise each other due to sequence 
similarity, so it is difficult to say with certainty which Trx protein is present. To test this, 
both anti-Trx1 and anti-Trx2 could be saturated with purified recombinant Trx1 and Trx2 
prior to their use; however, anti-Trx1 was raised against recombinant Trx1 and so it 
should be relatively specific. Peroxisomes would also need to be isolated from trx1D, 
trx2D, trx1D/trx2D and galErv1 yeast. 
  
Only the redox-regulated proteins like Gpx3, Trx1, Trx2 and Erv1 are likely to be dually 
localised to both organelles given that the other mitochondrial proteins analysed by 
western blotting (Porin1, Cpn10 and Tom40) were mostly enriched in the mitochondrial 
fraction.  
  
To gather complimentary evidence from a bioinformatics perspective on whether or not 
the proteins identified could be bona fide peroxisomal proteins, one can look for possible 
PTS1 or PTS2 motifs in the C- or N-terminal regions, respectively. Sequence analysis, 
based on what is currently known from the literature, suggests that both Trx1 and Trx2 
harbour PTS1 targeting signals (see next Section 5.3.2, Table 5.1). Although no targeting 
signals could be detected in the Gpx3, Erv1 and Mia40 proteins, not all bona fide 
peroxisomal proteins have had their targeting signals identified yet. In addition, based on 
the potential localisation of Erv1 to peroxisomes, it would make sense that its 
mitochondrial binding partner, Mia40, would also be present within the organelle. 
Although the initial western blot data in Figure 5.2D only shows a faint band against anti-
Mia40, which is more than likely attributed to mitochondrial contamination, the isolated 
fractions were re-probed using anti-Mia40 across the full-sized membrane. A strong band 
with a lower molecular weight was detected (see later Section 5.3.3, Figure 5.4). 
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5.3.2. Sequence analysis of mitochondrial proteins found in 
peroxisomal fractions 
  
Peroxisomal targeting signals are somewhat perplexing as different consensus exist for 
both PTS1 and PTS2 motifs (Brocard and Hartig, 2006). PTS1 motifs are found in the 
majority of known peroxisomal proteins, but, although they are universal, they can be 
species specific (Aitchison et al., 1991). To make matters more complicated, some 
genuine peroxisomal proteins, such as carnitine acetyl transferase (and Catalase A 
without its –SKL), are still successfully imported into peroxisomes (Elgersma et al., 1995; 
Kragler et al., 1993). Some are even ‘piggy-backed’ in under stress conditions, such as 
Pnc1 by Gpd1 (Kumar et al., 2016). Despite this, an analysis of the putative perixosomal 
proteins identified in Section 5.3.1, along with Mia40, for either PTS1 or PTS2 motifs is 
shown in Table 5.1. Due to the majority of available PTS predictors no longer accessible 
online due to their web links not working, a ‘by eye’ analysis was conducted based on the 
consensus motifs shown in Figure 5.3. Genuine peroxisomal proteins were included as 
controls in this analysis. 
 
 
 
 
 
 
Figure 5.3. PTS1 and PTS2 consensus motifs. Consensus amino acid sequences of 
peroxisomal targeting signal 1 (PTS1) and peroxisomal targeting signal 2 (PTS2) motifs (Swinkel et 
al., 1991; Osumi et al., 1992; Dodt et al., 2001; Kiel et al., 2006; Lazarow et al., 2006; Brocard and 
Hartig, 2006). PTS1 are found at the extreme C-terminus; two versions of this consensus motif are 
shown in red – PTS1 and PTS1 ‘relaxed’. PTS2 are found within the N-terminal region; two 
consensuses are shown in blue – PTS2 and PTS2 ‘relaxed’. Relaxed motifs are less strict and can be 
used to identify lesser known targeting signals that might otherwise be missed. 
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Table 5.1. Predicting peroxisomal targeting signals based on consensus PTS1 and 
PTS2 motifs. The amino acid sequences of various mitochondrial and peroxisomal proteins 
were analysed for consensus peroxisomal targeting signals (see Figure 5.3 for motifs). Bona fide 
peroxisomal proteins were used as controls, whereby for some, but not all, their targeting signals 
are already known and fit the consensus for either PTS1 or PTS2. These included Gpx1, Pex11, 
Pex21, Pot1, Cta1 and Mdh3. Gpx3 has also been found in the peroxisomes both in this study and 
by Ohdate and Inoue (2012). * - Known localisations. ** - A possible ‘PTS2-like’ signal (see text 
below). Red indicates PTS1/PTS1-like motifs; blue indicates PTS2/PTS2-like motifs. 
 
 
 
Search for peroxisomal targeting signals 
Protein Localisation* PTS1 PTS1 ‘relaxed’ PTS2 PTS2 ‘relaxed’ 
Gpx3 
Cytosol/ 
Peroxisomal 
matrix/IMS 
No No No No 
Erv1 IMS No No No No 
Trx1 Cytosol/IMS No Yes (ANA) No No 
Trx2 Cytosol No Yes (SNV) No No 
Trx3 Mitochondrial matrix No No No No 
Trr1 Cytosol/IMS No No No No 
Trr2 Mitochondrial matrix No No No No 
Mia40 IMS No No No No 
Gpx1 Peroxisomal matrix/IMS No No No No 
Pex11 
Peroxisomal 
membrane/ 
cytosol 
No No No** No 
Pex21 Peroxisomal membrane No No No Yes (RLNSSRQHL) 
Pot1 Peroxisomal matrix/IMS No No No Yes (RLQSIKDHL) 
Cta1 
Peroxisomal 
matrix/ 
Mitochondrial 
matrix 
No Yes (SKF) No** No 
Mdh3 Peroxisomal matrix Yes (SKL) n/a No No 
174 
 
Based on these predictions, neither Gpx1 nor Gpx3 contain any identifiable peroxisomal 
targeting signals. However, no peroxisomal targeting signal could be identified for Pex11 
either, which is a genuine peroxisomal membrane protein. Pex11 does appear to contain 
two ‘PTS2-like’ motifs which might be responsible for its import: RLXXXLAXXL and 
RVXXVLXXXXXA (the underlined letters indicate those that do not fit the PTS2 
consensuses), although these have never been verified experimentally. In addition, it is 
known that the SKF C-terminal PTS1 of Cta1 is indispensable for its peroxisomal import; 
an N-terminal signal near Cta1’s FXXXW domain has recently been shown to direct its 
peroxisomal import (Rymer et al., 2018). Furthermore, a study by Freitag et al. (2012) 
uncovered cryptic PTS1 motifs in the fungus Ustilago maydis that result from either 
ribosomal read-through or alternative splicing. Cryptic PTS1 motifs by ribosomal read-
through were not detected for any of the proteins in Table 5.1 (ExPASy translate - data 
not shown). 
  
Interestingly, Trx1 and Trx2 were the only proteins other than the positive controls, Cta1 
and Mdh3, found to contain putative PTS1 ‘relaxed’ motifs – ANA and SNV, respectively. 
The mitochondrial matrix thioredoxin, Trx3, which is made with a typical N-terminal 
mitochondrial targeting signal, was not found to contain any potential PTS1 or PTS2 motif. 
Along with the western blot data in Figure 5.2, this suggests that both Trx1 and Trx2 may 
localise within peroxisomes. Future studies could delete their C-terminal tripeptides, or 
mutagenise them, and test whether this affects their potential peroxisomal import.  
 
Altogether, the analysis here unequivocally suggests that we are far from understanding 
the true extent of peroxisomal targeting signals. The lack of an identifiable PTS1 or PTS2 
does not discount the chance that a protein may be able to import into peroxisomes, 
whether that is by a ‘yet to be confirmed’ variation of a PTS1/PTS2 or by an entirely novel 
signal, or, perhaps even cryptic signals remains to be determined. Therefore, whilst no 
consensus signals were found for Gpx3, Mia40, or Erv1, further experiments are still 
warranted in order to validate their localisation. 
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5.3.3. ‘Peroxisomal’ Mia40 
  
Mia40, Mitochondrial intermembrane space Import and Assembly 40, is a 44 kDa protein 
well known for its crucial role in the mitochondrial IMS oxidative folding pathway (Mordas 
and Tokatlidis, 2015). Erv1, an essential IMS sulphydryl oxidase, interacts with and re-
oxidises Mia40 in order to maintain the oxidation state of Mia40 required for introducing 
disulphide bonds to incoming proteins. As both proteins co-localise in the IMS and are 
heavily involved in this pathway, and our detection of Erv1 in a peroxisomal fraction 
(Figure 5.2), we wondered whether Mia40 was also present. Although western blots using 
anti-Mia40 only detected a very weak band in the peroxisomal fraction which was likely 
due to mitochondrial contamination (Figure 5.2D), a lower band running between the 17-
22 kDa marker was detected when anti-Mia40 was probed across the full membrane after 
transfer from SDS-PAGE (Figure 5.4). 
 
 
 
 
 
 
 
 
Figure 5.4. Detection of yeast Mia40 in mitochondria vs peroxisomes. (A) Diagram to 
show fractions 3-6 from Nycodenz gradient centrifugation (final step of isolation protocol, refer to 
Figure 5.1 and Chapter 2, Section 2.2.2.1). Mitochondria are enriched in fractions 3 & 4; 
peroxisomes are enriched in fractions 5 & 6. (B) Western blot to detect Mia40 (using anti-Mia40) 
in fractions 3-6. NOTE: Full length mitochondrial Mia40 is 44 kDa but always runs higher on SDS-
PAGE, at ~60 kDa, due to its low isoelectric point (pI: 4.2). 
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Whilst it is possible that anti-Mia40 is non-specifically binding to a lower molecular 
weight species in the peroxisomal fractions 5 and 6 (Figure 5.4B), or a degradation 
product of full length Mia40, it is interesting to speculate that there is a shorter, 
alternatively translated version of Mia40. This shorter product may start translation at 
Met272 within the Mia40 amino acid sequence which would remove the N-terminal 
mitochondrial targeting signal (Figure 5.5). In Arabidopsis, Mia40 (AtMia40) is a shorter 
soluble protein that is found in both mitochondria and peroxisomes (Figure 5.5). AtMia40 
is known to be involved in the import of proteins to both organelles (Carrie et al., 2010). 
No other Mia40 homolog has been found in peroxisomes in other organisms to date. 
  
 
Figure 5.5. Mia40 amino acid sequence in S. cerevisiae vs A. thaliana. ScMia40 is 
403aa in length and has eight cysteine residues (red) including those that make up its redox active 
CPC and …CX9C…CX9C… motifs. The light/dark grey shading together indicates the full-length 
ScMia40 protein; the dark grey highlights the potential shorter version. AtMia40 is 162aa 
containing six cysteine residues which also include its redox active CPC and …CX9C…CX9C… motifs. 
AtMia40 has a C-terminal peroxisomal targeting tripeptide, SKL (yellow). Yeast Mia40 has a C-
terminal SKP tripeptide (green). 
  
The C-terminal tripeptide SKL of AtMia40 is responsible for its targeting and import into 
Arabidopsis peroxisomes. Could the yeast C-terminal tripeptide SKP of yeast Mia40 be a 
weak peroxisome targeting sequence that acts when the N-terminal mitochondrial 
targeting signal is absent? 
 
Saccharomyces cerevisiae Mia40 
 
MLRNLVVRNACRNRPSIQVARGLCRHQTRRLMASSPQFGRNSNQEKTAGFIMGILSMAGALYFI
APNRKPLFASRKVESDKTAEEELSSGGEQSPENEDDNNSKSDENGDDNDSKNDETEAGPQLGGD
KIGASKVAEDGELVVLAEEDNKSSEDKDTDESKVSTKDDEQSNEDNATANNQKDENISSENSEE
NTSDKTLDNNAGSSEKKDPEHSDDEKSQQGQSDDKTTTEDNNGEEESSKKTVSDSENSAKQSES
SDEEKEELRKQEEKQMGPTEEEVQHEGAYNPDTGEINWDCPCLGGMAHGPCGEEFKSAFSCFVY
SEAEPKGIDCVEKFQHMQDCFRKYPEHYAEQLKETSDDEEPQDKVKVNTIESAPNVSSAKENAA
KKAEQSDVKKEPLNEESKP 
 
Arabidopsis thaliana Mia40 
 
MGQAQSDENSIPTTTTTNTPPPSANSPRDSEDTSSPSMDSLLAEAAAYGEDDNENESLEAKAQR
ALDCPCIADLRNGSCGSQFSEAFLCFLKSTAEEKGSDCVNPFVALQSCINANPDAFSKSVTGDE
KETEKKEEQPPVQDHRIIPPLWAKDPPRSGNSKL  
 
 
177 
 
Although SKP does not fit any current PTS1 consensus, evidence from a study over two 
decades ago would suggest otherwise. A study conducted by Elgersma et al. (1996) 
investigated whether various tripeptide combinations fused to the peroxisomal malate 
dehydrogenase, Mdh3, without its canonical SKL found that SKP still resulted in import, 
albeit at a much lesser amount of around 5-20% in comparison to SKL. Thus, a SKP 
tripeptide might in theory be enough to direct the import of proteins to peroxisomes in 
the absence of other targeting signals. 
  
To investigate whether any other proteins within the S. cerevisiae genome database 
contain SKP tripeptides at their extreme C-terminus, a yeast genome pattern matching 
search was carried out using PatMatch at www.yeastgenome.org. Four proteins were 
detected using SKP> as the search parameter: Mia40 (as expected), Bud27, Ybr209w and 
Ynl162w-a. Bud27 is an unconventional prefoldin which is involved in promoting 
translation initiation, especially under nutrient stress conditions (Gstaiger et al., 2003; 
Deplazes et al., 2009). Ybr209w is a 12 kDa protein of unknown function with a …CX3C… 
motif but no detectable human homolog (Fisk et al. 2006). Ynl162w-a is an 8 kDa protein 
of unknown function with a …CX2CX7CX11CX4C… motif but also no human homolog 
(Blandin et al., 2000). It should be noted that this motif is different from the OXLD domain 
described in Chapter 4. 
  
In order to elucidate whether a shorter version of Mia40 exists in yeast peroxisomes, the 
first approach taken was to repeat the isolation of mitochondria and peroxisomes from 
galMia40 yeast. Mia40 is an essential protein so a yeast strain whereby Mia40 is under a 
galactose controlled promoter was used to reduce, but not entirely eliminate, Mia40 
production. Cells were first grown in galactose before a switch to oleic acid to induce 
peroxisome proliferation and reduce Mia40 levels. The results suggest that the lower 
molecular weight band detected by anti-Mia40 is specific to Mia40 as it is not detected in 
galMia40 peroxisomes and only very weakly in the crude organelle fraction before 
density gradient centrifugation (Figure 5.6). However, the signal seen in this fraction is 
most likely because Mia40 is never completely absent in galMia40 yeast. Organelles were 
also isolated from yeast lacking the GPX3 gene sequence (gpx3D) to verify the specificity 
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of anti-Gpx3 in detecting Gpx3 in peroxisomes from wild-type yeast. No Gpx3 was 
detected in gpx3D yeast (Figure 5.6).  
 
 
 
 
 
 
 
 
 
 
Figure 5.6. Isolation of mitochondria and peroxisomes from gpx3D and galMia40 
yeast. Western blots to analyse crude organelle (CO), mitochondrial (Mito), and peroxisomal 
(Pero) fractions from gpx3D and galMia40 yeast grown in 0.12% oleic acid. WT CO – wild-type 
crude organelle fraction. Antibodies against the following proteins were used: Hsp70 – matrix; 
Gpx3 – cytosol/IMS/peroxisomal matrix; Mia40 – IMS; Tom40 – OM; and Erv1 – IMS. NOTE: The 
control peroxisomal antibody against the peroxisomal membrane protein Pex11 (anti-Pex11) did 
not work during this analysis. Thus, it can only be assumed that the Pero fraction is enriched for 
peroxisomes based on the use of an established protocol that is commonly used within the field, 
and the presence of the putative peroxisomal Mia40 detected in only CO and Pero (but not in 
Pero from galMia40).  
  
Other observations from Figure 5.6 suggest that the import of Gpx3 to peroxisomes may 
require the presence of Mia40, as only a very faint band was detected by anti-Gpx3 in 
peroxisomes isolated from galMia40 yeast. This faint band is probably due to a slight 
mitochondrial contamination within the peroxisomal fraction. By contrast, the signal for 
Gpx3 was stronger in the peroxisomal fraction compared to the mitochondrial fraction in 
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wild-type yeast (Figure 5.2). Previous experiments by Kritsiligkou et al. (2017) have shown 
that Mia40 is not required for the import of Gpx3 into the mitochondrial IMS, but perhaps 
it is needed for Gpx3 to be imported into the peroxisomal matrix. An in organello 
peroxisomal vs mitochondrial import assay, akin to the standard import assay used 
throughout this thesis, would need to be established in order to investigate this 
possibility. It would also be useful in elucidating whether a truncated version of Mia40, 
starting at amino acid residue 272, could be imported into either organelle.  
  
Intriguingly, Erv1 was absent from galMia40 and gpx3D peroxisomes which either 
suggests that the band detected in Figure 5.2D was an artefact or that the import of Erv1 
into peroxisomes requires Gpx3 and/or Mia40. However, it cannot be ruled out in this 
instance that the isolation of these peroxisomes was not successful given that the 
antibody against Pex11 did not recognise anything in this western blot. Therefore, these 
fractions remain to be verified as peroxisomal. In repeat western blots using the fractions 
previously obtained from wild-type cells, anti-Pex11 could no longer detect Pex11. Thus, 
the conclusion was that the anti-Pex11 obtained from Santa Cruz Biotechnology was in no 
way reliable at detecting Pex11. It is extremely important for the validity of these data 
that these isolations are repeated with antibodies that work against one or more 
peroxisomal proteins. Unfortunately, attempts to obtain peroxisomal antibodies through 
requests from three other labs did not come to fruition during the course of this thesis.  
  
Whilst antibodies were being sought, work on this chapter temporarily continued with 
the material already collected in the hope that verification would happen at a later date, 
and the next section began to explore potential interactors of peroxisomal Gpx3.  
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5.3.4. In vitro binding assays to investigate peroxisomal Gpx3 
interactors 
  
Akin to the in vitro binding assays to investigate mitochondrial interactors of Gpx3 
(Section 3.3.5), the same was carried out for peroxisomal interactors. Peroxisomes were 
solubilised whilst His-tagged versions of Gpx3 were bound in excess to Ni-NTA beads. The 
solubilised proteins were then passed over the saturated beads which were then washed 
before bound material was eluted (refer to Section 2.2.3.1 for methodology). Initially, the 
cysteine trap mutants of both Gpx3 and N18Gpx3 (Gpx3C82AHis and 
N18M20LGpx3C82AHis) were used as bait. Elutions were analysed by western blotting, 
first to check whether the His-tagged protein was present in the elutions (using anti-His) 
and then with anti-Mia40, anti-Trx1 and anti-Trr1 (Figure 5.7). These mitochondrial 
proteins were chosen due to the suspected presence of Mia40 and Trx within 
peroxisomes; anti-Trr1 was used as Trr1 is the reductase partner of Trx1. 
 
 
 
 
 
 
 
Figure 5.7. In vitro binding assays to detect peroxisomal interactors of Gpx3 
cysteine mutants. N18M20LGpx3C82AHis and Gpx3C82AHis were bound to Ni-NTA beads and 
solubilised peroxisomal proteins were passed over. Unbound material can be seen in the flow 
throughs (Fth) and co-eluted material detected in the elutions (EL). W – indicates the third and 
final wash before elution with imidazole. CONTROL – control assay where no His-tagged protein 
was bound to Ni-NTA beads prior to addition of peroxisomal proteins. Western blots were used to 
probe for His-tagged proteins (using anti-His) and putative peroxisomal Mia40 (using anti-Mia40). 
Anti-Trx1 and anti-Trr1 were used as additional markers due to their potential localisation within 
peroxisomes. No peroxisomal antibodies were used as anti-Pex11 could not detect Pex11 even in 
total cell extracts, and no other antibodies were available. 
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The results suggest that both cysteine trap mutants may interact with peroxisomal 
‘putative Mia40’ and Trr1, whilst the N18 extended cysteine trap mutant may also 
interact with Trx1 (Figure 5.7). However, these results should be analysed with caution 
because of the slight mitochondrial contamination within the isolated peroxisomal 
fractions. It is possible that Trr1 and Trx1 co-eluting in this assay came from solubilised 
mitochondria. Nevertheless, as the putative shorter version of Mia40 is only found within 
the peroxisomal fractions (refer back to Figure 5.5), and it is known that full-length Mia40 
interacts with Gpx3 in the mitochondrial IMS (Sections 3.3.3 – 3.3.5 and Kritsiligkou et al., 
2017), it is plausible that peroxisomal Gpx3 can interact with a peroxisomal Mia40. The in 
vitro binding assays were repeated to include Gpx3His and N18M20LGpx3His with no 
cysteine mutations (Figure 5.8). 
 
 
 
 
 
 
 
 
 
  
Figure 5.8. Further in vitro binding assays to detect peroxisomal interactors of 
Gpx3. (A) N18M20LGpx3His, (B) Gpx3C82AHis and (C) Gpx3His were bound to Ni-NTA beads and 
solubilised peroxisomal proteins were passed over. Unbound material can be seen in the flow 
throughs (Fth) and co-eluted material detected in the elutions (EL). W – indicates the third and 
final wash before elution with imidazole. (D) CONTROL – control assay where no His-tagged 
protein was bound to Ni-NTA beads prior to addition of peroxisomal proteins. Western blots were 
used to probe for putative peroxisomal Mia40 (using anti-Mia40), Trx1 (using anti-Trx1) and Trr1 
(using anti-Trr1). No peroxisomal antibodies were used as anti-Pex11 could not detect Pex11 even 
in total cell extracts, and no other antibodies were available. 
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This time no ‘peroxisomal’ Mia40 was detected in the co-elution with N18M20LGpx3His 
(Figure 5.8A) and only a weak band in the co-elution with Gpx3His (Figure 5.8C). The 
cysteine trap mutant, Gpx3C82AHis, again co-eluted with Mia40 (Figure 5.8B). This 
indicates that the resolving cysteine of Gpx3 (C82) is required for its interaction with 
‘peroxisomal’ Mia40. Trx1 was found co-eluting with N18M20LGpx3His and Gpx3C82AHis 
(Figure 5.8A and 5.8B). However, as noted previously the antibody against Trx1 may also 
recognise Trx2 due to sequence similarity, therefore it may be that Trx1 and/or Trx2 co-
eluted with N18M20LGpx3His and Gpx3C82AHis. Strikingly, anti-Trr1 detected a band in 
all three in vitro binding assays in Figure 5.8 and in the previous assay using 
N18M20LGpx3C82AHis (Figure 5.7). The relevance of this is unknown as the well-
established binding partner of Trr1 is Trx1.  
  
No further experiments were carried out on the isolated peroxisomal fractions due to not 
having any reliable peroxisomal antibodies. Instead, attempts to visualise S. cerevisiae 
organelles by electron microscopy were made in the hope of being able to detect both 
mitochondria and peroxisomes. 
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5.3.5. Electron microscopy to visualise S. cerevisiae organelles  
  
Rather than analysing mitochondrial and peroxisomal fractions for the presence of 
proteins, an alternative approach was sought – electron microscopy. The idea behind 
optimising an electron microscopy protocol was to be able to visualise yeast organelles 
(including mitochondria and peroxisomes) in wild-type vs mutant yeast strains. For 
example, the morphology of peroxisomes could be assessed in galMia40 and gpx3D yeast. 
A protocol by Bauer et al. (2001) claiming to have found an improved electron microscopy 
technique for visualising yeast membrane structures was used. This protocol was 
followed (see Section 2.2.7 for detailed methodology) and the images from wild-type 
yeast cells, using a transmission electron microscope (TEM), are shown in Figure 5.9.  
 
  
 
  
 
 
 
 
Figure 5.9. Wild-type yeast cells visualised by transmission electron microscopy. 
Wild-type D273-10B yeast cells were grown to stationary phase in liquid YPD overnight at 30°C 
and then diluted the next morning to OD600nm: 0.05 in fresh YPD. Cells were then grown at 30°C 
until they reached OD600nm: 0.7-1.0 before being harvested and prepared for TEM (see Section 
2.2.7 for detailed methodology). TEM was carried out by Margaret Mullen at the Electron 
Microscopy Facility (University of Glasgow). (A) and (B) are TEM images from two identical yeast 
cell preparations.  
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Unfortunately, our attempts to visualise S. cerevisiae organelles (Figure 5.9) did not yield 
clear images. The yeast cell shown on the left-hand side of Figure 5.9A appears to have 
burst and its cytosolic contents released; whereas the yeast cell shown in Figure 5.9B 
does not appear to have an intact cell wall. The reason behind both these outcomes is 
unknown; however, it could be that the Zymolyase treatment used to ‘punch’ tiny holes 
into the yeast cell walls to allow the fixatives to enter was too harsh. Future optimisation 
of this stage of the protocol is thus required.  
  
The following sections delve into the possibility of Pex11 as a potential dually-localised 
mitochondrial protein which was based on the results shown in Section 5.3.1. 
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5.3.6. Import and localisation of Pex11 in mitochondria 
  
Given that Pex11 ‘mislocalises’ to mitochondria in pex3D yeast that lack peroxisomes 
(Mattiazzi Usaj et al., 2015; Wróblewska et al., 2017), and Pex11 was initially detected in 
both mitochondrial and peroxisomal fractions, the import of Pex11 in mitochondria was 
investigated. PEX11 was cloned into a pSP64 vector for production of a 35S-labelled 
precursor that was then presented to isolated wild-type yeast mitochondria following a 
standard import assay protocol. Pex11 was indeed imported into a protease-protected 
compartment and, interestingly, its import was independent from the membrane 
potential (Figure 5.10). 
 
 
 
 
 
 
 
 
 
Figure 5.10. Import of radiolabelled Pex11 and Su9-DHFR. Pex11 and Su9-DHFR were 
synthesised as 35S-labelled precursors and imported into isolated wild-type yeast mitochondria. 
Precursors were imported straight after translation: (A) Pex11 import and (B) Su9-DHFR import. 
Import reactions were stopped after 30 minutes. DY - membrane potential. All import reactions 
were treated with trypsin to destroy unimported material (M), and a combination of Triton-X-100 
and trypsin as a negative control (Tx). 5% corresponds to 5% of the precursor used for each 
import reaction. Radiolabelled precursors were detected by digital autoradiography. * - full length 
Pex11, ** - Cleaved Pex11, Pre – Su9-DHFR precursor, i – IMS stalled Su9-DHFR intermediate 
(incompletely cleaved in transition), Mat – mature Su9-DHFR (cleaved after import into matrix). 
The lower molecular weight bands seen in both gels are likely degradation products resulting from 
incomplete inactivation of trypsin, or incomplete cleavage by trypsin.  
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Although there is a possibility that the radiolabelled Pex11 is ‘mislocalising’ to 
mitochondria in this import assay (due to the unlikelihood of other organelles being 
present), it was still of interest to determine which mitochondrial subcompartment Pex11 
resides in upon import, and whether it is a soluble, peripheral or integral membrane 
protein. First, a localisation assay was carried out after import to determine if (i) Pex11 is 
protease protected after mitoplasting – a process where the OM is broken by osmotic 
shock – leaving soluble IMS proteins susceptible to protease degradation, (ii) whether 
Pex11 is extracted from mitoplasts by urea and (iii) whether Pex11 is soluble after 
carbonate extraction.  
  
The results show that radiolabelled Pex11 remains in the pellet fraction after mitoplasting 
which rules out the possibility that it is a soluble IMS protein (Figure 5.11). However, it 
appears that some of Pex11 is cleaved when Proteinase K is added to the mitoplast buffer 
which suggests that it might have a domain that is exposed on the IMS side of either the 
IM or OM. For some reason the signal for Pex11 is largely lost during the urea extraction 
from mitoplasts but this also occurred for the control Tim44, a peripheral IM protein. The 
reason for this is unknown. Finally, the carbonate extraction reveals that Pex11 is mostly 
found in the pellet fraction and is therefore mostly membrane bound. Overall, when 
compared to the control proteins, the assay points towards Pex11 as an integral 
membrane protein of either the IM or OM that has a region exposed to the IMS. 
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Figure 5.11. Radiolabelled Pex11 localisation after mitochondrial import. Pex11 was 
synthesised as a radiolabelled precursor and imported into isolated wild-type yeast mitochondria 
straight after translation. The import reaction was stopped after 30 minutes and treated with 
trypsin to destroy unimported material (M), and a combination of Triton-X-100 and trypsin as a 
negative control (Tx). Osmotic shock to rupture the OM, mitoplasting, resulted in pellets (P) 
containing the matrix/IM and supernatants (S) containing IMS proteins, -/+ proteinase K (PK). 
Urea extraction from mitoplasts using 3 M and 5 M urea to disrupt hydrophobic interactions and 
release peripheral membrane proteins.  Carbonate extraction (C.E) to separate insoluble from 
soluble proteins from intact mitochondria after Pex11 import: (P) – insoluble proteins associated 
with mitochondrial membranes; and (S) – soluble proteins. (A) Analysis by autoradiography to 
detect radiolabelled Pex11. (B) Analysis by western blotting to detect mitochondrial proteins from 
different subcompartments: anti-Hsp70 (soluble matrix); anti-Tim44 (peripheral IM); anti-Por1 
(integral OM); anti-Erv1 (soluble IMS); anti-Cytc (soluble IMS); and anti-Tim10 (soluble IMS). 5% 
corresponds to 5% of the precursor used for each import reaction. Radiolabelled precursors were 
detected by digital autoradiography. * - full length Pex11, ** - Cleaved Pex11?  
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5.3.7. Import of N17Pex11 – does an N17 extension exist? 
  
As the western blot data from the isolation of mitochondria and peroxisomes (Figure 5.2) 
detected two bands using anti-Pex11, one with a slightly larger molecular weight in the 
mitochondrial fraction, it was suggested that perhaps Pex11 might have an N-terminal 
extension that targets it to mitochondria, akin to Gpx3. A putative upstream translation 
read reveals a sequence of ~17 amino acids with similarities to the N18 of Gpx3 (Figure 
5.12). Whilst this is purely hypothetical and there is no data to support that upstream 
translation of Pex11 occurs from a non-canonical start site, it was interesting to pursue 
this possibility given the evidence for association of Pex11 with mitochondria (Mattiazzi 
Usaj et al., 2015).  
 
 
 
 
 
 
 
 
 
Figure 5.12. Alignment of the N18 upstream of Gpx3 with the putative N17 upstream 
of Pex11. Alignment performed using Clustal Omega at EMBL-EBI (McWilliam et al., 2013). Seven 
out of 17 residues within the putative N17 of Pex11 are fully conserved, five are conserved 
between groups of strongly similar properties, and one is conserved between groups of weakly 
similar properties.  
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To compare the import of Pex11 with the putative N17Pex11, N17PEX11 was cloned into 
a pSP64 vector, and both Pex11 and N17Pex11 were produced as 35S-labelled precursors 
that were then presented in parallel to isolated wild-type yeast mitochondria for various 
time points. The results show that both the wild-type Pex11 and the N17Pex11 are 
successfully imported into mitochondria; however, there does not appear to be any 
advantage of the N17 to Pex11 import as kinetics show a similar import efficiency across 
multiple time points (Figure 5.13). Thus, it was concluded that the putative N17 extension 
does not provide a more efficient mitochondrial import when presented to isolated 
mitochondria. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13. Radiolabelled import of Pex11 vs N17Pex11 in mitochondria. Pex11 and 
N17Pex11 were synthesised as 35S-labelled precursors and imported into isolated wild-type yeast 
mitochondria. Precursors were imported straight after translation. Import reactions were stopped 
after 1 minute (1’), 2 minutes (2’), 5 minutes (5’), 10 minutes (10’) and 20 minutes (20’). All import 
reactions were treated with trypsin to destroy unimported material, and a combination of Triton-
X-100 and trypsin as a negative control (Tx). 5% corresponds to 5% of the precursor used for each 
import reaction. Radiolabelled precursors were detected by digital autoradiography (top panel). A 
western blot using anti-Hsp70 against the matrix heat shock protein 70 was performed as a 
loading control (bottom panel). 
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5.4. Discussion  
  
Over the past decade and since work on this thesis began, evidence has continued to 
mount on how mitochondria and peroxisomes may be intricately linked, both in terms of 
physical contact and metabolism (Mattiazzi Ušaj et al., 2015; Wanders et al., 2016; Luis 
and Michael, 2018; Shai et al., 2018). Increasing data supports the existence of a ‘redox 
triangle’ comprising of mitochondria, peroxisomes and the ER - otherwise known as a 
redoxosome (Cohen et al., 2014; Mattiazzi Usaj et al., 2015). The peroxisomal redox state 
is known to influence the mitochondrial redox state (Baumgart et al., 2001; Ivashchenko 
et al., 2011), and it known that ROS can readily cross amongst organelle membranes 
(Boveris et al., 1972; Biernet and Chaumont, 2014). But how exactly do peroxisomes and 
mitochondria co-ordinate such a fine-tuned interplay with ROS, and what controls their 
contact sites? The results presented in this chapter add to this ever-confounding but 
intriguing puzzle.  
   
The first aim was to isolate both mitochondria and peroxisomes from wild-type yeast and 
detect which fractions Gpx3 resided in. Western blots confirmed the localisation of Gpx3 
to both organelles (Figure 5.2) and also indicated the presence of Trx1/Trx2 and Erv1. 
Although the results should be analysed with caution as there was very slight 
mitochondrial contamination within the peroxisomal fraction, and the control 
peroxisomal antibody against Pex11 was unreliable, it is more than likely that Gpx3 and 
Trx1/Trx2 are bona fide peroxisomal proteins given the identification of Gpx3 and Trx 
(unknown which paralog) in a previous study by Ohdate and Inoue (2012). Future studies 
should aim to repeat these isolations under different conditions, i.e. H2O2 stress, glucose 
vs oleic acid, and decipher under what conditions these proteins localise to either 
organelle, whilst making sure to use trustworthy control antibodies. Also of importance is 
how are these proteins targeted to peroxisomes, and how do the cells regulate when and 
where each protein will go? 
  
Sequence analysis was performed to try to identify potential peroxisomal targeting 
signals within these putative peroxisomal proteins which could be responsible for their 
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import. PTS1, PTS1 ‘relaxed’, PTS2 and PTS2 ‘relaxed’ consensus motifs were searched for 
within various proteins, including genuine peroxisomal proteins (Figure 5.3, Table 5.1). 
Though it is clear that there is a lot still to be understood about how some proteins are 
targeted to peroxisomes (no signals were identified for Pex11, Gpx1 or Gpx3), surprisingly 
PTS1 ‘relaxed’ motifs were identified at the extreme C-terminus of both Trx1 and Trx2. 
Future work to confirm this would require mutating or deleting these tripeptides and 
testing their import capacity. It would also be interesting to determine through which 
peroxisomal import pore/mechanism these proteins enter, which receptors they interact 
with, and whether any chaperone proteins are required to ‘piggy-back’ them in.  
  
Intriguingly, anti-Mia40 recognised a smaller protein running between the 17 – 22 kDa 
protein marker only in peroxisomal fractions (Figure 5.4); this protein disappeared when 
organelles were obtained from galMia40 yeast (Figure 5.6). But why would a shorter, 
soluble version of Mia40 be present within peroxisomes, and how is it targeted there? In 
A. thaliana, Mia40 is a shorter soluble protein which localises to mitochondria and 
peroxisomes, playing a role in protein import in both organelles (Figure 5.5; Carrie et al., 
2010). Different methods are needed to confirm whether Mia40 truly does exist in S. 
cerevisiae peroxisomes, such as: confocal microscopy using fluorescently tagged versions, 
immunoprecipitations using anti-Mia40 and solubilised peroxisomes, and import assays 
to name a few. In A. thaliana, a PTS1 SKL motif is responsible for its peroxisomal import; 
can the SKP of ‘peroxisomal’ Mia40 in yeast target it to peroxisomes in the absence of an 
N-terminal mitochondrial targeting signal? Akin to Trx1/Trx2, its tripeptide SKP could be 
mutated or deleted and any effects on import assessed. 
  
In addition, ‘peroxisomal’ Mia40 was found to interact with Gpx3 when in vitro 
interaction assays were carried out using solubilised peroxisomal proteins and His-tagged 
versions of Gpx3 bound to Ni-NTA beads (Figures 5.7 & 5.8). This interaction was more 
apparent when the cysteine trap mutants Gpx3C82AHis and N18M20LGpx3C82AHis were 
used which suggests that ‘peroxisomal’ Mia40 might interact with Gpx3 via disulphide 
bonds (Figure 5.8). Of course, this interaction with Gpx3 would need to be checked in vivo, 
for example by immunoprecipitation, and further characterised. Could Gpx3 be involved 
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in re-oxidising Mia40 in peroxisomes like it does with full-length Mia40 in the 
mitochondrial IMS (Kritsiligkou et al., 2017)? 
  
The final part of this chapter was aimed at tackling the import and localisation of Pex11 in 
mitochondria as the literature has thus far suggested that Pex11 is mistargeted to 
mitochondria in the absence of peroxisomes (Mattiazzi Usaj et al., 2015; Wróblewska et 
al., 2017). Radiolabelled Pex11 could be imported into mitochondria in a protease-
protected manner and was independent of membrane potential (Figure 5.10). Import 
kinetics was then performed to compare the radiolabelled import of Pex11 against a 
hypothetical N17Pex11 but the results show no advantage of a N-terminal extension 
(Figure 5.13). Whilst it remains to be elucidated whether an N17 extension of Pex11 could 
actually exist in vivo, if it does exist then one hypothesis would be that it may be required 
for mitochondrial import when peroxisomes are also present. A dual import assay with 
both organelles could be set up in the future to assess this, but only if an N17Pex11 is 
found to be translated in vivo. Yeast would need to be grown under various conditions, i.e. 
-/+ H2O2, -/+ oleic acid, and combinations thereof, to determine whether an extension 
similar to the N18 of Gpx3 occurs. 
 
The localisation assays carried out here point towards Pex11 as an integral membrane 
protein of either the IM or OM with a domain exposed to the IMS (Figure 5.11). In 
peroxisomes, there has been conflicting evidence on where Pex11 resides – the first 
paper in 1996 suggested it to be a peripheral membrane protein facing the inner side 
(Marshall et al., 1996), whereas a later paper in 2016 indicates it to be an integral 
membrane protein with pore-forming capabilities, acting as a non-selective channel 
(Mindthoff et al., 2016). Could Pex11 act as a similar pore-forming channel in 
mitochondria? Finally, it remains to be tested whether Gpx3 and Pex11 are interactors, 
either within mitochondria, peroxisomes or both. Attempts to express and purify a 
recombinant His-tagged version of Pex11 from E. coli were unsuccessful (data not shown) 
during this thesis. Further optimisation of the protein purification protocol is required in 
order to purify Pex11 and carry out in vitro interaction assays. 
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6. General discussion 
 
6.1. Mitochondrial interactors of Gpx3 
  
In S. cerevisiae, Gpx3 is an atypical 2-Cys peroxiredoxin that acts as a H2O2 sensor within 
the yeast cytosol where it has generally been well-characterised. However, in 2012 it was 
discovered within a mitochondrial IMS proteomics study (Vögtle et al., 2012). Another 
study published in the same year suggested that Gpx3 could be translated from an 
upstream non-AUG codon after exposure to H2O2 (Gerashchenko et al., 2012), thus 
producing an N-terminal extension that might act as a targeting signal. Work carried out 
by our lab in collaboration with the lab of Prof. Chris Grant (University of Manchester) 
confirmed the IMS localisation of Gpx3 both under physiological and H2O2 stress 
conditions, and revealed that an N-terminal extension of around 18 amino acids produced 
under H2O2 stress resulted in more efficient targeting to the IMS; although it was not 
necessary for import (Kritsiligkou et al., 2017). As previous studies only focused on the 
role of cytosolic Gpx3, namely its activation of the transcription factor Yap1, the role of 
both Gpx3 and N18Gpx3 in the IMS was yet to be determined. 
 
 Whilst the paper by Kritsiligkou et al. (2017) highlighted an interaction between Gpx3 and 
the IMS oxidoreductase Mia40, the work presented in this thesis aimed to define in an 
unbiased manner the potential mitochondrial-specific interactors of Gpx3/N18Gpx3, and 
went on to investigate one that may be of importance – the IMS electron carrier Cytc 
(Chapter 3). Future work is required to validate an in vivo interaction between Gpx3 and 
Cytc and to determine its physiological relevance. As both Mia40 and Cytc are involved in 
oxidative protein folding in the IMS (following the MIA import pathway) (see Mordas and 
Tokatlidis, 2015), it is possible that Gpx3 also plays a role in oxidative folding and could 
act to regulate (or ensure the proper function of) the MIA pathway under oxidative stress. 
However, in mammals Cytc is a multi-functional protein that plays roles outside of 
respiration and oxidative folding, such as its ability to interact with cardiolipin to attain 
peroxidase activity and trigger apoptosis (Schweitzer-Stenner, 2018). Interestingly, 
195 
 
questions remain as to how structural changes in Cytc determine its function; perhaps 
Gpx3 helps Cytc associate with cardiolipin at the IM by influencing its protein structure. 
Here, the only cysteine residue in Gpx3 that we found affected its in vitro interaction with 
Cytc was Cys64. This cysteine is not involved in the interaction cycle with Yap1, and its 
function is not yet known although it is a highly conserved residue. Therefore, further 
investigation into the role of Cys64 of Gpx3 and its putative effect on a potential 
interaction with Cytc will be of interest.  
  
Another putative interactor of mitochondrial Gpx3 that warrants validation is the IMS 
protein Cytb2, a L-lactate cytochrome c oxidoreductase that is required for utilising 
lactate as a carbon source (Guiard, 1985). Other than this, its function is uncertain. Aside 
from confirming the IMS interactors identified in this study, future work should also aim 
to determine whether there are differences between Gpx3 and N18Gpx3 interactors, and 
whether specific physiological conditions such as oxidative stress are required for those 
interactions to occur. 
  
6.2.  Missing mitochondrial proteins? 
  
Amongst the mass spectrometry data that was collected in Chapter 3, we identified six 
small proteins that had not been previously characterised or associated with 
mitochondria: Ybr124w, Ydr193w, Ygl024w, Yor293c-a, Ypl107w and Ypr010c-a. Out of 
these, three have interesting cysteine motifs, some of which are similar to the targeting 
signals found in substrate proteins of Mia40 (Ybr124w and Ygl024w). However, the only 
protein that we could identify a human homolog for was Ypl107w which also contains a 
highly conserved oxidoreductase-like domain, but so far the function of this protein (in 
any organism) is completely unknown. We focused on testing whether Ybr124w, Ygl024w 
and Ypl107w could be imported into mitochondria by producing radiolabelled proteins 
and following a standard import assay. Unfortunately, we were unable to clone YGL024W 
into a suitable plasmid for translation during this thesis. Upon successful production of 
radiolabelled Ybr124w and Ypl107w, only Ypl107w could be imported into mitochondria. 
Based on this, Ypl107w became the focus of the next results chapter as we aimed to 
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uncover some of its characteristics (Chapter 4). Nearing the end of my work, a large 
mitochondrial proteomics study was published that identified Ypl107w and Ypr010c-a as 
bona fide mitochondrial proteins and they were named Dpc25 and Min8, respectively 
(Morgenstern et al., 2017). Ypl107w was named Dpc25 for delta-psi dependent 
mitochondrial import and cleavage protein of ~25 kDa, as the protein exhibited defects in 
import when membrane potential was abolished and had a cleavable sequence upon 
successful import. Ypr010c-a was named Min8 for mitochondrial-MINi protein of 8 kDa.  
This provided reassurance that our methodology was successful in detecting previously 
unidentified mitochondrial proteins. Therefore, it would be of interest to confirm 
whether any of the other proteins identified in our list indeed reside in mitochondria as 
this would continue to add to our current understanding of the yeast mitochondrial 
proteome.  
  
6.3. A new mitochondrial matrix protein – Ypl107w 
  
Before we began our work, not much was known about Ypl107w apart from some large-
scale phenotypic studies indicating that ypl107wD cells have a decreased resistance to 
H2O2, salt, and elesclomol (a drug that targets the mitochondrial respiratory chain), and a 
defect in fragmentation of vacuoles (Brown et al., 2006; Yoshikawa et al., 2009; Breslow 
et al., 2008; Blackman et al., 2012; Michaillat and Mayer, 2013). Another study had also 
suggested its localisation within mitochondria based on GFP-tagging of Ypl107w as part of 
a large genome screen (Huh et al., 2003). No study had solely focused on Ypl107w or its 
human homolog, hOXLD1, despite the presence of a highly conserved oxidoreductase-like 
domain (OXLD). This domain is present in more than 2000 proteins across 749 species 
(Pfam - PF09791; Finn et al., 2016), yet nothing is known about the function of OXLD. 
  
In this study, we found that the ypl107wD null mutant exhibits growth defects only when 
grown on non-fermentable carbon sources such as lactic acid and glycerol (but not when 
grown on glucose), and confirmed the previous finding that ypl107wD null yeast mutant 
cells are less resistant to H2O2; these phenotypes are most probably attributed to an 
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impaired mitochondrial function. Our bioinformatics analysis on Ypl107w also heavily 
pointed towards its association with mitochondria through a number of findings: (i) a 
predicted cleavable N-terminal targeting sequence with an alpha-helical structure 
resembling that of a mitochondrial targeting signal; (ii) 23/75 predicted genetic 
interactors of YPL107W were genes encoding mitochondrial proteins; and (iii) inputting 
these proteins into a GO term finder revealed  three common processes (mitochondrial 
tRNA thio-modification, mitochondrial organisation and protein lipoylation) and two 
functions (sulphurtransferase and oxidoreductase activity). Furthermore, an analysis of 
hOXLD-1 revealed that 38/49 physical interaction partners are mitochondrial proteins, 
and a GO term finder came up with a large number of significant ontology terms relating 
to mitochondrial functions including metabolism, gene expression, organisation, RNA 
processing and translation. Based on this information, our hypothesis is that Ypl107w and 
hOXLD-1 are involved in mitochondrial assembly, for example through helping to 
assemble some respiratory complexes and/or regulating mitochondrial gene expression 
and translation. Alternatively, Ypl107w may help assist in protein transport into the 
matrix by interacting with Ssc1.  
  
Next, we confirmed the import of Ypl107w into mitochondria and found that its import 
was dependent on the inner membrane potential and its N-terminal 26 amino acid 
sequence. We also determined its localisation within the mitochondrial matrix where it 
remains as a soluble protein after import and maturation. Future import experiments 
should examine which import pathway Ypl107w follows by using mitochondria from 
different mutant strains such as tom40-ts, tim23-ts, galMia40 and galErv1. We predict 
that Ypl107w import would be dependent on the presence of the TIM23 complex as this 
is the default pathway for proteins containing presequences which are destined for the 
mitochondrial matrix. This prediction is also based on the potential interaction between 
Ypl107w and a catalytic component of the TIM23-PAM complex, Ssc1. 
  
We then began to investigate whether Ypl107w was part of any protein complexes with 
other mitochondrial proteins after import to the organelle. Although our BN-PAGE results 
were unclear, they were suggestive that Ypl107w likely participates in multiple complexes 
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due to the presence of many ‘smeary’ bands. One hypothesis is that Ypl107w may 
transiently interact with multiple proteins/complex subunits as it could be acting as a 
chaperone or assembly protein. Future BN-PAGE experiments should be performed using 
either a recombinant Ypl107w protein purified from E. coli, or by detecting the 
endogenous protein using antibodies against Ypl107w, or generating a tagged version of 
the protein in yeast. At present, none of these tools exist and attempts to purify Ypl107w 
from bacteria during the course of this thesis were unsuccessful. It would also be 
interesting to determine whether respiratory complexes are affected in ypl107wD yeast. 
This could be done by performing BN-PAGE and detecting the respiratory complexes 
using antibodies against individual subunits from each. In addition, pulldowns could be 
performed (akin to those done for Gpx3) to detect Ypl107w interactors. 
  
Mitochondria from wild-type and ypl107wD cells were isolated and the levels of several 
mitochondrial proteins were quantified (those which we had antibodies against). We 
detected less Gpx3 and Cytc when Ypl107w was absent. As Gpx3 and Cytc are potential 
interactors, and Ypl107w was also a putative hit in the mass spectrometry data shown in 
Chapter 3, it is intriguing to speculate whether there is a link between all three. Future 
work should address this by carrying out a combination of in vitro interaction assays, 
reciprocal pulldowns, and immunoprecipitations to help determine whether Ypl107w 
interacts with Gpx3 and/or Cytc. Furthermore, it would be interesting to determine 
whether the levels of other cytochrome proteins (or matrix proteins) are affected in 
ypl107wD yeast. However, this would require access to antibodies against numerous 
proteins which are not commercially available; therefore, quantitative mass spectrometry 
using isolated mitochondria could be a suitable alternative approach. Future work should 
also test whether the inner membrane potential is affected in ypl107wD mitochondria 
given its hypothesised role. Finally, an important question to address is whether hOXLD-1 
acts in a similar manner to Ypl107w and is a true functional homolog. Parallel work using 
human cells would help elucidate the roles of proteins containing this elusive OXLD 
domain.  
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6.4. Does the MIA pathway exist in peroxisomes? 
  
In recent years, there has been significant growth in the number of papers exploring the 
intricate links between mitochondria and peroxisomes, especially given that the redox 
state of peroxisomes has been shown to influence that of mitochondria (Baumgart et al., 
2001; Ivashchenko et al., 2011; Wanders et al., 2016) and the increasing number of 
known membrane-membrane contact sites between both organelles (Mattiazzi Ušaj et al., 
2015; Shai et al., 2018). However, there is still much to be understood about how these 
two organelles co-ordinate their interplay with ROS. Furthermore, researchers are still 
trying to identify the full extent of the peroxisomal proteome, especially as it is known to 
change in response to the metabolic environment (Yifrach et al., 2016). The work 
presented in Chapter 5 adds to the literature regarding the peroxisomal proteome and 
may help to understand the complex mitochondria-peroxisome relationship. 
 
When confirming the presence of Gpx3 within peroxisomes, we serendipitously stumbled 
upon the presence of a putative version of Mia40 in peroxisomes (which is a shorter, 
soluble form compared to the full length protein present in mitochondria), as well as Trx1 
and/or Trx2 – three proteins that had not previously been associated with peroxisomes. 
As mentioned earlier, due to the sequence similarity between Trx1 and Trx2, it is not 
currently possible to tell which, or both, Thioredoxin(s) were detected. Whilst future work 
must validate the presence of these, for example by mass spectrometry analysis, confocal 
microscopy and import assays, our analysis is certainly suggestive of their localisation to 
both organelles. Our hypothesis is that the extreme C-terminal SKP tripeptide of Mia40, 
which is similar to the classical C-terminal SKL PTS1 signal, is enough to target Mia40 to 
peroxisomes in the absence of its N-terminal mitochondrial targeting signal which could 
result from alternative translation starting at a downstream methionine (although we 
have not looked specifically for such an alternative protein translation mechanism for 
Mia40). Whereas we found that both Trx1 and Trx2 contain PTS1 ‘relaxed’ motifs, ANA 
and SNV, respectively that could result in their dual-targeting as full-length proteins. It is 
imperative that future work investigates these ideas further by mutating or deleting these 
tripeptides and testing their ability to import into both organelles. It should also be 
determined precisely which physiological conditions dictate any dual localisations. 
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Although the import of peroxisomal proteins is largely known to occur via a considerably 
different machinery compared to those for mitochondrial proteins, in A. thaliana the 
Mia40 pathway is present and operates in both organelles (Carrie et al., 2010). 
Furthermore, whilst attempting to identify interactors of peroxisomal Gpx3 we found a 
putative interaction between Gpx3 and ‘peroxisomal’ Mia40; an interaction which was 
more apparent when the cysteine trap mutant of Gpx3 (Gpx3C82A) was used as bait. 
Thus, although a peroxisomal Gpx3-Mia40 interaction must first be validated, we can 
hypothesise that Gpx3 may be involved in re-oxidising Mia40 in peroxisomes, akin to its 
known ability to re-oxidise Mia40 in the mitochondrial IMS (Kritsiligkou et al., 2017). In 
this respect, it is notable that the default oxidant protein for Mia40 (which is Erv1) is not 
known to reside in peroxisomes. This opens the possibility that Gpx3 may functionally 
replace the Erv1 action in peroxisomes, whereas in mitochondria it may serve a more 
backup role to Erv1. However, there is some evidence presented here that suggests Erv1 
may also be present in peroxisomes. Thioredoxin (Trx1 and/or Trx2) were also identified 
as potential interactors of peroxisomal Gpx3, and as Trx1 in the IMS can affect Mia40 
oxidation (Mauricio Cárdenas-Rodriquez, 2019, PhD Thesis, University of Glasgow), and 
Trx1 reduces Gpx3 in the cytosol, it is plausible that Gpx3, Mia40 and Trx1 (and/or Trx2) 
are also interconnected in peroxisomes. Perhaps the MIA pathway regulates the import 
of proteins in both organelles which helps maintain their close redox relationship? 
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6.5. Conclusion 
  
The work presented in this thesis has added to our knowledge of Gpx3 in two organelles, 
mainly the mitochondrion but also, to a lesser extent, the peroxisome. No previous 
literature existed on the role of Gpx3 outside of the cytosol, other than the publication on 
the targeting of Gpx3 to the IMS and its interaction with Mia40 reported by our lab during 
the course of this thesis (Kritsiligkou et al., 2017). Here, two new putative IMS interactors 
of Gpx3 were identified: Cytc and Cytb2. We also uncovered six small proteins in our mass 
spectrometry analysis, none of which had been previously associated with mitochondria, 
and we went on to investigate one in more detail – Ypl107w. We also discovered 
components of the MIA pathway in yeast peroxisomes and hypothesise that this pathway 
may operate in both organelles, under the regulation of Gpx3 and Trx1 (and/or Trx2).   
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7. Appendices 
 
7.1. Appendix 1 – Gpx3 purifications 
 
 
 
 
 
 
 
Figure 7.1. Purification of Gpx3His – ÄKTA peaks. Purified recombinant Gpx3His was 
analysed on an ÄKTA Pure FPLC system using a Superdex 200 10/30 GL column in its native state. 
The most abundant peak is peak 2 which eluted at a retention volume of 16.9 ml with an 
estimated molecular weight of 20 kDa. A weak peak, peak 1, eluted at a retention volume of 15.4 
ml with an estimated molecular weight of 40 kDa. These estimations were calculated based on 
the standard curve shown in Section 2.2.1.7, Figure 2.1. Under these conditions, Gpx3His native is 
largely in its monomeric state (peak 2) with a small fraction of it in its dimeric state (peak 1). A 
third even weaker peak is likely to be a degradation product as its molecular weight is less than 
6.5 kDa.  
 
 
 
 
 
 
 
 
Gpx3His  
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Figure 7.2. Purification of Gpx3C36SHis – ÄKTA peaks. Purified recombinant 
Gpx3C36SHis, a peroxidatic cysteine mutant, was analysed on an ÄKTA Pure FPLC system using 
Superdex 200 10/30 GL column in its native state. The majority of Gpx3C36SHis (peak 1) eluted at 
a retention volume of 15.4 ml, with an estimated molecular weight of 40 kDa. A second peak 
eluted at a retention volume of 16.9 ml with an estimated molecular weight of 20 kDa. A third 
peak eluted at a retention volume of 17.9 ml with an estimated molecular weight of 13 kDa. 
These estimations are calculated based on the standard curve shown in Section 2.2.1.7, Figure 2.1. 
Under these conditions, Gpx3C36SHis is mostly in its dimeric state, with a small fraction remaining 
as monomeric. The third peak is likely to be a degradation product.  
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Figure 7.3. Purification of Gpx3C64SHis – ÄKTA peaks. Purified recombinant 
Gpx3C64SHis was analysed on an ÄKTA Pure FPLC system using Superdex 200 10/30 GL column in 
its native state. The majority of Gpx3C64SHis (peak 2) eluted at a retention volume of 16.9 ml 
with an estimated molecular weight of 20 kDa. A smaller peak (peak 1) eluted at a retention 
volume of 15.4 ml with an estimated molecular weight of 40 kDa. These estimations are 
calculated based on the standard curve shown in Section 2.2.1.7, Figure 2.1. Under these 
conditions, Gpx3C64SHis is mostly in its monomeric state, with a small fraction being dimeric.  
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Figure 7.4. Purification of Gpx3C82AHis – ÄKTA peaks. Purified recombinant 
Gpx3C82AHis, a resolving cysteine mutant, was analysed on an ÄKTA Pure FPLC system using 
Superdex 200 10/30 GL column in its native state. The most abundant peak (peak 1) eluted at a 
retention volume of 15.4 ml with an estimated molecular weight of 40 kDa. A second peak eluted 
at a retention volume of 16.9 ml with an estimated molecular weight of 20 kDa. A third peak 
eluted at a retention volume of 17.9 ml with an estimated molecular weight of 13 kDa. These 
estimations are calculated based on the standard curve shown in Section 2.2.1.7, Figure 2.1. 
Under these conditions, Gpx3C82AHis is mostly in its dimeric state, with a small fraction 
remaining as monomeric. The third peak is likely to be a degradation product which indicates that 
Gpx3C82AHis is more prone to degradation than the other Gpx3His recombinant proteins. 
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7.2. Appendix 2 – Ypl107w and hOXLD-1 bioinformatics 
  
Table 7.1. Genes with similar expression patterns to YPL107W.  
  
Gene Protein Localisation Description 
SPS22 Cytosol, plasma membrane Ascospore spore wall assembly and cell wall organisation 
PET20 Mitochondrion Stability of mitochondrial genome 
PEP12 Endosome, golgi apparatus, 
vacuole membrane 
SNAP receptor activity, golgi to vacuole transport, macroautophagy, protein localisation, vacuole 
inheritance 
DGA1 Lipid droplet, ER Diacylglycerol acyltransferase 
JID1 Mitochondrion Unknown function but suspected Hsp40 co-chaperone involved in ER-associated degradation of 
misfolded proteins 
CUB1 Cytoplasm, nucleus Unknown function 
AIM41 Mitochondrion Unknown function but possible mitochondrial genome maintenance 
ISU1 Mitochondrial matrix Iron sulphur cluster scaffold protein 
FYV6 Nucleus Unknown function 
CWC15 Nucleus mRNA splicing 
YOR062C Cytoplasm, nucleus Unknown function 
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HRT3 SCF-ubiquitin ligase 
complex 
SCF-ubiquitin ligase F-box protein 
NSG2 ER Regulation of sterol biosynthesis 
CMG1 Cytoplasm, nucleus Unknown function 
ATG19 Cytosol Cytoplasm-vacuole targeting receptor 
PEX15 Peroxisomal membrane Peroxisome biogenesis 
YNL115C Mitochondrion, vacuole Unknown function 
GLC8 Cytoplasm, nucleus Glycogen metabolism and chromosome segregation 
GTF1 Mitochondrion Glutaminyl-tRNA synthase activity 
 
  
Genes with similar expression profiles to YPL107W were generated using SPELL, Serial Pattern of Expression Levels Locator (Hibbs et al., 2007). A list of the top 19 
genes similar to YPL107W going from the most to least similar in descending order. ER – endoplasmic reticulum. 
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Table 7.2. GO Term Finder search of 38 mitochondrial hOXLD-1 interactors.  
Gene Ontology Term Finder 
GO term 
Cluster 
frequency 
Background 
frequency 
P-value Genes annotated to term 
Mitochondrial gene expression 10/38, 26% 0.8% 1.29E-10 TSFM, MTG2, TRMT61B, POLRMT, PUS1, AARS2, UQCC2, UQCC1, MRPP3, MTIF2 
Mitochondrion organisation 12/38, 32% 2.6% 4.47E-8 ALAS1, GRPEL2, POLRMT, SIRT3, NDUFAF5, AARS2, UQCC1, UQCC2, NDUFAF7, MGME1, POLG 
Small molecule metabolic process 19/38, 50% 10.2% 2.32E-7 CARS2, ACADVL, GLS, ACOT9, HSD17B8, AARS2, UQCC2, CPT2, MUT, NARS2, AK4, ACSF3, GLDC,  ALDH5A1, MMAB, DBT, HIBCH, PDSS2, AUH 
Cellular amino acid metabolic 
process 9/38, 24% 1.7% 3.46E-6 CARS2, GLS, GLDC, AARS2, ALDH5A1, HIBCH, NARS2, AUH, MUT 
Mitochondrial RNA metabolic 
process 5/38, 13% 0.2% 4.20E-6 TRMT61B, POLRMT, PUS1, MRPP3, AARS2 
Carboxylic acid metabolic process 13/38, 34% 5.0% 6.51E-6 CARS2, ACSF3, ACADVL, GLS, HSD17B8, GLDC, AARS2, ALDH5A1, CPT2, HIBCH, NARS2, AUH, MUT 
Organic acid catabolic process 8/38, 21% 1.4% 1.35E-5 ACSF3, ACADVL, GLS, GLDC, ALDH5A1, CPT2, HIBCH, AUH 
Carboxylic acid catabolic process 8/38, 21% 1.4% 1.35E-5 ACSF3, ACADVL, GLS, GLDC, ALDH5A1, CPT2, HIBCH, AUH 
Oxoacid metabolic process 13/38, 34% 5.5% 1.80E-5 CARS2, ACSF3, ACADVL, GLS, HSD17B8, GLDC, AARS2, ALDH5A1, CPT2, HIBCH, NARS2, AUH, MUT 
tRNA metabolic process 7/38, 18% 1.0% 2.25E-5 CARS2, TRMT61B, NARS2, TRMT2B, PUS1, MRPP3, AARS2 
Organic acid metabolic process 13/38, 34% 5.6% 2.38E-5 CARS2, ACSF3, ACADVL, GLS, HSD17B8, GLDC, AARS2, ALDH5A1, CPT2, HIBCH, NARS2, AUH 
Organic substance metabolic 
process 36/38, 95% 56.2% 4.61E-5 
TSFM, MTG2, CARS2, ACADVL, GLS, TRMT61B, HSD17B8, SIRT3, AARS2, UQCC2, CPT2, AK4, POLG, 
ALAS1, IBA57, NDUFAF5, NDUFAF7, DBT, HIBCH, AUH, ACOT9, PUS1, UQCC1, NARS2, TRMT2B,  
MGME1, ACSF3, GLDC, POLRMT, ALDH5A1, MMAB, PDSS2, MRPP3, MTIF2, MUT 
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Regulation of mitochondrial 
translation 4/38, 11% 0.1% 4.76E-5 UQCC2, UQCC1, TSFM, MTG2 
Mitochondrial translation 6/38, 16% 0.7% 7.70E-5 UQCC2, UQCC1, TSFM, MTG2, AARS2, MTIF2 
Cellular amide metabolic process 12/38, 32% 5.4% 0.00012 TSFM, MTG2, CARS2, ACSF3, ACOT9, AARS2, ALDH5A1, UQCC2, UQCC1, DBT, NARS2, MTIF2 
Cellular metabolic process 35/38, 92% 54.3% 0.00014 
TSFM, MTG2, CARS2, ACADVL, GLS, TRMT61B, HSD17B8, SIRT3, AARS2, UQCC2, CPT2, AK4, POLG, 
ALAS1, IBA57, NDUFAF5, NDUFAF7, DBT, HIBCH, AUH, ACOT9, PUS1, UQCC1, NARS2, TRMT2B,  
MGME1, ACSF3, GLDC, POLRMT, ALDH5A1, MMAB, PDSS2, MRPP3, MTIF2, MUT 
Metabolic process 36/38, 95% 58.8% 0.0002 
TSFM, MTG2, CARS2, ACADVL, GLS, TRMT61B, HSD17B8, SIRT3, AARS2, UQCC2, CPT2, AK4, POLG, 
ALAS1, IBA57, NDUFAF5, NDUFAF7, DBT, HIBCH, AUH, ACOT9, PUS1, UQCC1, NARS2, TRMT2B,  
MGME1, ACSF3, GLDC, POLRMT, ALDH5A1, MMAB, PDSS2, MRPP3, MTIF2, MUT, C7ORF55 
Cofactor metabolic process 9/38, 24% 2.8% 0.00023 DBT, ALAS1, ACSF3, IBA57, ACOT9, PDSS2, MMAB, ALDH5A1, MUT 
Mitochondrial tRNA processing 3/38, 8% 0.1% 0.00035 TRMT61B, PUS1, MRPP3 
Mitochondrial respiratory chain 
complex assembly 5/38, 13% 0.5% 0.00036 UQCC2, UQCC1, NDUFAF7, NDUFAF5, AARS2 
Small molecule catabolic process 8/38, 21% 2.2% 0.00048 ACSF3, ACADVL, GLS, GLDC, ALDH5A1, CPT2, HIBCH, AUH 
Mitochondrial RNA processing 3/38, 8% 0.1% 0.00097 TRMT61B, PUS1, MRPP3 
tRNA processing 5/38, 13% 0.6% 0.00113 TRMT61B, TRMT2B, PUS1, MRPP3, AARS2 
Cellular amino acid catabolic 
process 5/38, 13% 0.6% 0.00113 HIBCH, GLS, GLDC, AUH, ALDH5A1 
Primary metabolic process 34/38, 90% 54.4% 0.00118 
TSFM, MTG2, CARS2, ACADVL, GLS, TRMT61B, HSD17B8, SIRT3, AARS2, UQCC2, CPT2, AK4, POLG, 
ALAS1, NDUFAF5, NDUFAF7, DBT, HIBCH, AUH, ACOT9, PUS1, UQCC1, NARS2, TRMT2B, MGM1, 
ACSF3, GLDC, POLRMT, ALDH5A1, PDSS2, MRPP3, MTIF2, MUT, C7ORF55 
Alpha-amino metabolic process 6/38, 16% 1.1% 0.00139 HIBCH, GLS, GLDC, MUT, AUH, ALDH5A1 
Tetrapyrrole metabolic process 4/38, 11% 0.3% 0.00142 ALAS1, IBA57, MUT, MMAB 
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All mitochondrial-associated hOXLD-1 physical interactors were entered into a Gene Ontology Term Finder tool (available at www.go.princeton.edu). P-value cut-off 
at 0.01. 
 
Monocarboxylic acid catabolic 
process 5/38%, 13% 0.7% 0.00149 CPT2, ACADVL, HIBCH, AUH, ALDH5A1 
Fatty acid metabolic process 7/38, 18% 1.8% 0.00167 CPT2, ACSF3, ACADVL, HIBCH, HSD17B8, AUH, ALDH5A1 
Fatty acid beta-oxidation 4/38, 11% 0.4% 0.00343 CPT2, ACADVL, HIBCH, AUH 
Amide biosynthetic process 9/38, 24% 4.0% 0.00486 TSFM, MTG2, CARS2, ACSF3, AARS2, UQCC2, UQCC1, NARS2, MTIF2 
Peptide metabolic process 9/38, 24% 4.1% 0.00527 TSFM, MTG2, CARS2, AARS2, ALDH5A1, UQCC2, UQCC1, NARS2, MTIF2 
Tetrapyrrole biosynthetic process 3/38, 8% 0.1% 0.00549 ALAS1, IBA57, MMAB 
Organonitrogen compound 
biosynthetic 13/38, 34% 9.2% 0.00646 TSFM, MTG2, ALAS1, CARS2, ACSF3, IBA57, GLS, AARS2, MMAB, UQCC2, UQCC1, NARS2, MTIF2 
Translation 8/38, 21% 3.2% 0.00742 TSFM, MTG2, CARS2, AARS2, UQCC1, UQCC2, NARS2, MTIF2 
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7.3. Appendix 3 – ypl107wΔ mitochondria 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5. Steady-state protein levels in wild-type BY4741 vs ypl107wD 
mitochondria. BY4741 and ypl107wD yeast cells were grown in liquid YPLac media and their 
mitochondria were isolated by cell fractionation (crude) followed by density gradient 
centrifugation to yield highly purified mitochondria (pure) - refer to Materials and Methods, 
Section 2.2.2.1 for detailed protocol. Samples were separated by SDS-PAGE and analysed by 
western blotting to detect various mitochondrial proteins; each lane represents 50µg protein. 
Antibodies against OM proteins include: anti-Por1 and anti-Tom40. IMS proteins include: anti-
Mia40, anti-Gpx3, anti-Trx1, anti-Erv1 and anti-Cytc. Anti-Tim11 was used as an IM protein marker 
and anti-Hsp70 as a matrix protein marker. 
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7.4. Appendix 4 – Supplementary materials and methods 
  
7.4.1. Primers 
  
Table 7.3. List of primers.  
Primers 
Primers for cloning  Primer sequence 5’ -3’ Description/use 
His-tag REV EcoRI  CCGGAATTCTCAGTGGTGGTGGTGGTG 
Reverse primer designed to amplify genes from pET24 and sublcone into pSP64 or other 
plasmids, incorporating the His-tag.  
Frw_+18Gpx3 NdeI CGCCATATGCTTTCCACGTCTCTCTCTTC Forward primer to subclone +18Gpx3 from pSP64 into pET24 
Rev_+18Gpx3 XhoI CCGCTCGAGTTCCACCTCTTTCAAAAG Reverse primer to subclone +18Gpx3 from pSP64 into pET24 
Frw_Atp23 XbaI CGCTCTAGAATGACGATGCGAACAAATAA Forward Atp23 primer for cloning in pSP64 
Rev_Atp23 XmaI CCCCCCGGGTCATCTGTAAATCTCATCAA Reverse Atp23 primer for cloning in pSP64 
Frw_Atp23 NdeI CGCCATATGACGATGCGAACAAATAAGAA Forward Atp23 primer for cloning in pET24 
Rev_Atp23 NotI ATTTGCGGCCGCTCTGTAAATCTCATCAA Reverse Atp23 primer for cloning in pET24 
Frw_Cyc1 NdeI CGCCATATGACTGAATTCAAGGCCGGTTC Forward Cyc1 primer for cloning in pET24 
Rev_Cyc1 XhoI CCGCTCGAGCTCACAGGCTTTTTTCAAGT Reverse Cyc1 primer for cloning in pET24 
Frw_Cyc1 XbaI CGCTCTAGAATGACTGAATTCAAGGCCGG Forward Cyc1 primer for cloning in pSP64 
Rev_Cyc1 XmaI CCCCCCGGGTTACTCACAGGCTTTTTTCA Reverse Cyc1 primer for cloning in pSP64 
Frw_Pex11 BamHI/NdeI CGCGGATCCCATATGGTCTGTGATACACT Forward primer to clone Pex11 in pET24 and pSP64 
Rev_Pex11 EcoRI CCGGAATTCCTATGTAGCTTTCCACATGT Reverse primer to clone Pex11 in pSP64 
Rev_Pex11 XhoI (no stop, pET24) CCGCTCGAGTGTAGCTTTCCACATGTCTT Reverse primer to clone Pex11 in pET24 
Frw_N17Pex11 BamHI/NdeI CGCGGATCCCATATGTTGTCTCCATCTACTAC Forward primer to clone N17Pex11 in pET24 and pSP64 
Frw_YBR124W XbaI CGCTCTAGAATGCCCCCACACATTTTTAT Forward Ybr124w primer for cloning in pSP64 
Rev_YBR124W XmaI CCGCCCGGGTTAGTACAGAGAAGTCCTCT Reverse Ybr124w primer for cloning in pSP64 
Frw_YGL024W XbaI CCGCGCTCTAGAATGTTTGCCATTATCTGTAT Forward Ygl024w primer for cloning in pSP64 
Rev_YGL024W XmaI CCGCCGCCCGGGTTAATATAATATGATATAAT Reverse Ygl024w primer for cloning in pSP64 
Rev_YBR124W 3Met CCGCCCGGGTTACATCATCATGTACAGAGAAGTCC For adding three methionines to the end of YBR124W for radiolabelled expression 
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All primers were designed in the lab and sent to Sigma Aldrich for synthesis; primers were kept as 100 µM stocks at -20°C. 
 
 
 
 
 
 
Frw_N18GPX3 HindIII GCCAAGCTTATGCTTTCCACGTCTCTC Forward primer for cloning N18Gpx3 in pSF-COOH-TEV-V5 
Frw_PEX11 HindIII GCCAAGCTTATGGTCTGTGATACACTG Forward primer for cloning Pex11 in pSF-COOH-TEV-V5 
Frw_N17Pex11 HindIII GCCAAGCTTTTGTCTCCATCTACTAC Forward primer for cloning N17Pex11 in pSF-COOH-TEV-V5 
Fwd_YPL107W PstI/NheI GGGCTGCAGGCTAGCATGATAAGAAATCAG Forward primer to clone Ypl107w in pET24 and pSP64 
Rev_YPL107W NotI (no stop) AGTGCGGCCGCAACCAAAGCTGTCCTC Reverse primer to clone Ypl107w in pET24 
Rev_YPL107W XmaI TCGCCCGGGTCAAACCAAAGCTGTCCT Reverse primer to clone Ypl107w in pSP64 
Primers for mutagenesis Primer sequence 5’ -3’ Description/use 
Frw_C36S_Gpx3 GTTAATGTTGCCTCCAAATCTGGATTCACTCCTCAATAC Forward primer for the mutagenesis of Cys36 to Ser in Gpx3/N18Gpx3 
Rev_C36S_Gpx3 GTATTGAGGAGTGAATCCAGATTTGGAGGCAACATTAAC Reverse primer for the mutagenesis of Cys36 to Ser in Gpx3/N18Gpx3 
Frw_Gpx3 C64S ATCATCGGGTTCCCATCCAACCAGTTTGGCCAC Forward primer for the mutagenesis of Cys64 to Ser in Gpx3/N18Gpx3 
Rev_Gpx3 C64S GTGGCCAAACTGGTTGGATGGGAACCCGATGAT Reverse primer for the mutagenesis of Cys64 to Ser in Gpx3/N18Gpx3 
Frw_+18Gpx3 M20L GTATTCAAGTTTATCCTGTCAGAATTCTATAAG Forward primer for the mutagenesis of Methionine to Leucine in N18Gpx3/pET24 plasmid 
Rev_+18Gpx3 M20L CTTATAGAATTCTGACAGGATAAACTTGAATAC Reverse primer for the mutagenesis of Methionine to Leucine in N18Gpx3/pET24 plasmid 
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7.4.2. Antibodies 
  
Table 7.4. List of antibodies. All antibodies used in this study. 
Antibodies 
Antibody Company Origin Conditions Source 
anti-Cpn10 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk  Tokatlidis lab 
anti-Cytc Davids Biotechnologie Rabbit polyclonal 
1:2000 in 5% 
milk 
Gifted by Prof. N. 
Pfanner 
anti-Erv1 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk (Lionaki et al., 2010) 
anti-Gpx3 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk 
(Kritsiligkou et al., 
2017) 
anti-His AbD Serotec (Bio-Rad) Mouse monoclonal 
1:2000 in 1% 
milk 
Obtained from Bio-
Rad 
anti-Mia40 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk (Sideris et al., 2009) 
anti-mtHsp70 Davids Biotechnologie Rabbit polyclonal 
1:2000 in 5% 
milk 
Gifted by Prof. N. 
Pfanner 
anti-Pex11 Santa Cruz Biotechnology Goat 1:500 in 1% milk Obtained from Santa Cruz Biotech 
anti-Porin1 Davids Biotechnologie Rabbit polyclonal 
1:2000 in 5% 
milk 
Gifted by Prof. N. 
Pfanner 
anti-TAP CusAb (Flarebio) Mouse 1:5000 in 1% milk 
Obtained from 
Flarebio 
anti-Tim10 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk Tokatlidis lab 
anti-Tim11 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk Tokatlidis lab 
anti-Tim23 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk 
Gifted by Prof. N. 
Pfanner 
anti-Tim44 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk 
Gifted by Prof. G. 
Schatz 
anti-Tim9 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk Tokatlidis lab 
anti-Tom22 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk 
Gifted by Prof. N. 
Pfanner  
anti-Tom5 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk 
Gifted by Prof. N. 
Pfanner  
anti-Tom70 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk Tokatlidis lab 
anti-Trr1 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 1% 
milk Tokatlidis lab 
anti-Trx1 Davids Biotechnologie Rabbit polyclonal 
1:1000 in 5% 
milk Tokatlidis lab 
anti-rabbit IgG 
HRP 
Sigma Aldrich or 
Elabscience Goat 
1:10000 in 1% 
milk 
Sigma Aldrich or 
Elabscience 
anti-mouse IgG 
HRP 
Elabscience or 
CALIBIOCHEM Goat 
1:10000 in 1% 
milk 
Elabscience or 
CALIBIOCHEM 
anti-goat IgG 
HRP Sigma Aldrich Rabbit 
1:10000 in 1% 
milk Sigma Aldrich 
anti-rabbit IRDye 
680RD LI-COR Goat 
1:10000 in dH2O LI-COR  
anti-mouse IRDye 
800CW LI-COR Goat 
1:10000 in dH2O LI-COR  
anti-mouse IgG 
DyLight 680 Invitrogen Goat 
1:500 in 
blocking buffer 
Obtained from 
Thermo Fisher 
anti-mouse IgG 
DyLight 488 Invitrogen Goat 
1:500 in  
blocking buffer 
Obtained from 
Thermo Fisher 
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 7.5. Appendix 5 – Characterisation of T. gondii Erv3 
 
7.5.1. Localisation of TgErv3  
  
To investigate the potential mitochondrial localisation of the TgErv homologs, TgERV gene 
sequences were cloned into a plasmid suitable for transfection and expression in T. gondii 
parasites (i.e. pTUB8/MYC-TgERV3). An N-terminal MYC gene sequence was also inserted 
to produce myc-tagged recombinant TgErv proteins. The S. cerevisiae ERV1 gene along 
with an N-terminal MYC was also cloned into the pTUB8 plasmid to determine whether 
ScErv1 can be imported into T. gondii mitochondria. These plasmids were created by a 
previous lab member, E. Kallergi. In this project, the plasmids were transfected into T. 
gondii parasites expressing an endogenously GFP-tagged mitochondrial protein (Mys) and 
visualised using fluorescent microscopy. The only TgErv homolog to successfully express 
was Myc-TgErv3 which co-localised with Mys, indicating its mitochondrial localisation 
(Figure 7.6A). Myc-ScErv1 expression was observed in some parasites, however its 
mitochondrial localisation was uncertain as it appeared to express throughout (Figure 
7.6B). It is possible that some Myc-ScErv1 was imported into mitochondria but that some 
remained in the cytosol. Unfortunately, the results were inconclusive from Myc-TgErv1 
and Myc-TgErv2 as the proteins could not be detected. Attempts to clone TgErv1 and 
TgErv2 into alternative plasmids suitable for parasite expression, and with C-terminal myc 
tags, are ongoing. 
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Figure 7.6. Fluorescent microscopy to detect localisation of TgErv3 and ScErv1 in T. 
gondii mitochondria. Plasmids containing the gene sequences for either TgErv3-myc or ScErv1-
myc were transfected into T. gondii parasites that express an endogenously GFP-tagged Mys 
protein (green) that localises to mitochondria. Parasites were grown within human fibroblast 
foreskin cells. Primary antibodies against myc (anti-myc) and a red fluorescently-labelled 
secondary antibody was used to visualise myc-tagged proteins. DAPI staining (blue) was used to 
visualise the nucleus. Fluorescent microscopy was performed with the help of Jana Ovciarikova 
(Sheiner lab) who then analysed and created these images. Refer to Section 2.2.4.2 for detailed 
methodology. Top panels – monochrome fluorescence images; bottom two left panels – multi-
channel fluorescence images; bottom right panel,  POL – polarised light only.  
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7.5.2. Purification of GST-TgErv3 and GST 
  
The purification of recombinant GST-TgErv3 was first attempted from insoluble inclusion 
bodies (IB) (Figure 7.7A) as the majority of GST-TgErv3 expressed in all strains of E. coli 
tested remained in the pellet fraction after cell disruption (data not shown). The yield of 
GST-TgErv3 obtained from inclusion bodies after purification with Glutathione Sepharose 
4B beads was very low – this was due to a large amount of protein being lost to 
aggregation. Attempts to optimise the purification protocol from inclusion bodies were 
not successful in either preventing or limiting aggregation, therefore we endeavoured to 
purify the very small amount of GST-TgErv3 that was found in the initial soluble fraction 
after protein expression and cell disruption (Figure 7.7B). It was hoped that by using the 
already soluble GST-TgErv3, the amount of protein lost to aggregation would be minimal. 
Unfortunately, the yield of GST-TgErv3 was still low; however, a higher molecular weight 
band appeared that corresponds to that of a potential GST-TgErv3 dimer. 
  
Intriguingly, the purification eluates from both the inclusion bodies and soluble fraction 
contained a large amount of protein running at molecular weights that do not correspond 
with GST-TgErv3, or TgErv3 or GST alone – especially in the latter soluble purification 
(Figures 7.7A & 7.7B, E1-3 lanes). One possibility is that they are degradation products 
due to an unstable GST-TgErv3 protein that has fragmented at multiple regions. Despite 
this, eluates from both purifications were analysed using an ÄKTA Pure FPLC system. GST 
alone was purified as a control to assess whether the fusion of GST to TgErv3 could be 
affecting the results as GST itself is known to be dimeric (Figure 7.8). As GST is a soluble 
protein, it was purified from the soluble fraction after cell disruption. The yield obtained 
was high and corresponded to the correct molecular weight of GST at ~26 kDa.  
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Figure 7.7. Purification of GST-TgErv3. GST-TgErv3 purifications from C+ (DE3) E. coli after 
induction with 0.4 mM IPTG (-/+) and 10 µM FAD for 4 hours at 37°C. Cells were fractionated 
using a French Press (P – pellet fraction containing insoluble proteins/inclusion bodies; S – 
supernatant fraction containing soluble proteins). Purification of GST-TgErv3 was attempted from 
both the pellet fraction containing GST-TgErv3 in inclusion bodies (A) and the soluble fraction (B) 
using Glutathione Sepharose 4B beads. Inclusion bodies were solubilised in urea to release GST-
TgErv3 (IB S) which was then renatured. Supernatants, IB S from (A) after renaturation and S from 
(B), were incubated with pre-equilibrated beads and the flow throughs (FTH) collected. Beads 
were then washed three times (W1, W2 and W3) followed by three elutions with reduced 
glutathione (E1, E2 and E3). Image shown is a Coomassie stained SDS-PAGE gel loaded with b-me. 
BSA was loaded as a control for protein concentration (BSA/µg).  
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Figure 7.8. Purification of GST. GST purification from DE3 E. coli after induction with 0.4 mM 
IPTG (-/+) for 4 hours at 37°C. Cells were fractionated using a French Press (P – pellet fraction 
containing insoluble proteins/inclusion bodies; S – supernatant fraction containing soluble 
proteins). GST from the supernatant (S) was purified using Glutathione Sepharose 4B beads. 
Soluble material was incubated with pre-equilibrated beads and the flow through (FTH) collected. 
Beads were then washed three times (W1, W2 and W3) followed by three elutions with reduced 
glutathione (E1, E2 and E3). Image shown is a Coomassie stained SDS-PAGE gel loaded with b-me. 
BSA was loaded as a control for protein concentration (BSA/µg). 
  
An ÄKTA Pure FPLC system was used to check the purity of the GST-TgErv3 recombinant 
proteins obtained from both purifications and to estimate their molecular weights; 
however, the results were puzzling (Figures 7.9 & 7.10). When the GST-TgErv3 eluate 
from the IB purification shown in Figure 7.7A was run through the system using a GFC 200 
column, four distinct peaks appeared with estimated molecular weights of ³2000 kDa 
(peak 1), 179 kDa (peak 2), 50 kDa (peak 3), and <6.5 kDa (peak 4) (Figure 7.9, top panel). 
Pre-treatment of GST-TgErv3 with 10 mM DTT prior to its run through the column did not 
seem to affect the size of these peaks, although it did produce an extra two peaks both 
estimated at <6.5 kDa (Figure 7.9, bottom panel). Samples from all of these peaks were 
analysed by SDS-PAGE (Figure 7.10).  Despite the ÄKTA estimating a molecular weight of 
³2000 kDa for peak 1, the corresponding SDS-PAGE peak ran at ~50 kDa which equals 
that of one GST-TgErv3 monomer. It is possible that the denaturing SDS-PAGE conditions 
were enough to break a much larger oligomeric species but this is yet to be determined. 
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Figure 7.9. Purification of GST-TgErv3 from inclusion bodies – ÄKTA peaks. Purified 
recombinant GST-TgErv3 from inclusion bodies (IBs) was analysed on an ÄKTA Pure FPLC system 
using a GFC 200 column in both its native (top panel) vs reduced state (bottom panel).  In the 
latter, GST-TgErv3 was pre-treated with 10 mM DTT for 30 minutes on ice to reduce disulphide 
bonds. X axis – retention volume; y axis – absorbance (mAU); purple – collection fractions; orange 
– UV chromatogram. Peak molecular weight estimations are calculated based on the standard 
curve shown in Section 2.2.1.7, Figure 2.1. Peaks represent fractions to be analysed by SDS-PAGE.   
GST-TgErv3 from IBs (no DTT) 
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Figure 7.10. Purification of GST-TgErv3 from inclusion bodies – Fractions from 
ÄKTA peaks. Purified recombinant GST-TgErv3 from inclusion bodies (IBs) was analysed on an 
ÄKTA Pure FPLC system using a GFC 200 column, without pre-treatment with DTT (A) vs with pre-
treatment with 10 mM DTT (B).  Fractions containing peaks (as seen in Figure 7.9) were collected 
and loaded onto SDS-PAGE gels without b-me. Fractions were also loaded onto SDS-PAGE gels 
with the addition of b-me but the data is not shown as the results were the same. 
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ÄKTA analysis of GST-TgErv3 purified from the soluble fraction using the same GFC 200 
column showed different results to that from the IBs. Three peaks were detected when 
soluble GST-TgErv3 was run through the column natively (without DTT pre-treatment) 
with estimated molecular weights of ³2000 kDa (peak 1), 60 kDa (peak 2), and <6.5 kDa 
(peak 3) (Figure 7.11, top panel). Pre-treatment of soluble GST-TgErv3 with 10 mM DTT 
again produced an extra two peaks with estimated molecular weights of <6.5 kDa (Figure 
7.11, bottom panel). However, the major species detected in Figure 7.11 is peak 2 which 
corresponds to roughly the expected molecular weight of one GST-TgErv3 monomer; 
whereas the most abundant species in Figure 7.10 is estimated at a staggering ³2000 kDa. 
The logical explanation for the differences in the two purifications (IB vs soluble fraction) 
is that the former produced a very large oligomeric species which is likely attributed to 
incorrect refolding/aggregation of the protein during renaturation; the exact molecular 
weight of which could not be accurately determined using the GFC 200 column due to its 
molecular weight cut off point at 2000 kDa. Whereas the latter purification produced a 
species which is most likely to be correctly folded.  
  
Samples from all peaks seen in Figure 7.11 were analysed by SDS-PAGE but only those 
from the top panel whereby GST-TgErv3 was loaded to the column in its native state are 
shown (Figure 7.12). When the samples were loaded without the addition of b-me in the 
sample buffer, multiple bands were detected from peaks 2 and 3 that ran between 48-
190 kDa and 25-35 kDa (Figure 7.12A). When samples were loaded with b-me, multiple 
bands were detected but only between 25-35 kDa (Figure 7.12B). Explanations for these 
findings may be that the GST-TgErv3 protein can form dimeric/higher oligomeric species 
but is also highly sensitive to degradation. GST alone was analysed by the ÄKTA using the 
same parameters (Figure 7.13) but it eluted as expected with an estimated molecular 
weight of ~52 kDa, indicating a GST dimer. Thus, it was unlikely that the fusion of GST to 
TgErv3 was affecting our analysis of GST-TgErv3. Even so, we attempted to cleave GST 
from the fusion protein using Thrombin, but the results were inconclusive as TgErv3 
appears to be a very unstable protein upon purification (data not shown). Different 
purification protocols are warranted, i.e. using different tags, optimising the renaturation 
steps, use of different elution/storage buffers etc. to try to improve the yield and stability 
of soluble GST-TgErv3 so that it can be properly structurally analysed.  
224 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 7.11. Purification of GST-TgErv3 from the soluble fraction – ÄKTA peaks. 
Purified recombinant GST-TgErv3 was analysed on an ÄKTA Pure FPLC system using a GFC 200 
column in both its native (top panel) vs reduced state (bottom panel).  In the latter, GST-TgErv3 
was pre-treated with 10 mM DTT for 30 minutes on ice to reduce disulphide bonds. X axis – 
retention volume; y axis – absorbance (mAU); purple – collection fractions; orange – UV 
chromatogram.  Peak molecular weight estimations are calculated based on the standard curve 
shown in Section 2.2.1.7, Figure 2.1. Peaks represent fractions to be analysed by SDS-PAGE. 
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Figure 7.12. Purification of GST-TgErv3 from the soluble fraction – Fractions from 
ÄKTA peaks (-DTT). Purified recombinant GST-TgErv3 from the soluble fraction was analysed 
on an ÄKTA Pure FPLC system using a GFC 200 column. Fractions containing peaks (as seen in 
Figure 7.11, top panel) were collected and loaded onto SDS-PAGE gels either without b-me (A) or 
with b-me (B). The red box highlights where a faint band corresponding to the molecular weight 
of GST-TgErv3 can be seen in peak 1. 
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Figure 7.13. GST alone – ÄKTA peaks. Purified recombinant GST was analysed on an ÄKTA 
Pure FPLC system using a GFC 200 column in its native state. X axis – retention volume; y axis – 
absorbance (mAU); purple – collection fractions; orange – UV chromatogram. GST native eluted at 
a retention volume of ~15 ml with an estimated molecular weight of 52 kDa, equalling that of the 
expected GST in its dimeric state. This estimation was calculated based on the standard curve 
shown in Section 2.2.1.7, Figure 2.1. 
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